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ABSTRACT 
 
 
 
 
TRPA1 CHANNELS IN COCHLEAR SUPPORTING CELLS 
REGULATE HEARING SENSITIVITY AFTER NOISE EXPOSURE 
 
TRPA1 channels are sensors for noxious stimuli in a subset of nociceptive neurons. 
TRPA1 channels are also expressed in cells of the mammalian inner ear, but their 
function in this tissue remains unknown given that Trpa1–/– mice exhibit normal hearing, 
balance and sensory mechanotransduction. Here we show that non-sensory (supporting) 
cells of the hearing organ in the cochlea detect tissue damage via the activation of 
TRPA1 channels and subsequently modulate cochlear amplification through active cell-
shape changes.  
 
We found that cochlear supporting cells of wild type but not Trpa1–/– mice generate 
inward currents and robust long-lasting Ca2+ responses after stimulation with TRPA1 
agonists. These Ca2+ responses often propagated between different types of supporting 
cells and were accompanied by prominent tissue displacements. The most prominent 
shape changes were observed in pillar cells which here we show possess Ca2+-dependent 
contractile machinery. Increased oxidative stress following acoustic overstimulation leads 
to the generation of lipid peroxidation byproducts such as 4-hydroxynonenal (4-HNE) 
that could directly activate TRPA1. Therefore, we exposed mice to mild noise and found 
a longer-lasting inhibition of cochlear amplification in wild type than in Trpa1–/– mice.  
 
Our results suggest that TRPA1-dependent changes in pillar cell shape can alter the 
tissue geometry and affect cochlear amplification. We believe this novel mechanism of 
cochlear regulation may protect or fine-tune the organ of Corti after noise exposure or 
other cochlear injuries. 
 
 
 
 
 
 
 
 
 
 
KEYWORDS: Transient receptor potential A1 channel, cochlear supporting cells, 
reactive oxygen species, cochlear amplification, 4-hydroxynonenal 
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CHAPTER 1 
An introduction to cochlear cell morphology and function 
 
1.1 Overview of mammalian hearing 
Air pressure sound waves that reach the pinna of the outer ear (a cartilaginous 
structure that protrudes on the side of the head) are reflected into the ear canal and 
toward the tympanic membrane (colloquially known as the ear drum) (Figure 1.1). When 
the tympanic membrane vibrates, it causes the movement of the chain of three small 
bones in the middle ear, known as ossicles. The ossicles are in charge of transmitting 
vibrations from the tympanic membrane to the oval window at the base of the cochlea in 
the inner ear. The oval window is significantly smaller than the tympanic membrane, 
resulting in a necessary large increase in force –given that the sound pressure waves now 
need to travel in a fluid-filled environment.  
Sound waves reach the coiled cochlea and cause the vibration of the sensory 
epithelium contained within. This sensory epithelium rests on the basilar membrane, a 
membrane that gradually decreases in stiffness, but increases in size, from the base to the 
apex of the cochlea [1, 2]. Sound-induced vibrations of the sensory epithelium initiate 
traveling waves that resonate at specific regions of the basilar membrane depending on 
their frequency, with high frequencies toward the base and low frequencies toward the 
apex of the cochlea. And, as explained in greater detail in section 1.4, there are cells 
within the cochlear sensory epithelium that can transduce such tonotopically-arranged 
vibrations into neurotransmitter release and excitation of cochlear nerve afferent neurons. 
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Figure 1.1†. Overview of the human ear 
Modified from reference [3]. A, Diagram showing the main structures of the 
external, middle and inner ear with sound vibrations traveling through the ear 
canal. B, Cross-section of the cochlea (from a perpendicular plane positioned at 
the red dashed line in A) through the cochlear modiolus.   
 
1.2 The cochlea 
The bony structure in the middle of the cochlea, known as the modiolus, has a conical 
shape and it is filled with cell bodies and axons from cochlear nerve neurons. In a 
cochlear cross section, the modiolus constitutes the medial part of the cochlea while the 
outer shell localized to both sides is referred to as the lateral wall (Figure 1.1). The 
outermost layer of the lateral wall is the otic capsule made up of bone. The basilar 
membrane spans from the modiolus to the lateral wall, and its sites of insertion at each 
end are known as the spiral limbus (medial) and spiral prominence (lateral) (Figure 1.2). 
The spiral prominence spans the inner side of the otic capsule on the lateral wall. Several 
types of sensory and supporting cells rest on the basilar membrane, and they will be 
discussed in detail in sections 1.4 and 1.6. 
A cross-section of the cochlea reveals the presence of three distinct compartments: 
scala vestibuli, scala media and scala tympani (Figure 1.2). 
 
† All drawings and data figures in this dissertation are my original artwork and 
experimental results, unless otherwise stated. 
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Figure 1.2. Diagram showing the three fluid compartments found in the 
mammalian cochlea  
A small region in a cochlear partition (indicated by the red box in the inset) is 
shown at greater magnification. The scalae vestibuli and tympani are rich in 
Na+ while the scala media is filled with an unusual extracellular fluid high in 
K+ and a high extracellular potential. Labels pointing to the positions of the 
lateral wall and modiolus are shown as reference.    
 
The scalae vestibuli and tympani contain perilymph, a Na+-rich solution similar to the 
cerebrospinal fluid. In contrast, the scala media contains a K+-rich solution that has an 
electric potential of about +80 to +120 mV (Figure 1.2) [1, 4]. The scalae media and 
vestibuli are separated by a thin epithelial layer known as the Reissner’s membrane. 
Similarly, the sensory and supporting cells located above the basilar membrane are 
connected with tight junctions at their apical side and form a barrier known as the 
reticular lamina, which keeps the endolymph in the scala media separate from the 
perilymph in the scala tympani. 
The stria vascularis, which rests on the spiral prominence and constitutes the inner 
layer of the lateral wall (Figure 1.2), is a highly vascularized tissue that contains three 
4 
 
layers of specialized epithelial cells in charge of pumping K+ ions into the endolymph to 
establish the positive extracellular potential. 
 
1.3 The cochlear sensory epithelium 
Several types of sensory and supporting cells compose the epithelium located over the 
basilar membrane (Figure 1.3). The sensory hair cells and the supporting cells in close 
proximity are known as the organ of Corti (Figure 1.2). A unique extracellular matrix 
structure, the tectorial membrane, extends from the medial region of the cochlea and 
covers the apical surface of the organ of Corti.  
When sound vibrations cause the basilar membrane to move up and down, a shear 
force is produced between the hair cells and the tectorial membrane (Figure 1.4). This 
leads to the deflection of the mechanosensitive apparatus located on the surface of the 
hair cells (see section 1.4.1 for more details) [5, 6]. 
 
 
Figure 1.3. Diagram of the adult mammalian cochlear epithelium 
Redrawn from reference [3]. Colored labels indicate the different types of 
sensory and supporting cells (black), extracellular membranes (red) and fluid-
filled compartments (blue) present in the adult mammalian cochlear 
epithelium.   
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1.4 Cochlear sensory cells and mechano-electrical transduction 
There are two types of sensory cells in the mammalian cochlea: inner and outer hair 
cells. They receive the name of hair cells due to the modified microvilli projections 
present on their apical surface, which have been inaccurately named as stereocilia 
(Figure 1.5). Hair cells are arranged in one row of inner hair cells (IHC) medially and 
three to four rows of outer hair cells (OHC) laterally (Figures 1.3 and 1.5A).  
The stereocilia in the tallest row of OHC (but not IHC) are directly connected to the 
overlaying tectorial membrane and thus basilar membrane movements directly lead to 
OHC stereocilia bundle deflections (see inset in Figure 1.4B). In contrast, IHC stereocilia 
seem to get deflected by the fluid motion initiated with the basilar membrane vibrations.  
 
 
Figure 1.4. Diagram of hair cell stereocilia deflections induced by basilar 
membrane movements 
A, Diagram of the organ of Corti at a resting position (i.e. without sound-
induced basilar membrane vibrations). B, Sound stimulation leads to basilar 
membrane vibrations toward and away from the scala vestibuli, but only the 
phase of the upward movement is illustrated. The dashed line is placed as a 
reference of the basilar membrane position at rest. Insets illustrate the OHC 
bundle deflection that occurs during the basilar membrane movement. 
 
1.4.1 Mechano-electrical transduction 
Stereocilia bundles are highly organized actin-filled projections [7, 8]. IHC and OHC 
stereocilia are usually arranged in three rows, ordered by height in a staircase-like manner 
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(Figure 1.5B). Within a given bundle, stereocilia are connected by several types of links. 
In particular, links that connect the top of a stereocilium to the side of a taller 
stereocilium are known as tip links (Figure 1.5B inset). Tip links are formed by the 
interaction of a dimer (or perhaps a trimer) of cadherin-23 molecules on the top, and a 
dimer of protocadherin-15 molecules on the bottom (reviewed in [9]). 
 
 
Figure 1.5. View of the apical surface of the organ of Corti 
A, Scanning electron micrograph (SEM) showing the apical surface of a wild 
type organ of Corti dissected at postnatal day 4. The stereocilia bundles of the 
three rows of OHCs (top) and one row of IHCs (bottom) are visible. B, Higher 
magnification SEM picture of an IHC stereocilia bundle from the explant shown 
in A. Notice the staircase arrangement of the stereocilia rows and the presence of 
tip links (inset) and side links. 
 
Stereocilia are rigid structures due to a core made up of actin filaments arranged in a 
paracristaline fashion [10]. Thus, bundle deflections do not bend stereocilia, but instead, 
cause them to pivot at their base (taper region) (Figure 1.6) [11]. This leads to a force 
build up at the tip link region and mechano-electrical transduction (MET) channel gating. 
MET channels are located on the top of shorter stereocilia [12], but their molecular 
identity is still under debate. Tip links are most likely unstretchable structures [13, 14], 
and it is unknown whether they pull directly on the MET channels or on the membrane 
nearby to induce their gating. Due to the negative intracellular potential of hair cells 
(about -50mV) and the large positive extracellular potential in the endolymph, opening of 
the non-selective cation MET channels produces a large K+ and Ca2+ inward current that 
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leads to hair cell depolarization (Figure 1.6). Dedicated K+ channels (KCNQ4 type) on 
the basolateral membrane mediate the efflux of the large amount of K+ ions that entered 
through the MET channels [15, 16]. Next, these K+ ions are presumably reabsorbed from 
the perilymph by neighboring supporting cells (see section 1.6).  
 
 
Figure 1.6. Diagram of stereocilia deflection and MET gating 
A, Staircase arrangement of hair cell stereocilia at a resting position, where 
most MET channels are closed. B, Stereocilia bundle deflection leads to 
tension buildup at the tip links and MET gating, allowing the influx of K+ and 
Ca2+ ions and subsequent hair cell depolarization. 
 
1.4.2 Outer hair cells and cochlear amplification  
Changes in the membrane potential of OHCs induce cell shape changes, termed 
electromotility, with depolarizations leading to cell contraction and repolarizations to cell 
elongation (Figures 1.7A and 1.7B) [17-19]. These changes in cell shape are driven by 
the protein prestin, which is expressed at a high density in the OHC plasma membrane 
[20, 21]. Prestin molecules exhibit a piezoelectric behavior, since they undergo 
conformational changes dependent on the membrane potential (reviewed in [22]). 
Because such piezoelectric action results in the movement of charges in the plasma 
membrane, changing the membrane potential of OHCs leads to apparent changes in 
membrane capacitance with a characteristic non-linear relationship (Figure 1.7C). 
Ultimately, the contractions and elongations of the OHCs, enhance the vibrations of the 
basilar membrane and thus OHCs act as active amplifiers within the cochlea. 
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1.4.3 Inner hair cells 
IHCs have specialized structures, known as synaptic ribbons, where large quantities of 
neurotransmitter-filled vesicles accumulate (Figure 1.8) (reviewed in [23]). Upon 
stereocilia bundle deflection, IHCs depolarize and voltage-gated Ca2+ channels are 
activated. The Ca2+ influx at the base of the IHCs triggers the release of vesicle contents 
at the synapses with afferent cochlear nerve endings, with the major neurotransmitter 
released most likely being glutamate (reviewed in [24]). IHCs are capable of releasing 
contents from large quantities of vesicles [25] and, in addition, they can sustain vesicle 
release at high frequencies and for long periods of time [26].    
 
 
Figure 1.7. Diagram of OHC electromotility 
A, Elongated OHC with the stereocilia bundle at a resting position. B, OHC 
contraction after the deflection of its hair bundle. C, Typical changes in OHC 
membrane capacitance (Cm) induced by changes in membrane potential (V). 
The red squares indicate actual data points obtained from a young postnatal 
OHC from a wild type mouse, while the black line corresponds to a double 
Boltzmann fit. The results shown in C were obtained by Dr. Ruben Stepanyan, 
a former member of the Frolenkov laboratory.  
 
1.5 Cochlear innervation 
In general, IHCs synapse with afferent neurons while OHCs receive efferent 
innervation (for a comprehensive review, see [24]). There are two types of spiral 
ganglion cells (SGC), the afferent fibers in the cochlear nerve. The majority of the SGCs 
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(90 – 95%) are type I large bipolar neurons that innervate IHCs (Figure 1.8A). Each type 
I SGC receives input from a single IHC, but each IHC synapses with nerve terminals 
from several type I SGC neurons. The rest of the SGCs (5 – 10%) are the type II 
pseudounipolar neurons. Each type II SGC neuron branches to innervate several OHCs 
(Figure 1.8B), sometimes from all three OHC rows [27]. The function of the type II SGC 
fibers has not been completely elucidated, but they are presumed to be activated in the 
presence of harmful noise exposure [28]. 
 
 
Figure 1.8. IHC and OHC innervation 
A, B, Diagrams illustrating the afferent (blue) and efferent (yellow) 
innervation in IHCs (A) and OHCs (B). SGC, spiral ganglion cell; LOC, lateral 
olivocochlear terminal; MOC, medial olivocochlear terminal. 
 
Two types of efferent fibers leave the brain stem and reach the cochlea: the lateral 
olivocochlear (LOC) and medial olivocochlear (MOC) fibers. LOC fibers innervate the 
ipsilateral cochlea while the majority of MOC fibers innervate the contralateral cochlea. 
LOC fibers form synapses with the terminals of the type I SGCs underneath the IHCs 
(Figure 1.8A) and, since they contain both excitatory (e.g., acetylcholine) and inhibitory 
(e.g., GABA) neurotransmitters, they presumably fine tune the sensitivity of the SGCs. 
Each MOC fiber directly innervates several OHCs (Figure 1.8B). The main 
neurotransmitter in MOC fibers is acetylcholine, which induces OHC hyperpolarization 
and changes in OHC electromotility. LOC and MOC fibers might provide a feedback 
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loop controlling hearing sensitivity and amplification to adapt to different sound levels or 
to protect during noise exposure. 
Branches from type II SGCs and efferent fibers can also form synapses with the 
supporting cells near the OHCs (see sections 1.6.4 and 1.6.5 for more details) [27, 29-31]. 
The efferent fibers that contact supporting cells are believed to be of MOC origin, but this 
has yet to be fully determined. Moreover, the functional role of the afferent and efferent 
innervation of supporting cells remains largely unknown. 
 
1.6 Cochlear supporting cells and fluid-filled compartments 
There are several distinct types of supporting cells in the cochlea. They have been 
named and/or classified based on their morphology and location in relation to the hair 
cells (Figure 1.3). For more comprehensive reviews see [24, 32]. 
Supporting cells make up the complex architecture of the organ of Corti and provide 
physical support for the hair cells. In addition, supporting cells play an important role 
maintaining the ionic homeostasis of cochlear fluids. All supporting cells are 
electrochemically connected via gap junctions, with permeability profiles that vary 
generally between different cell types [33], most likely due to differences in connexin 
composition of the gap junctions [34]. This gap junctional network allows for the fast 
spread of small molecules between most supporting cells but limits the propagation of 
larger molecules. Notably, supporting cells reabsorb the K+ ions that are released by hair 
cells into the perilymph after sound stimulation. Presumably, this gap junctional network 
allows the recycling of the K+ ions back into the stria vascularis (reviewed in [35, 36]).   
Supporting cells also play an important role after hair cell death due to acoustic 
overstimulation or ototoxic trauma. Supporting cells sense hair cell death via mechanisms 
that involve the release of ATP to the extracellular space. This generates robust Ca2+ 
waves that can travel throughout the cochlear epithelium [37, 38], but their biological 
significance still remains under study (see section 1.7 for more details). It is known, 
however, that some supporting cells can act as macrophages to engulf dying hair cells 
[39-42]. They can also help reseal the cochlear epithelium to maintain the barrier between 
different cochlear fluids intact [43-45]. 
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1.6.1 Inner sulcus cells and the Kolliker’s organ 
In the adult mammalian cochlea, the inner sulcus (located medially to the IHCs) is 
covered by small cuboidal cells. Early in development, however, the inner sulcus is filled 
with large columnar cells which are collectively known as the Kolliker’s organ and are in 
direct contact with the tectorial membrane (Figure 1.9) [46]. The cells of the Kolliker’s 
organ are known to spontaneously release ATP to the extracellular space, which is 
believed to play an important role in the fine tuning of tonotopicity in cochlear neural 
pathways (see section 1.7 for more details). The Kolliker’s organ gradually decreases in 
size over the first couple of weeks during postnatal development [46, 47]. While most 
cells of the Kolliker’s organ are presumed to undergo apoptosis, it is still unknown 
whether some of them can transdifferentiate into the inner sulcus cells of the adult 
cochlea.  
 
 
Figure 1.9. Diagram of the cochlear epithelium at an early postnatal age 
Cochlear supporting cells are still changing their morphology during early 
postnatal days. At this developmental stage, the organ of Corti is still 
collapsed, and no flui-filled spaces are evident yet. In addition, the inner 
sulcus is filled by the Kolliker’s organ.  
 
1.6.2 Inner border and inner phalangeal cells 
A thin row of inner border cells is located between the inner sulcus cells (or the cells 
of the Kolliker’s organ) and the IHCs. Inner border cells do not reach all the way to the 
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reticular lamina and therefore are not in direct contact with the endolymph. A thin row of 
inner phalangeal cells is present between the IHCs and the inner pillar cells. Inner 
phalangeal cells provide support for the IHCs and extend small projections to the 
reticular lamina between adjacent IHCs. Inner border and inner phalangeal cells form an 
envelope around the base of IHCs, where nerve synapses are formed, and they express 
high levels of channels and transporters required for the uptake of K+ ions and glutamate 
after IHC stimulation [48-51]. 
 
1.6.3 Pillar cells 
Two rows of pillar cells are located between the rows of IHCs and OHCs. In the adult 
mammalian cochlea, inner and outer pillar cells separate at the base to create a triangular 
perilymph-filled space known as the tunnel of Corti (compare diagrams of the adult vs. 
early development cochleae in Figures 1.3 and 1.9, respectively) [52]. Pillar cells have a 
particular morphology with three distinct regions in each cell (reviewed in [32]). The feet 
of the pillar cells rest directly on the basilar membrane and are filled with actin filaments. 
The middle regions, also known as pillar shafts, are densely packed with arrangements of 
microtubules and actin filaments [53]. The head plates of inner and outer pillar cells are 
tightly joined together by desmosomes and adherens junctions, with the heads of outer 
pillar cells partially localized underneath those of inner pillar cells. In addition, each 
outer pillar head plate surrounds one OHC. Interestingly, the microtubules in these cells 
have 15 protofilaments (instead of the typical 13 protofilaments found in microtubules 
from other cell types) [54]. Large amounts of intermediate filaments are found in the feet 
of outer pillar cells, and lower amounts at the feet of inner pillar cells and head plates of 
both [55]. 
 
1.6.4 Deiters’ cells 
Three rows of Deiters’ cells, also known as outer phalangeal cells, are located 
underneath of the OHCs and they extend small projections, termed phalangeal processes, 
from their cell body to the reticular lamina. The top region in each Deiters’ cell body is 
shaped like a cup and forms a place where the base of an OHC can rest. The phalangeal 
process of a given Deiters’ cell does not attach to the OHC directly above it, but to a 
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more apical (1 to 3 cells away) OHC instead. The cytoskeleton within the phalangeal 
processes of Deiters’ cells resembles that of the pillar cell shafts because it contains 
arrangements of microtubules and actin filaments, but it also contains large amounts of 
intermediate filaments. These phalangeal processes have been shown to exhibit 
mechanical changes in isolated Deiters’ cells upon stimulation with extracellular ATP 
[56] or through the uncaging of cytosolic Ca2+ [57]. Large amounts of intermediate 
filaments are also found at the top and bottom regions of the cell body [55]. 
OHC and Deiters’ cell bodies are surrounded by perilymph. In particular, the area 
between the outer pillar cells and the first row of OHCs and Deiters’ cells is known as the 
space of Nuel (Figure 1.3) [52]. Moreover, similarly to inner border and inner phalangeal 
cells, Deiters’ cells express K+ channels and transporters needed for the recycling of K+ 
ions upon OHC stimulation [48-50]. Some Deiters’ cells have also been reported to form 
synapses with thin branches from type II SGC fibers [27, 29, 30] and efferent fibers [31]. 
These synapses have been observed in the Deiters’ phallangeal processes as well as in the 
cell bodies; and they seem to only be present in one half of the cochlear epithelium 
(apical half in guinea pig and basal half in the cat) [27, 58, 59]. 
 
1.6.5 Hensen’s and Claudius’ cells 
Two to three rows of Hensen’s cells are located laterally to the OHCs. The perilymph-
filled space between the OHCs and the Hensen’s cells is known as the outer tunnel 
(Figure 1.3) [52]. Hensen’s cells are large columnar cells notorious for the presence of 
prominent lipid droplets in their cytoplasm [60]. These lipid droplets have been suggested 
to modify the mechanical properties of the organ of Corti by changing its geometry or 
increasing the load on the basilar membrane. In addition, Hensen’s cells may be able to 
modulate anti-inflammatory responses by releasing the contents of these lipid droplets 
into the endolymph [60] in response to certain stimuli (e.g., glucocorticoids) [61]. 
Similarly to Deiters’ cells, some Hensen’s cells are in contact with branches from type II 
SGC fibers. And, there seems to be a direct correlation in Hensen’s cells between the 
presence of lipid droplets and the incidence of innervation by type II SGC fibers [27, 30].  
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Much less is known about the Claudius’ cells, the cuboidal cells that cover the outer 
sulcus of the cochlea (i.e. the region from the Hensen’s cells to the spiral prominence) in 
a monolayer fashion.  
 
1.7 Purinergic signaling in cochlear supporting cells 
Several types of P1 and P2 receptors are expressed in sensory and supporting cells of 
the cochlear epithelium and in auditory nerve fibers; moreover, ATP has been shown to 
be released to the cochlear fluids during the normal development of the cochlea and also 
after noise exposure or tissue damage (reviewed in [62]). P1 receptors are coupled to G-
proteins, and are activated by the binding of adenosine. There are two types of P2 
receptors: metabotropic P2Y (G protein-coupled) and ionotropic P2X (ligand-gated ion 
channels). There are several subtypes of P2Y receptors. They are activated by ATP, UTP, 
ADP and/or UDP. Moreover, the potencies of each agonist vary between subtypes which 
allow, to some extent, to identify the expression of P2Y subtypes using pharmacological 
approaches. There are also several P2X isoforms that can form homomeric or 
heteromeric channels –with three subunits forming one functional channel. These P2X 
isoforms are mainly activated by ATP. For a comprehensive review of the pharmacology 
of P2Y and P2X receptors see references [63, 64]. 
 
1.7.1 Spontaneous release of ATP during postnatal development 
 In rodents, it was shown that the cells of the Kolliker’s organ spontaneously release 
ATP to the extracellular space, which induces Ca2+ responses that propagate between 
supporting cells [65]. These Ca2+ responses in the Kolliker’s organ were accompanied by 
changes in their cell shape, specifically, cell crenations that lead to an increase in the 
extracellular space between adjacent cells [65, 66]. These cell crenations were largely 
diminished by a Cl- channel inhibitor, suggesting that the extrusion of water might be the 
underlying cause of such cell contractions. In addition, the spontaneous release of ATP 
by the cells of the Kolliker’s organ can cause IHCs to depolarize and trigger action 
potentials in the type I SGC fibers [65, 67]. These spontaneous Ca2+ waves peak (in 
frequency and magnitude) around postnatal days 6 to 8 and they cease soon after the 
onset of hearing (around postnatal day 12 in mice and rats). Importantly, they were 
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shown to induce synchronous responses between neighboring IHCs (cell depolarization) 
and SGCs (excitatory postsynaptic currents and action potentials). And, this correlation 
between spontaneous Ca2+ waves and IHC/SGC responses was limited to areas encoding 
similar frequencies [65, 67]. Therefore, this spontaneous activation of neighboring IHCs 
and SGCs before the hearing onset is believed to provide important cues for the tonotopic 
maturation of auditory neural pathways.  
 
1.7.2 Pathophysiological release of ATP 
ATP is also released into the cochlear fluids after noise exposure [68] or hair cell 
damage [37, 38] and induces robust Ca2+ waves able to propagate throughout large areas 
of the cochlear epithelium [38]. The Ca2+ responses in the supporting cells are known to 
activate several members of the MAP kinase family [37, 69] that seem to favor cell 
survival. In addition, the release of ATP after noise exposure might be able to trigger 
action potentials in type II SGC fibers via the activation of P2X receptors [28]. Centrally, 
these afferent signals could potentially trigger the activation of efferent fibers to modify 
hearing sensitivity during noise exposure.  
Hair cell damage also induces a fast-propagating Ca2+ wave along the rows of the 
sensory hair cells. This wave seems to require the influx of Ca2+ from the extracellular 
space via P2X channels [38], however, its functional role is still under examination.  
 
1.7.3 Mechanism of propagation of ATP-induced Ca2+ waves in supporting cells   
The expression of P2Y receptors provides supporting cells with high sensitivity to the 
presence of extracellular ATP, and concentrations in the nanomolar range are able to 
trigger Ca2+ waves that propagate rapidly from cell to cell [37]. When ATP binds P2Y 
receptors in a supporting cell, it induces an IP3-dependent increase in intracellular Ca
2+. 
This response propagates to neighboring cells by (i) the diffusion of IP3 through gap 
junctions, and (ii) the further release of ATP through connexin hemichannels (Figure 
1.10) [34, 70]. However, it is currently unknown whether the ATP is released through the 
apical or basolateral membranes. Nonetheless, the self-propagating nature of these ATP-
induced Ca2+ waves allows them to travel both from supporting cells in the inner to the 
outer sulcus and vice versa [34]. 
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Figure 1.10. Mechanism of propagation of ATP-induced Ca2+ waves in 
supporting cells 
ATP that is released to the extracellular fluid after tissue damage, or through 
connexin hemichannels (i.e. one connexon formed by six connexin subunits), 
binds P2Y metabotropic receptors on the plasma membrane of supporting 
cells. IP3 is then generated via the activation of Phospholipase C (PLC) and 
leads to the release of Ca2+ from intracellular stores. IP3 also diffuses to 
neighboring cells through gap junctions and somehow induces the release of 
more ATP, which ultimately leads to the propagation of Ca2+ waves from cell 
to cell [34, 70]. 
 
1.8 Impact of noise exposure on hearing thresholds 
Acoustic overstimulation typically leads to an increase in hearing thresholds that can 
be temporary or permanent, depending on the magnitude and duration of the exposure. 
Clinically, a permanent threshold shift (PTS) is diagnosed when hearing thresholds have 
not recovered to baseline levels at least 2 weeks after the acoustic overstimulation (Figure 
1.11). PTS is associated with extensive damage to the stereocilia bundles and/or 
sensory/supporting cell death [71-73]. In addition, a decrease in the endocochlear 
potential, usually recoverable, can occur after the exposure to loud sounds that lead to 
PTS [72, 74, 75]. In contrast, temporary threshold shifts (TTS) can last from hours to 
several days, but the hearing thresholds eventually recover to baseline levels (Figure 
1.11). 
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Figure 1.11.Diagram of temporary vs. permanent shifts in hearing thresholds 
Acoustic overstimulation leads to an increase in hearing thresholds. This 
increase is considered to be a temporary threshold shift (TTS) if it recovers 
around two weeks after the cochlear overstimulation (blue trace). In contrast, 
if the hearing thresholds continue to be elevated and do not recover, this 
constitutes a permanent threshold shift (PTS) (black trace). The dashed line 
indicates the hearing threshold before noise exposure, and the red arrow 
indicates the time point when noise exposure occurred. dB SPL, decibel sound 
pressure level. 
 
Several histopathological findings that could explain the development of TTS have 
been identified. For instance, the continuous release of neurotransmitters after IHC 
overstimulation leads to the swelling of the type I SGC postsynaptic terminals and their 
retraction away from the IHC basolateral membrane, presumably due to glutamatergic 
excitotoxicity [76, 77]. In addition, a reduction in the number of presynaptic (IHC) 
ribbons was also observed soon after the exposure to low noise [77]. Temporary changes 
in the architecture of the organ of Corti, involving changes in supporting cell shape, have 
been observed after acoustic overstimulation (see section 1.9). Because changes in the 
shape of supporting cells can alter the overall tissue geometry (e.g., changing the angle 
between the tectorial membrane and the OHC stereocilia bundles at the resting position), 
it is no surprise that these changes can modify hearing sensitivity. Some changes in the 
cell density and the balance of inhibitory and excitatory circuits in central auditory 
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pathways have also been observed after noise exposure to a TTS-producing noise [78, 
79]. These modifications in central auditory pathways represent a secondary level of 
adaptation to the changes that occur in the periphery; however, they have the potential to 
alter sound perception after acoustic trauma. 
Even though hearing thresholds return to normal levels after a TTS, some of the 
pathophysiological findings described above do not recover completely [71, 77]. And, in 
fact, they might constitute a risk factor for the development of PTS after subsequent noise 
exposures and/or eventually underlie the progression toward age-related hearing loss 
[80]. However, the occurrence of TTS can also constitute a protective response to 
minimize tissue damage during longer periods or stronger levels of acoustic 
ovestimulation. For instance, mice lacking P2X2 channels are more susceptible to 
develop PTS after exposure to loud noise [81]. Interestingly, when exposed to low noise, 
these mice do not exhibit changes in hearing thresholds; not even to noise levels that 
induce TTS in wild type mice. Although the exact role of P2X2 in TTS has not been 
elucidated yet, it does imply the involvement of extracellular ATP. The TTS protective 
effects have also been abundantly shown during sound conditioning experiments 
(reviewed in [82]), where animals become resistant to noise that initially induced TTS. 
The sound conditioning is achieved through long-term exposure to low sound levels, in 
either a continuous or intermittent manner, and has been shown to prevent PTS after the 
exposure to a loud and typically damaging noise. Even though the exact mechanisms are 
largely unknown, there is evidence that these sound conditioning protocols might provide 
protection by increasing the expression of antioxidants, heat-shock proteins, Ca2+ buffers 
and neurotrophic factors [82]. 
 
1.9 Impact of noise exposure on the geometry of the organ of Corti 
Several reports have shown a ‘contraction’ of the organ of Corti (i.e. a reduction in the 
height of the tissue) after noise exposure in vivo (awake or anesthetized animals) [71, 73, 
74, 83] or in vitro (temporal bone preparations) [84-86]. These changes in the tissue 
architecture often involved (i) Hensen’s and Deiters’ cells getting closer to the basilar 
membrane and the tunnel of Corti, (ii) a reduction in the space of Nuel and (iii) the 
buckling of inner and/or outer pillar cells.  
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Sound stimulation leads to the vibration of the basilar membrane and the elongation 
and contraction of OHCs (section 1.4). Therefore, loud and/or prolonged noise exposure 
can potentially involve damaging tissue vibrations and changes in the architecture of the 
cochlear epithelium simply as a result of mechanical damage. However, it is plausible 
that the modified tissue architecture observed after acoustic overstimulation is the result 
of active changes in the shape of the supporting cells surrounding the sensory hair cells. 
To date, Deiters’ cells are the only type of cochlear supporting cells reported to have 
Ca2+-dependent contractile machinery (section 1.6.4). The cytoskeleton of pillar cells (in 
particular of outer pillar cells) resembles that of Deiters’ cells and, therefore, they may 
potentially contract upon an increase of cytosolic Ca2+.  
Sound induced depolarizations of the hair cells create currents that are large enough to 
be measured by an electrode placed near the round window of the cochlea. This 
technique known as cochlear microphonics can be used to assess cochlear sensitivity 
(reviewed in [87]). Interestingly, the supporting cell-driven changes in the organ of Corti 
geometry after acoustic overstimulation seem to be reversible and often correlate with an 
improvement in cochlear microphonics or with TTS [71, 73, 83, 85]. 
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CHAPTER 2 
A comprehensive review of literature on TRPA1 channels 
 
2.1 The TRP channel family 
Based on their homology to the transient receptor potential (TRP) channels in 
Drosophila, several genes have been grouped into the big TRP family of ion channels 
[88]. TRP channels have been divided into seven groups according to their amino acid 
sequence homology: ankyrin (TRPA), canonical (TRPC), melastatin (TRPM), mucolipin 
(TRPML), NompC-like (TRPN), polycystin (TRPP) and vanilloid (TRPV). The TRPN 
channel, however, has been found in the genomes of invertebrates (fly and worm [89]) 
and lower vertebrates (zebrafish [90] and frog [91]) but not in mammalian genomes [90].  
TRP proteins have six transmembrane segments (S1 through S6), intracellular amino 
(N) and carboxy (C) termini [92, 93], and four subunits assemble into homo- or 
heterotetramers to form functional ion channels (reviewed in [94]). The pore region in 
TRP channels seems to be comprised of the linker segment between the transmembrane 
segments S5 and S6. While all TRP channels are permeable to cations, different channels 
exhibit specific degrees of selectivity between mono- and divalent cations (reviewed in 
[95]). The intracellular termini of TRP channels vary greatly between subfamilies, but in 
general they allow the interaction of the channels with intracellular signaling molecules 
and pathways. For instance, three members of the TRPM subfamily have protein kinase 
activity in their C-termini [96] and TRP channels usually possess intracellular domains 
such as ankyrin repeat, pleckstrin homology (PH)-like or EF-hand-like domains 
(reviewed in [97]) that allow for protein-protein or protein-ligand interactions. TRP 
channels can be activated by a wide variety of mechanical, thermal and chemical stimuli 
(reviewed in [98]) and, together with their broad intracellular responses, constitute 
powerful modulators of cell physiology.  
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At present, 28 mammalian TRP channels have been identified and their role in human 
pathophysiology is rapidly growing after the generation of specific TRP knockout mice 
and the identification of disease-causing TRP mutations in humans (see Table 2.1 for 
details). A quantitative analysis of mRNA expression of all 28 channels performed in 
developing cochlear tissue (from embryonic to early postnatal stages) could not detect 
mRNA of TRPC7 or TRPM8 at all, or TRPV5 in half the samples tested. However, this 
study did revealed different degrees of expression for the remaining 25 TRP channels 
[99]. But, given the scope of this dissertation project, the main focus of this review will 
be on TRPA1 channels.  
 
2.2 TRPA1: from gene to protein 
TRPA1 is the only member of the mammalian TRPA subfamily. Given that the animal 
model used in this dissertation project was the mouse, this review will focus largely on 
mouse, rat (given its homology) and human (due to its translational relevance) TRPA1 
channels. 
 
2.2.1 The mouse Trpa1 gene 
The mouse Trpa1 gene is located in chromosome 1, it contains 27 exons and two 
TRPA1 splice variants have been identified [100]. While the full TRPA1 mRNA 
transcript encodes a protein of 1,125 amino acid residues (UCSC ID: uc007ajc.1), the 
splice variant encodes a protein 30 residues smaller that lacks exon 20 (UCSC ID: 
uc033fid.1). The missing 30 residues are part of the transmembrane segment S2 and part 
of the intracellular linker between S2 and S3.  
 
2.2.2 The rat TRPA1 gene 
The rat TRPA1 gene is in found in chromosome 5 and, like the mouse TRPA1 gene, it 
has 27 exons and encodes a 1,125 amino acid protein (UCSC ID: RGD_1303284). No 
TRPA1 mRNA splice variants have been reported in the rat [100]. Notably, the rat and 
mouse proteins share over 96% identity (see Appendix B for the protein sequence 
alignment).  
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Table 2.1. Mammalian TRP channels 
Sub- 
Family 
Members* Mouse knockout phenotypes 
Human 
pathophysiology† 
TRPA 
TRPA1 
(ANKTM1) 
Defective pain sensitivity to cold, 
mechanical stimuli, chemical 
irritants and bradykinin [101, 
102] 
Debilitating episodes of 
pain in the upper body  
[103] 
TRPC 
TRPC1 
Increased body size and impaired 
salivary gland fluid secretion  
[104, 105] 
 
TRPC2‡ 
Impaired pheromone-induced 
behaviors [106, 107] 
‡ 
TRPC3 Defective walking behavior [108]  
TRPC4 
Impaired regulation of blood 
vessel tone and permeability of 
lung microvessels [109] 
 
TRPC5 
Reduced anxiety-like behavior 
[110] 
 
TRPC6 
Increased blood vessel tone and 
contractility [111] 
Renal dysfunction  
[112, 113] 
TRPC7 
Resistance to pilocarpine-induced 
seizures [114] 
 
TRPM 
TRPM1 
Loss of light-induced inward 
currents in retinal ON bipolar 
cells [115-117] 
Reduced central vision, 
nystagmus and eczema 
[118-121] 
TRPM2 
Impaired chemokine production 
by monocites [122] 
Coding SNP associated 
with bipolar disorder 
[123] 
TRPM3 
Defective pain sensitivity to 
inflammation and heat [124] 
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Table 2.1. Mammalian TRP channels (continued) 
TRPM 
TRPM4 
Augmented degranulation and 
histame release in mast cells 
[125], impaired dendritic cell 
migration [126], and protection 
against spinal cord injury [127]. 
Conduction 
abnormalities in the 
heart [128-130] 
TRPM5 
Abolished sweet, umami and 
bitter taste reception [131], and 
defective insulin release [132, 
133] 
 
TRPM6 
Embryonic or early postnatal 
death with neural tube defects 
[134] 
Hypomagnesemia and 
hypocalcemia [135, 136] 
TRPM7 Embryonic lethal [137] 
Susceptibility for a 
neurodegenerative 
disorder [138] 
TRPM8 
Defective pain sensitivity to cold 
[139-141] 
 
TRPML 
TRPML1 
Neurodegeneration, elevated 
plasma gastrin and retinal 
degeneration [142] 
Neurodegeneration with 
ophthalmologic 
abnormalities [143, 144] 
TRPML2   
TRPML3   
TRPP 
TRPP1 
(PKD2) 
Embryonic lethal [145]  
Renal cysts leading to 
renal failure [146] 
TRPP2 
(PKD2L1) 
  
TRPP3 
(PKD2L2) 
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Table 2.1. Mammalian TRP channels (continued) 
TRPP 
TRPP3 
(PKD2L2) 
  
TRPV 
TRPV1  
Defective pain sensitivity to heat 
[147], and enhanced insulin 
sensitivity [148] 
 
TRPV2 Impaired innate immunity [149]  
TRPV3 
Impaired behavioral responses to 
heat [150], and abnormalities in 
fur and whiskers [151] 
Severe skin 
abnormalities [152] 
TRPV4 
Impaired antidiuretic hormone 
regulation [153, 154], defective 
pain sensitivity to mechanical 
stimuli [155], impaired bladder 
function [156, 157], and hearing 
loss [158].  
Skeletal dysplasia [159-
161]; osteoarthritis [162, 
163]; muscle paresis, 
paralysis, atrophy or 
congenital absence 
[164-167] and dwarfism 
[160, 168]. Coding SNP 
associated with 
hyponatremia [168] 
TRPV5 
Hypercalciuria, polyuria and 
reduced bone thickness  
[169, 170] 
 
TRPV6 
Possible role in intestinal Ca2+ 
absorption [171, 172] 
 
* Other common names for each member are listed within parenthesis. 
† Clinical features caused by mutations in human TRP genes. For details about 
the exact syndromes and inheritance patterns see Appendix A.  
‡ TRPC2 is a pseudogene in humans [173]. 
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2.2.3 The human TRPA1 gene 
In humans, the TRPA1 gene is located in chromosome 8, it contains 27 exons, it 
encodes a protein of 1,119 amino acid residues (UCSC ID: uc003xza.3) and no splice 
variants have been identified [100]. The human TRPA1 protein shares about 80% identity 
with both the mouse and rat TRPA1 proteins (see Appendix B for the protein sequence 
alignment), making mice and rats interest models for the study of TRPA1 function. 
 
2.2.4 Tissue expression of TRPA1  
TRPA1 mRNA has been detected in a wide variety of tissues and cell types. In 
addition, the generation of Trpa1 knockout (Trpa1–/–) mice has allowed to confirm 
TRPA1 expression at the protein level in some of these tissues. Immunolabeling of the 
TRPA1 protein has also been described in a wide variety of tissues, but only the reports 
showing strict controls for the antibodies used have been included in this review.  
In the mouse, TRPA1 mRNA is highly expressed in dorsal root (DRG), trigeminal and 
nodose ganglia [174-176] and in the cochlear epithelium [99, 177]. In addition, lower 
transcription levels have been detected in the tongue [178], stomach, small intestine and 
colon [179]. The presence of an active Trpa1 promoter and functional TRPA1 channels 
in DRG neurons (including C and Aδ fibers) innervating the skin has been confirmed 
using tissue from wild type and TRPA1-deficient mice [180]. Immunoreactivity against 
the TRPA1 protein in bronchial epithelium and smooth muscle has also been detected in 
tissue from wild type but not Trpa1–/– mice [181].  
In the rat, high expression of TRPA1 mRNA is detected in dorsal root ganglia [174], 
small intestine and colon [179, 182]. Lower mRNA expression levels are also detected in 
brain, stomach [179], bladder [183], cerebral arteries [184] and pancreatic beta cells 
[185].   
In human tissues, TRPA1 mRNA has been detected in fibroblasts [181, 186], small 
intestine, colon, skeletal muscle, heart, pancreas, lymph nodes, spleen [187], skin [188, 
189] and stomach [179]. TRPA1 immunolabeling has also been reported in primary lung 
epithelium, lung smooth muscle cells [181], urethral cells [190] and several cell lines of 
human origin. However, cautious consideration needs to be given to some of these 
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immunolabeling reports given the limitations in tests about antigen specificity of the 
antibodies used.  
For more details about TRPA1 tissue expression in the mouse, rat and human, see 
reference [191]. 
 
2.2.5 Channel assembly from TRPA1 subunits 
Four TRPA1 subunits assemble to form a functional channel. In mice, the two TRPA1 
splice variants can interact (presumably forming heteromeric channels) and lead to 
increased TRPA1 expression in the plasma membrane and larger agonist-induced 
currents [100]. There is also evidence that TRPA1 and TRPV1 subunits can form 
heteromeric channels [192, 193]. Moreover, TRPA1-TRPV1 heteromeric channels seem 
to have slightly different gating and inactivation kinetics, and sensitivity to both TRPA1 
and TRPV1 agonists. Some decreases in agonist sensitivity can be simply explained by 
the decrease in binding sites (e.g., an agonist specific for TRPV1 could potentially have 4 
binding sites in a homomeric TRPV1 channel, but only 2 binding sites in a TRPA1-
TRPV1 heteromeric channel with 2 subunits of each type [192]). However, some agonists 
seem to prefer specific channel configurations and may involve interactions between 
neighboring subunits. 
 
2.2.6 Ankyrin repeats in the intracellular N-terminus of TRPA1 
TRPA1 subunits exhibit six transmembrane domains (see Appendix C for the 
prediction of transmembrane segments in mouse, rat and human TRPA1 subunits), which 
are a hallmark in the TRP family. TRPA1 also contains a unique intracellular N-terminus 
with a large number (~14 to 18) of ankyrin repeats [186] (Figure 2.1). TRPN channels 
have even larger numbers of ankyrin repeats (~29) but, as mentioned earlier, they are not 
expressed in mammals.  
Ankyrin repeat domains are found in a broad variety of proteins, including 
transcription factors, scaffold proteins, enzymes, regulatory subunits an even other 
members of the TRP family (i.e. TRPC and TRPV channels, with a rather small number 
of repeats: 4 to 6). The amino acid sequence of an ankyrin motif varies significantly 
between proteins but, on average, it consists of 30 to 34 residues arranged into a helix-
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turn-helix domain coupled to a β-hairpin loop. The structure of several ankyrin repeats 
has been resolved and, amusingly, a tandem of five repeats resembles a hand, where the 
helix-turn-helix domains form the palm and each β-hairpin loop forms a finger.  
 
 
Figure 2.1. Diagram of a TRPA1 channel subunit  
The diagram illustrates a TRPA1 subunit with its six transmembrane segments 
(for clarity, only S1 and S6 are labeled), both intracellular N- and C-termini 
and several ankyrin repeats (ANK) in the N-terminus. The pore-forming region 
is located between S5 and S6. The cyan circle indicates a methionine residue 
required for caffeine activation. A highly hydrophobic ankyrin repeat that 
might interact with the plasma membrane is shown in magenta (Appendix C). 
The ankyrin repeat that is known to contain an EF-hand-like domain to bind 
Ca2+ has been colored orange. The yellow starts indicate areas where several 
cysteine residues are required for channel gating by reactive agonists. The 
green circles designate cysteine (N) and histidine (C) residues required for 
activation by Zn2+. The blue circle in S5 shows the position of a glycine residue 
required for channel gating by cold temperature and inhibition by menthol. 
 
Ankyrin repeats are known to allow protein-protein interactions (that sometimes 
involve covalent bindings) and, in TRPA1 channels in particular, they are important for 
agonist-induced gating (see section 2.3 for more details). In fact, one of the ankyrin 
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repeats in TRPA1 is known bind Ca2+ ions [194] but, technically, it does not constitute a 
classic EF-hand domain [195] (see section 2.3.4 for more details). In addition, it has been 
proposed that ankyrin repeats might provide elastic properties to proteins that express 
large numbers of them [196]. For more comprehensive reviews on ankyrin repeats, see 
[195, 197]. 
 
2.2.7 The intracellular C-terminus and pore-forming regions of TRPA1 
Based on its homology to the other channels in the TRP family, the pore-forming 
region in a TRPA1 subunit is thought to be comprised of the loop between the 
transmembrane segments S5 and S6 (Figure 2.1). TRPA1 channels are permeable to 
monovalent and divalent cations. The selectivity between K+, N+, Cs+, Mg2+ and Ca2+ 
ions has not been extensively characterized for TRPA1 channels, however, results from 
one study correlate with a non-selective cation channel: PCs/PNa = 1.42, PMg/PNa = 1.23, 
PK/PNa = 1.19 and PNa/PCa = 1.19 [174]. Consistent with this, TRPA1 permeability to Cl
– 
is low: PCl/PNa = 0.28 [174]. Single-channel recordings have shown several conductance 
levels for TRPA1 but, on average, the channel conductance is around 100 pS [175]. 
Interestingly, single channel conductance is greatly reduced by Ca2+ (~ 54% reduction) 
[175]. Importantly, these changes in conductance can arise from agonist-induced dilation 
of the TRPA1 pore [198]. 
Although most agonists bind to the N-terminus of TRPA1 (see section 2.3), there is 
evidence suggesting that the intracellular C-terminus is involved in channel gating by a 
few agonists (e.g. Zn2+) [199]. In addition, mutations to several C-terminal amino acid 
residues show impaired TRPA1 sensitivity to voltage and to the potent agonist, mustard 
oil [200]. The TRPA1 transmembrane segments S5 and S6 and the pore-forming region 
are important for the binding and activation by other agonists as well.  
 
2.3 TRPA1 agonists and the mechanisms of TRPA1 channel gating 
There is a large inventory of compounds that activate TRPA1 channels; for a 
comprehensive list see Table 2.2 and reference [191]. Two general mechanisms of 
ligand-induced TRPA1 gating have been recognized: (i) ‘classical’ binding of 
structurally-related agonists to –one, perhaps more– binding pockets within the TRPA1 
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channel, and (ii) covalent modifications to the TRPA1 subunits mediated by ‘reactive’ 
agonists. These reactive chemical compounds and endogenous agonists typically lead to 
channel gating by modifying amino-acid residues within the TRPA1 intracellular N-
terminus (Figure 2.1) [201, 202]. These covalent modifications can remain in the TRPA1 
proteins from minutes to hours, and can sometimes lead to long-lasting TRPA1 channel 
activation [201-203].  
 
Table 2.2. List of TRPA1 agonists 
Agonist 
Species
* 
Mechanism and/or  
site of action 
Other TRP 
channels† 
Ref. 
Δ12-PGJ2 H Covalent modifications  [204] 
1-butanol H   [205] 
1-heptanol H   [205] 
1-hexanol H 
Interaction with N-terminal 
Cys and C-terminal His 
 [205, 206] 
1-octanol H 
Interaction with N-terminal 
Cys and C-terminal His 
 [205, 206] 
1-pentanol H   [205] 
1-propanol H   [205] 
15dPGJ2 H, M Covalent modifications  [204, 207] 
2-APB H ‘Classical’ binding 
TRPV1, 
TRPV3 
[202, 208] 
4-HHE H, M Covalent modifications  [207, 209] 
4-HNE H, M, R 
N-terminal Cys and Lys 
covalent modifications 
 [210, 211] 
4-ONE H, M Covalent modifications TRPV1 [207, 209] 
8-iso PGA2 H Covalent modifications  [204] 
AA    [212] 
Acetaldehyde H, M   [213] 
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Table 2.2 List of TRPA1 agonists (continued) 
Acrolein H, M, R 
N-terminal Cys covalent 
modifications 
 
[101, 202, 
214] 
AITC H, M, R 
N-terminal Cys and Lys 
covalent modifications 
 [201, 215] 
Allicin H, M, R   [216] 
BITC H Covalent modifications  [202] 
Butenal M   [211] 
Ca2+ H   [194, 217] 
Caffeine M Binding to intracellular Met  [178] 
Cannabinol H, R   [215] 
Carvacrol R ‘Classical’ binding TRPV3 [218] 
CA H, M 
N-terminal Cys covalent 
modifications 
 
[201, 202, 
212] 
Cd2+ H, M   [219] 
Crotonaldehyde M, R   [214] 
Cu2+ H, M   [219] 
DADS H, R 
N-terminal Cys covalent 
modifications 
 [202, 216] 
Desflurane M, R   [206, 220] 
Diclofenac H, R ‘Classical’ binding  [208] 
DPDS    [221] 
Ethanol H   [205] 
Etomidate M, R   [206] 
Eugenol M  
TRPV1, 
TRPM8 
[212] 
FFA H, R ‘Classical’ binding  [208] 
Flurbiprofen H, R ‘Classical’ binding  [208] 
Formaldehyde M  TRPV1 [211] 
Gingerol M  TRPV1 [212] 
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Table 2.2 List of TRPA1 agonists (continued) 
H+ H 
Interaction with S5 and S6, 
and N-terminal cys 
TRPV1 [222, 223] 
H2O2 M, R 
N-terminal Cys and Lys 
covalent modifications 
TRPM2 
[207, 224] 
[225] 
Hexenal M   [211] 
Heptenal M   [211] 
Hypochlorite H, M 
N-terminal Cys and Lys 
covalent modifications 
 [225] 
IA M Cys covalent modifications  [201, 211] 
IAA M Cys covalent modifications  [201] 
Icilin M ‘Classical’ binding TRPM8 [201] 
Indomethacin H, R ‘Classical’ binding  [208] 
Isoflurane M, R   [206, 220] 
Ketoprofen H, R ‘Classical’ binding  [208] 
Lidocaine H, M, R Binding to intracellular Cys  [226] 
Menthol H, M Interaction with S5 TRPM8 [227, 228] 
Methanol H   [205] 
Methyl salicylate M  TRPV1 [212] 
MFA H, R ‘Classical’ binding  [208] 
MOA M Cys covalent modifications  [201] 
MpBZ M   [229] 
MTSEA M 
N-terminal Cys covalent 
modifications 
 [201, 202] 
NFA H, R ‘Classical’ binding  [208] 
Nicotine H, M ‘Classical’ binding  [230] 
Nifedipine H ‘Classical’ binding  [208] 
Nitrooleic acid H, M   [231] 
NMM H 
N-terminal Cys covalent 
modifications 
 [202] 
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Table 2.2 List of TRPA1 agonists (continued) 
Octenal M   [211] 
Pentenal H, M   [101, 211] 
PGA2 H Covalent modifications  [204] 
Propofol M, R   [206] 
SC M Cys covalent modifications  [201] 
SCA M Cys covalent modifications  [201] 
TDI H, M Cys covalent modifications  [232] 
THC H, R ‘Classical’ binding  [202, 215] 
Theobromine M Binding to intracellular Met  [178] 
Theophylline M Binding to intracellular Met  [178] 
Thymol H, M Interaction with S5 
TRPM8, 
TRPV3 
[227, 228] 
Umbellulone H, M, R Covalent modifications  [233] 
Zn2+ H, M 
Interaction with N-terminal 
Cys and C-terminal His 
 [199, 219] 
* Species where TRPA1 activation has been reported by the agonist: human (H), 
mouse (M) or rat (R). 
† Ligand promiscuity with other mammalian TRP channels. 
Abbreviations: 2-APB, 2-amino-phenyl borane; 4-HHE, 4-hydroxyhexenal; 4-
HNE, 4-hydroxynonenal ; 4-ONE, 4-oxononenal; AA, arachidonic acid; AITC, 
allyl isothiocyanate (mustard oil); BITC, benzyl isothiocyanate; CA, 
cinnamaldehyde; Cys, cysteine; DADS, diallyl disulfide; DPDS, dipropyl 
disulfide; FFA, flufenamic acid; IA, iodoacetamide; IAA, iodoacetamide alkyne; 
MFA, mefenamic acid; MOA, mustard oil alkyne (propargyl isothiocyanate); 
MpBZ, methyl p-hydroxybenzoate; MTSEA, (2-aminoethyl) 
methanethiosulphonate; NFA, niflumic acid; NMM, N-methyl maleimide; Ref., 
References; SC, super cinnamaldehyde; SCA, super cinnamaldehyde alkyne; TDI, 
toluene diisocyanate; THC, Δ9-tetrahydrocannabinol. 
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Channel inactivation following covalent modifications could be achieved through 
several mechanisms. For instance, while some covalent modifications appear to be 
completely irreversible (e.g., by the reactive agonist N-methyl maleimide –NMM) others 
appear to be temporary [201, 202]. TRPA1 channels are also susceptible to voltage-
induced inactivation (after cell depolarizations) [234] and to blockage by intracellular 
Ca2+ [175, 235]. In addition, TRPA1 protein turnover and endocytosis rates would also 
affect the amount of covalently-modified TRPA1 channels present in the plasma 
membrane.        
 
2.3.1 Pungent compounds 
The pungent perception after the ingestion of certain foods is mediated by the 
activation of TRPA1 channels in nerve terminals in the mouth. These, sometimes painful, 
sensations are induced by specific compounds, such as: allyl isothiocyanate –AITC– (also 
known as ‘mustard oil’, found in wasabi, mustard and horseradish) [215], 
cinnamaldehyde –CA– (cinnamon) [212], carvacrol and thymol (oregano and thyme) 
[218, 227], gingerol (ginger) [212], eugenol (clove) [212], allicin and diallyl disulfide –
DADS– (garlic and onion) [216].  
Some of these pungent compounds are electrophiles and, as such, can potentially react 
with neuclophilic amino acid residues like cysteine, lysine and histidine. In fact, the 
mechanism of TRPA1 gating by some of these reactive agonists (i.e. AITC, CA and 
DADS) has been shown to specifically involve covalent modifications of cysteine and/or 
lysine residues in the TRPA1 N-terminus (Figure 2.1) [201, 202]. These covalent 
modifications might even involve to the formation of disulfide bonds between cysteine 
residues [236]. Several key N-terminal cysteine residues have been reported to be 
necessary for channel gating by these reactive agonists [201, 202]. Moreover, agonist 
sensitivity depended on the amount of cysteine residues present (in targeted mutation 
studies). However, when three of the cysteine residues were mutated in the same 
construct, TRPA1 sensitivity to non-reactive agonists was also decreased, suggesting a 
general defect in TRPA1 gating [199]. Similarly, TRPA1 sensitivity to AITC was 
impaired when several C-terminal lysine, arginine and alanine residues were mutated 
[200]. The sensitivity of these C-terminal TRPA1 mutants to non-reactive agonists was 
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not tested and, therefore, it is plausible that these mutations cause structural changes that 
affect TRPA1 gating. 
Because some of these pungent compounds are non-reactive agonists, their mechanism 
of action seems to involve the ‘classical’ binding between an agonist and a receptor (i.e. 
TRPA1 channel). In particular, TRPA1 activation by thymol requires amino acid residues 
located within the transmembrane segment S5 [228].  
The noxious effects caused by topical application or subcutaneous injection of these 
pungent compounds are described in section 2.4.1. 
 
2.3.2 Airborne irritants 
Several aldehydes in cigarette smoke, air pollution or tear gas (e.g., acrolein –2-
propenal–, crotonaldehyde and acetaldehyde [237]), as well as some volatile 
environmental (i.e. umbellulone) and industrial chemicals (i.e. toluene diisocyanate –
TDI–, hypochlorite and formaldehyde) are known to gate TRPA1 channels [211, 213, 
214, 225, 232, 233]. These reactive agonists seem to activate TRPA1 channels in a 
manner similar to the reactive pungent agonists described above, which involves covalent 
modifications to cysteine and lysine residues in the N terminus of TRPA1 subunits 
(Figure 2.1) [202, 225]. In the airways, they can activate TRPA1 channels present in 
bronchial epithelial and smooth muscle cells, as well as in neurons innervating the nasal 
cavity and the bronchi. Inhalation of these volatile TRPA1 agonists causes noxious 
responses in the meninges and in the respiratory airways, which are described in more 
detail in section 2.4.1. 
 
2.3.3 Byproducts of reactive oxygen and nitrogen tissue damage 
The generation of reactive oxygen and nitrogen species (ROS and RNS, respectively) 
increases during instances of cellular stress (e.g., inflammation, hypoxia or mechanical 
trauma). These reactive molecules can cause damage to lipids, proteins and nucleic acids, 
and can eventually lead to cellular apoptosis.  
Some ROS, such as hydrogen peroxide (H2O2), act as TRPA1 agonists themselves 
[207]. Moreover, ROS-induced lipid peroxidation leads to the generation of byproducts 
such as 4-hydroxynonenal (4-HNE), 4-hydroxyhexenal (4-HHE) and 4-oxononenal (4-
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ONE) that can directly bind and trigger TRPA1 channel gating [207, 209-211]. On the 
other hand, RNS can add highly reactive NO2 groups to fatty acids. These nitrated 
phospholipids (e.g., nitrooleic acid –OA-NO2) can bind and activate TRPA1 channels as 
well [231]. In general, nitrated phospholipids seem to be more potent than peroxidation 
byproducts in the activation of TRPA1 channels.  
Notably, the mechanism of TRPA1 channel activation by 4-HNE seems to involve 
covalent modifications to the same cysteine and lysine residues required for activation by 
reactive pungent compounds and airborne chemicals (Figure 2.1) [210].  
 
2.3.4 Divalent cations 
As described in section 2.2.6, TRPA1 channels have an ankyrin domain that resembles 
an EF hand and is able to bind Ca2+ (Figure 2.1). Intracellular Ca2+ can directly trigger 
TRPA1 channel gating through its interaction with the EF hand-like domain [194, 217]. 
Because TRPA1 channels are permeable to Ca2+, channel activation by other agonists can 
be potentiated after the initial influx of Ca2+. 
In a similar manner, TRPA1 channels are permeable to Zn2+, a heavy metal that can 
directly bind to TRPA1 (on intracellular domains) and trigger channel gating [199]. Some 
anti-fungal and anti-parasitic drugs that act as Zn2+ ionophores can indirectly induce 
TRPA1 gating by increasing intracellular levels of Zn2+ [219]. Specifically, two cysteine 
and one histidine residues are important for the TRPA1 sensitivity to Zn2+ [199]. One of 
the cysteine residues, located in the N-terminus of TRPA1, is involved in channel gating 
by reactive agonists as well. The other cysteine residue and the histidine residue are 
located in the C-terminus of TRPA1 (Figure 2.1). 
Other divalent cations that can directly bind and gate TRPA1 channels are Cd2+ and 
Cu2+ [219]. Fe2+ can modulate TRPA1 activation by other agonists, but Fe2+ does not 
directly gate TRPA1 channels [207, 219].  
 
2.3.5 Noxious cold 
Initial reports showed that TRPA1 channels were gated by cold temperatures (< 17°C) 
[174]. However, even after a decade of studies, researchers do not agree on whether 
TRPA1 channels can directly sense noxious cold. Several groups have supported the 
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initial findings and have shown cold sensitivity in TRPA1 channels expressed in 
heterologous systems [217, 238]. Correlations between the percentages of TRPA1-
expressing and cold-sensitive DRG neurons were reported [212, 239]. Meanwhile, other 
groups failed to find correlations between AITC-sensitive and cold-sensitive DRG 
neurons [215, 238, 240]. In addition, cold seems to induce a small Ca2+ influx in 
heterologous systems that is independent of TRPA1 channels [217]. This result could 
indicate that noxious cold indirectly gates TRPA1 channels via a small increase in 
intracellular Ca2+ levels. Another level of complexity was added with the generation of 
Trpa1–/– mice by two independent groups that showed opposite behavioral results. While 
one group reported impaired sensitivity to noxious cold in TRPA1-deficient mice [102], 
the second group found no difference in cold sensation between TRPA1 knockout and 
wild type mice [101]. Further studies in mice indicated that cold exposure does not 
directly gate TRPA1 channels but instead potentiates TRPA1 activation when the channel 
has been primed by a different agonist [241]. Moreover, direct channel gating by cold, if 
present at all, is a property of mouse and rat but not human TRPA1 channels [242, 243]. 
A glycine residue in the TRPA1 transmembrane segment S5 is required for cold 
sensation (Figure 2.1), but other unknown amino acid residues might also be involved. 
For comprehensive reviews on cold sensitivity by TRPA1 channels see [244, 245].   
 
2.3.6 Pro- and anti-inflammatory agents 
Prostaglandins (PGs) are pro-inflammatory agents produced downstream of the 
hydrolysis of membrane phospholipids via the activity of cyclooxygenases (COXs). 
Several prostaglandins and their metabolites can trigger TRPA1 gating (i.e., 15dPGJ2, 
PGA2, 8-iso PGA2 and Δ
12-PGJ2) and cause pain [246]. Because only ‘reactive’ PG 
metabolites seem to lead to TRPA1 activation [204], the mechanism of channel gating 
seems to involve covalent modifications, perhaps, of the same amino acid residues 
targeted by other reactive agonists (Figure 2.1). The inflammatory pain induced by PGs is 
commonly treated with non-steroidal anti-inflammatory drugs (NSAIDs) that act as COX 
inhibitors. Interestingly, several of these NSAIDs are TRPA1 agonists as well (e.g., 
flufenamic acid –FFA–, mefenamic acid, niflumic acid, flurbiprofen, indomethacin, 
ketoprofen and diclofenac) [208], making them the most puzzling TRPA1 agonists. 
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While TRPA1 activation has been frequently linked to pain-like behaviors (as described 
in section 2.4), NSAIDs are extensively known for their analgesic effects. In addition, 
because these NSAIDs are non-reactive agonist, their mechanism of action probably 
involves ‘clasical’ binding or interaction between the agonist and the TRPA1 channel.  
 
2.3.7 Local and general anesthetics 
Several anesthetics can activate TRPA1 channels as well. Lidocaine, a membrane-
permeable local anesthetic, can activate TRPA1 channels when applied at high 
concentrations (> 3 mM) [226]. Interestingly, at even higher concentrations (> 100 mM), 
lidocaine acts as a channel blocker. In addition, the mechanism of TRPA1 activation by 
lidocaine seems to involve some of the cysteine residues typically targeted by reactive 
agonists. Some inhalation (e.g., isoflurane and desflurane) and intravenous (e.g., propofol 
and etomidate) general anesthetics can trigger TRPA1 gating [206]. General anesthetics 
of the inhalation class seem to activate TRPA1 channels via a mechanism similar to the 
one used by Zn2+ (Figure 2.1). In contrast, intravenous general anesthetics appear to 
involve a different, yet unknown, mechanism. Because some drugs indirectly activate 
TRPA1 channels (via an increase in intracellular Zn2+) [219], more studies are required to 
clarify whether inhalation-type anesthetics can directly bind and gate TRPA1 channels.       
 
2.3.8 Other TRPA1 agonists 
Some alcohols, xanthine derivatives and antibacterials are other compounds that can 
behave as TRPA1 agonists. In addition, menthol and weak acids can induce TRPA1 
gating as well. 
Primary alcohols (from methanol to 1-octanol) have been shown to activate TRPA1 
channels at high concentrations (> 1 mM), with greater potencies exhibited by those with 
larger carbon chains [205, 206]. However, there is a limit in the length of the alcohol 
carbon chain that can activate TRPA1 channels since decanol fails to trigger channel 
gating [206].  In addition, the mechanism of action of these alcohols seems to involve the 
same cysteine and histidine residues required for TRPA1 gating by Zn2+ and inhalation-
type anesthetics. Because agonist potency directly correlates with molecule size, the 
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presence of a binding pocket in TRPA1 subunits has been proposed [206], in manner 
analogous to other ligand-gated ion channels (e.g., GABAA and glycine receptors) [247]. 
Xanthine derivates, such as caffeine, can activate TRPA1 channels as well, and 
TRPA1 gating by these compounds does not require intracellular Ca2+ [178]. This favors 
the idea of a direct mechanism of channel gating rather than indirect activation via the 
effect of caffeine on intracellular stores. Moreover, a methionine residue in the 
intracellular N terminus of mouse TRPA1 is required for caffeine activation (Figure 2.1) 
[248].  
Methyl p-hydroxybenzoate (MpBZ), an inert compound with antibacterial properties, 
can activate TRPA1 channels [229]. The TRPA1 reactive agonists AITC, CA and allicin 
as well as the non-reactive agonists carvacrol and thymol (described in section 2.3.1) are 
pungent compounds that exhibit antibacterial properties as well. However, because 
MpBZ is a non-reactive TRPA1 agonist, the mechanism by which it can trigger channel 
gating might resemble that of the non-reactive antibacterial/pungent compounds. 
TRPA1 channels can directly sense both cytosolic and intracellular weak acidification 
[222, 223, 249]. Activation after extracellular acidification seems to be a property of 
human, but not mouse TRPA1 channels. In contrast, channel gating by intracellular 
protons is a feature conserved between mammals. TRPA1 activation by protons does not 
require the intracellular N-terminal cysteine residues that are involved in channel gating 
by reactive agonists. Instead, the transmembrane domains S5 and S6 are involved in 
TRPA1 sensing of extracellular acidosis. However, it is unknown whether intracellular 
protons activate TRPA1 channels through the same mechanism or protein region. 
Menthol is a non-reactive compound that can activate mammalian TRPA1 channels 
[227]. Menthol is structurally similar to thymol and carvacrol, which are two non-reactive 
isomeric pungent compounds known to activate TRPA1 channels (described in section 
2.3.1). Similar to thymol, menthol requires residues within the TRPA1 transmembrane 
segment S5 to induce channel activation [228], which seems to indicate the presence of a 
binding pocket near the pore region of TRPA1.  
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2.3.9 Agonists able to inhibit TRPA1 channels 
Ca2+ has a bimodal effect on the activation of TRPA1 channels by other agonists. 
While micromolar concentrations of intracellular Ca2+ can potentiate TRPA1 activation 
by reactive and non-reactive agonists (section 2.3.4), higher Ca2+ concentrations can lead 
to channel blockage or inactivation [175, 194, 235]. 
While a low dosage of menthol acts as a mouse TRPA1 agonist (section 2.3.8), higher 
concentrations (> 100 µM) are known to inhibit TRPA1 currents [227]. Interestingly, 
menthol is not able to inhibit human TRPA1 channels, even at high concentrations (3 
mM). In addition, the structurally similar compound thymol exhibits mouse TRPA1 
inhibition at higher concentrations as well (>250 µM) [227]. This species-dependent 
inhibition by menthol seems to involve the same TRPA1 region required for its activation 
(i.e. transmembrane segment S5) [228]. Specifically, the same glycine residue that is 
involved in TRPA1 activation by noxious cold (section 2.3.5) is required for TRPA1 
inhibition by menthol [243]. Like menthol, other TRPA1 agonists have shown different 
responses between species as well. For example, caffeine can trigger mouse and rat 
TRPA1 gating (section 2.3.8), but it behaves as an inhibitor for human TRPA1 channels 
[178]. 
Stimulation with PG metabolites, such as 15d-PGJ2, leads to TRPA1 activation 
initially (section 2.3.6) but it is subsequently followed by a long-lasting channel 
inactivation [250]. 
 
2.4 TRPA1 in nociceptive neurons 
TRPA1 is expressed in about 30 to 50% of the TRPV1-expressing neurons in dorsal 
root, trigeminal and nodose ganglia [174, 175]. Activation of TRPA1 channels (and 
TRPV1 channels as well) leads to the depolarization of these neurons and the 
development of action potentials that typically ‘encode’ pain-like sensations.  
 
2.4.1 TRPA1 activation in nociceptive neurons 
Subcutaneous injections of AITC, CA, MpBZ, H2O2, PGs, acetaldehyde, RNS-donors 
or 4-HNE activate TRPA1 channels in nociceptive neurons innervating the skin. TRPA1 
activation in these neurons produces pain, neurogenic inflammation (e.g., through the 
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release of substance P and calcitonin gene related peptide –CGRP), itch and hyperalgesia 
to mechanical and thermal stimuli [101, 102, 207, 210, 212, 213, 229, 251].  
Inhalation-type general anesthetics induce bronchoconstriction and neurogenic pain 
[252]. Similarly, the inhalation of TRPA1 volatile agonists like acrolein, formaldehyde or 
Zn2+ induce cough, bronchoconstriction, mucous secretion and a decrease in respiratory 
rate, among other symptoms [253]. These nociceptive effects presumably occur after the 
activation of TRPA1 channels in C- and Aδ-fibers innervating the respiratory tract, as 
well as activation of TRPA1 channels in bronchial epithelial and smooth muscle cells 
[101]. In mouse models of allergen-induced asthma the airway hyperreactivity was 
significantly reduced in TRPA1-deficient mice [254]. Inhalation of umbellulone (a 
reactive compound produced by the ‘headache tree’) or hypochorite (an oxidative agent 
in chlorine gas) activates TRPA1 channels in trigeminal neurons innervating the nasal 
cavity. TRPA1-induced activation of these nociceptive neurons leads to an increase in 
blood flow in the meninges and the development of migraine headaches [225, 233].  
In the gut, stimulation with TRPA1 agonists can increase the proportion of nociceptive 
neurons that express functional TRPA1 channels [255]. TRPA1 activation in these 
nociceptive neurons induces the release of pro-inflammatory neuropeptides and leads to 
mechanical hypersensitivity [255-258]. Impaired regulation of the immune responses in 
the gut typically underlies the development of inflammatory bowel diseases such as 
colitis and Crohn’s disease [259, 260]. During these chronic inflammatory states, TRPA1 
activation has been proposed to modulate, not only the pain responses, but the tissue 
inflammation as well [261, 262]. However, whether TRPA1 plays a protective or harmful 
role during inflammatory bowel diseases is still under debate. 
Altogether, these findings support the increasing interest in the study of TRPA1 
channels and their functional role in neuropathic pain, asthma, chronic obstructive 
pulmonary disease (COPD) and inflammatory bowel diseases (reviewed in [263-266]).  
Notably, PGs, H2O2, low pH and byproducts of ROS/RNS damage constitute 
endogenous TRPA1 agonists that are commonly generated upon tissue stress or injury 
(Figure 2.2). Because TRPA1 agonists employ several different mechanisms to achieve 
channel gating or inactivation, the simultaneous exposure to multiple agonists leads to 
complex responses. While some agonists counter-react the activity of others (perhaps by 
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competing for the same binding sites), there are agonist combinations that lead to 
synergistic and potent responses. Moreover, some TRPA1 agonists eventually induce 
channel inactivation and therefore exert analgesic effects as well. For example, PG 
metabolites have biphasic responses in nociceptive neurons. Initially they activate 
TRPA1 channels and produce pain-like behaviors, but later they can provide analgesia 
against other nociceptive signals through a TRPA1-depenent mechanism [250]. In 
addition, TRPA1 activation by these endogenous agonists can be potentiated by cold 
exposure [241]. 
  
 
Figure 2.2. Pathways for TRPA1 activation after tissue damage  
TRPA1 channels can be directly activated by byproducts of reactive oxygen 
(ROS) and nitrogen (RNS) species damage (e.g., 4-HNE and OA-NO2), weak 
acidosis, intracellular Ca2+ and prostaglandins (PGs). Additionally, TRPA1 
channels can be activated downstream of G-protein coupled receptors (such as 
the bradykinin –BK– receptor –BR) via the activation of phospholipase C 
(and perhaps the generation of diacyl-glycerol –DAG). Activation of TRPV1 
channels by tissue acidosis can also modulate TRPA1 activity (e.g., secondary 
to the influx of Ca2+). 
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2.4.2 Functional interplay between TRPA1 and TRPV1 channels 
TRPV1 channels are gated by low pH (Figure 2.2), heat and capsaicin (the main 
pungent compound of chili peppers) (reviewed in [97]). Several studies have shown that 
TRPA1 and TRPV1 channels can cross-modulate each others’ properties when co-
expressed in the same cell (reviewed in [267]). This is of particular importance given the 
fact that TRPA1 expression in nociceptive neurons seems to be limited to the cells that 
express TRPV1 channels [174, 175].  
TRPA1 and TRPV1 subunits can directly interact by forming heteromeric channels 
(section 2.2.5). However, it is still possible that the properties of homomeric TRPA1 and 
TRPV1 channels are regulated through close interaction of the channels in the plasma 
membrane or via intracellular second messengers. However, most reports showing the 
functional interplay between TRPA1 and TRPV1 cannot clearly distinguish between 
these two scenarios (i.e. heteromeric channels vs. cross-regulation of homomeric 
channels). Regardless of the exact mechanism of interaction, TRPA1-specific agonists 
clearly desensitize (although sometimes increase) responses to TRPV1 agonists when 
channels are co-expressed [268, 269]. The reverse interaction is also true since capsaicin 
desensitizes TRPA1-agonist currents. The potency of some TRPA1 agonists can be either 
lower or higher in cells co-expressing TRPA1 and TRPV1 [270]. Additionally, TRPA1 
and TRPV1 single channel properties (conductance, open probability and current-voltage 
relationships) are modified in cells expressing both proteins [193]. A single point 
mutation affecting the permeability to Ca2+ in TRPV1 subunits is able to modify cell 
currents in response to TRPA1 agonists [271]. Moreover, TRPA1 channels might get 
internalized after stimulation with AITC via a mechanism that is inhibited by the 
expression of TRPV1 [268]. 
 
2.5 Regulatory mechanisms of TRPA1 function 
TRPA1 channels can be activated and/or regulated by several G-protein coupled 
receptors (GPCRs) via the generation of second messengers. Some of the GPCRs known 
to modulate TRPA1 channel gating are the bradykinin receptor [212], m1 muscarinic 
acetylcholine receptor (m1AChR) [215], protease-activated receptor 2 (PAR2) [272, 273] 
and P2Y receptors (manuscript in preparation, Vélez-Ortega AC, et al., see Appendix D 
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for details). Notably, bradykinin is a potent pro-inflammatory peptide that induces 
vasodilation.  
Phospholipase C (PLC) signaling downstream of GPCR activation modulates TRPA1 
channels (Figure 2.2) as well as other members of the TRP family [212, 274]. Activation 
of PLC leads to the cleavage of phosphatidylinositol 4,5-biphosphate (PIP2) from the 
plasma membrane and generates diacyl glycerol (DAG) and inositol 1,4,5-triphosphate 
(IP3). Therefore, PLC stimulation could modulate TRPA1 activity via three mechanisms. 
First, PIP2 seems to inhibit TRPA1 channels and, therefore, PLC-mediated cleavage of 
PIP2 would remove such inhibition [273, 275]. Second, because IP3 leads to the release 
of Ca2+ from intracellular stores, PLC activation could induce TRPA1 gating via the 
increase in cytosolic Ca2+ [212, 215]. Third, DAG application was shown to activate 
TRPA1 channels as well, but its mechanism of action remains unknown [212]. 
Interestingly, in the presence of phospholipase-A2 (PLA2) activity, DAG can be 
converted into arachidonic acid (AA), a precursor in the generation of PGs. AA, PGs and 
their metabolites could activate TRPA1 channels (see section 2.3.6). However, TRPA1 
activation downstream of PLC does not seem to require the N-terminal cysteine residues 
that are involved in channel gating by these reactive agonists [202].  
PAR2 and bradykinin receptors can also stimulate protein kinase A (PKA) [272, 273]. 
Activation of PKA might increase the translocation of TRPA1 channels into the plasma 
membrane which could explain the increase in TRPA1 currents after stimulation of PKA 
[276].  
The toll-like receptor-7 (TLR7) is involved in innate immune responses. TLR7 
recognizes single stranded RNA (e.g., from viruses) and it is typically localized in the 
endosomes of immune cells (reviewed in [277]). However, TLR7 is also expressed in a 
subset of DRG neurons [278] and it can be activated by microRNAs (miRNAs). 
Moreover, miRNA-dependent activation of TLR7 in DRG neurons induces TRPA1 
gating and nociceptive behavior in mice [279]. The mechanism of TLR7-mediated 
TRPA1 activation remains unknown but it does not seem to require the TLR7 
intracellular signaling cascade. 
Annexin A2 (AnxA2) is involved in the trafficking of proteins to and from the plasma 
membrane (reviewed in [280]). Recently, AnxA2 was shown to directly interact with 
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TRPA1 subunits and to be able to control the amount of TRPA1 expression in the plasma 
membrane (without altering Trpa1 mRNA levels) [281]. Whether AnxA2-dependent 
expression of TRPA1 in the plasma membrane is regulated by PKA activity remains to be 
elucidated. 
 
2.5 TRPA1 as a hair cell MET channel candidate 
The inner ear sensory cells (i.e. hair cells) have particular cellular specializations (i.e. 
stereocilia bundles) in charge of detecting mechanical stimulation (sound in the cochlea 
and movement/acceleration in the vestibular system) (section 1.4.1). However, the 
molecular identity of the mechano-electrical transducer (MET) channel involved in this 
process is still unknown. Several candidate genes have been proposed in past years. In 
fact, the TRPA1 channel was proposed as a MET channel candidate in 2004 [177]. 
TRPA1 expression and channel properties strongly supported this hypothesis.  
Trpa1 mRNA was detected in the mouse cochlear epithelium through in situ 
hybridization. Although Trpa1 mRNA was in fact present in the sensory hair cells, 
mRNA levels appeared to be significantly higher in the surrounding supporting cells 
(specifically, in Hensen’s cells) [177]. Notably, TRPA1 channel properties seemed to 
perfectly mirror those of the hair cell MET channel: non-selective cation selectivity, 
average single channel conductance (~98 vs. ~100 pS) and current reduction by Ca2+ (53 
vs. 54% reduction) [175]. Moreover, the MET channel blockers gentamicin, ruthenium 
red, Gd3+ and amiloride were also able to block TRPA1 channels. However, the half 
maximal inhibitory concentrations (IC50) differed greatly between TRPA1 and MET 
channels for Gd3+ (0.1 vs. 10 µM) and amiloride (511 vs. 50 µM) [175, 282, 283]. 
In 2006, knockout mice generated by two independent groups ruled out TRPA1 as the 
MET channel. [101, 102]. In both groups, the pore-forming region of TRPA1 was 
deleted, which renders the subunits nonfunctional. The Trpa1–/– mice had defects in the 
nociception of mechanical, chemical and thermal noxious stimuli, yet they exhibited 
normal hearing and vestibular functions. 
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2.6 Research hypothesis and scope of the dissertation 
Trpa1 mRNA is highly expressed in the inner ear [177], but this tissue is not 
considered to have prominent nociceptive innervation. Given that Trpa1–/– mice exhibit 
normal hearing and hair cell mechanotransduction [101, 102], the function of TRPA1 
channels in the cochlear epithelium remains elusive.  
Acoustic overstimulation leads to an increase in reactive oxygen species (ROS) in the 
cochlear epithelium (reviewed in [284]). The oxidative stress following a single event of 
noise exposure can last for several days or even weeks and lead to the accumulation of, 
among others, the lipid peroxidation byproduct 4-HNE [285]. Because 4-HNE could 
behave as an endogenous agonist for TRPA1 channels in the cochlea, we hypothesized 
that cochlear TRPA1 channels act as sensors for oxidative damage after noise exposure.      
First, we sought to identify the specific cell types within the cochlear epithelium that 
expressed the TRPA1 gene and that contained functional TRPA1 channels (sections 4.1 
and 4.2). Next, we evaluated the responses of the cochlear epithelium to direct 
application of TRPA1 agonists, such as 4-HNE (sections 4.3 to 4.8). Lastly, we attempted 
to unveil the physiological significance of the TRPA1-induced responses observed by 
using in vitro and in vivo approaches (sections 4.9 to 4.11).  
Chapter 3 presents the experimental approaches used and Chapter 4 the results of the 
experiments and their analyses. In addition, Chapter 5 includes the discussion of the 
results of this project, taking into account the limitations of the study and possible future 
directions. 
 
 
 
 
 
 
 
 
 
Copyright © A. Catalina Vélez-Ortega 2014  
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CHAPTER 3 
Materials and methods 
 
3.1 Mice 
TRPA1-deficient mice (Trpa1–/–) and control littermates (Trpa1+/+) were a kind gift 
from Dr. David Corey and Dr. Kelvin Kwan (Harvard University) to the Frolenkov 
laboratory in 2006. These mice were then backcrossed with C57BL/6 mice. The Trpa1–/– 
mice, the pore-forming region (exons 22 to 24) was replaced with a vector containing an 
endoplasmic reticulum (ER) retention signal (KDEL), a stop codon, an internal ribosome 
entry site (IRES) and the human placental alkaline phosphatase (PLAP) gene as a 
reporter [102]. Genotyping of these mice was performed as previously published by our 
laboratory [286].  
Given that Trpa1+/– mice have exhibited an intermediate phenotype in several tests 
[101], all experiments in these study were performed with either Trpa1+/+ or Trpa1–/– 
mice. Therefore, two separate colonies of wild type (Trpa1+/+ x Trpa1+/+) and TRPA1-
deficient (Trpa1–/– x Trpa1–/–) breeding pairs were established and maintained. In some 
cases, to corroborate results obtained with the Trpa1+/+ and Trpa1–/– mice from the two 
separate colonies, Trpa1+/+ and Trpa1–/– mice were crossed, breeding pairs between F1 
heterozygous (Trpa1+/–) siblings were established and F2 Trpa1+/+ and Trpa1–/– 
littermates were used for comparisons within experiments.  
All animal procedures were approved by the Institutional Animal Care and Use 
Committee (IACUC) of the University of Kentucky (protocol 00903M2005). 
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3.2 Cochlear explants 
3.2.1 Tissue dissection 
Cochlear explants were isolated during the first postnatal week because cochlear hair 
cells die rapidly when tissue dissections are performed on or after the second postnatal 
week. Pups were placed in a cold chamber for 5 to 8 minutes and then decapitated. The 
skin around the skull and the facial bones were removed. Next, the skull and brain were 
cut into two hemispheres and placed in a plastic Petri dish with cold (~4-10°C) 
Leibovitz’s L-15 medium (Gibco) were the tissue dissection was continued. The brain 
and the meninges were removed to expose the inner surface of the skull. The tympanic 
bullae were dissected out of the temporal bones and placed into a new Petri dish with 
fresh L-15 medium. The otic capsule was carefully removed and the cochlear epithelium 
was pulled away from the cochlear modiolus. At this stage, the cochlear epithelium has a 
tubular conformation thus, in order to flatten out the tissue, the Reissner’s membrane was 
cut. This approach allowed the organ of Corti to remain attached to the outer supporting 
cells (i.e. Claudius’ and spiral prominence cells) and the stria vascularis (Figure 3.1A). In 
contrast, for experiments where the outer supporting cells were not needed, the tissue was 
held by the spiral limbus while the stria vascularis was pulled away. This maneuver 
caused the tissue to tear at the level of the Claudius’ cells but left the organ of Corti and 
inner supporting cells intact (Figure 3.1B). 
Explants were either allowed to attach to glass-bottom Petri dishes (in experiments 
with cultured explants) or held by two glass fibers glued onto a coverslip (in experiments 
on freshly-isolated tissue).  
 
3.2.2 Tissue culture of cochlear explants 
For direct attachment of the cochlear explants onto glass-bottom Petri dishes (MatTek 
Corporation), each explant was placed on a dish with a small amount of culture medium 
(~ 200 µL), which consisted of Dulbecco’s Modified Eagle’s Medium (DMEM) (Gibco) 
supplemented with 7% fetal bovine serum (FBS) (Atlanta Biologicals) and 10 µg/mL 
ampicillin (Calbiochem). The small amount of medium was dispersed throughout the 
glass bottom making the liquid surface tension keep the cochlear explant in place. Dishes 
were temporarily sealed with Parafilm® M (Bemis Company, Inc.) to minimize liquid 
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evaporation and then placed in an incubator at 37°C and 5% CO2 for 12-16 h. After this 
time, the explants had completely attached to the glass (Figure 3.1) so the Parafilm was 
removed and 2 mL of fresh culture medium were added to each dish. Explants were 
placed back in the incubator for 1-2 more days before imaging was performed. 
 
 
Figure 3.1. Cochlear epithelium attached to a glass-bottom dish 
A, B, Several overlapping pictures were taken with a 10X objective to cover 
the entire length (from base to apex) of a cochlear epithelium with (A) or 
without (B) outer supporting cells and stria vascularis (OSC), attached to a 
glass-bottom Petri dish. C, As a reference, a diagram is provided to illustrate 
the tissue configuration at the cross sections indicated by the two dashed lines. 
 
Often, changes in the morphology of the hair cell stereocilia bundles were observed in 
cultured cochlear explants that contained outer supporting cells and the stria vascularis 
(Figure 3.2). In some cases, the rows of OHCs were completely absent (data not shown), 
an indication that these cells had undergone apoptosis. In fact, a closer examination of the 
tissue revealed a large quantity of apoptotic cells within the stria vascularis after only 1 
day in culture (Figure 3.3). Because cochlear explants that did not contain the outer 
supporting cells or stria vascularis appeared healthy, we believe the dying cells in the 
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stria vascularis had a noxious effect on the rest of the tissue. Therefore, as described in 
the following section, we designed a strategy that would allow us to study cochlear 
explants immediately after dissection. 
 
 
Figure 3.2. Cochlear explants cultured with outer supporting cells and stria 
vascularis exhibited morphological abnormalities 
A, B, Bright field imaging of wild type cochlear explants dissected on 
postnatal day 4 (P4) and cultured without (top) or with (bottom) outer 
supporting cells for 1 (A) or 3 days (B). Three focal planes of each area are 
shown to highlight the stereocilia bundles of IHC (left) and OHC (middle and 
right). Arrow to some of the stereocilia bundles that did not exhibit normal 
morphology. IHC, inner hair cell; OHC, outer hair cell; OSC, outer supporting 
cells and stria vascularis. 
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Figure 3.3. Apoptotic cells are observed in the stria vascularis during culture 
A, B, Scanning electron micrographs of the organ of Corti (top) and stria 
vascularis (bottom) regions from wild type cochlear explants cultured for 1 
(A) or 2 days (B). After 1 day in culture most stereocilia bundles appear 
normal while several abnormally swollen cells are observed in the stria 
vascularis (arrows). After 2 days in culture, the swelling in the stria was less 
noticeable but the hair bundle morphology was disorganized. Several ‘holes’ 
were observed in the stria (arrow heads), and they probably represent areas 
were apoptotic cells had been recently removed. IHC, inner hair cell; OHC, 
outer hair cell; SV, stria vascularis. 
 
3.2.3 Freshly-isolated cochlear explants 
To perform experiments in freshly isolated cochlear explants, it was necessary to keep 
the tissue from moving freely. To do so, thin glass fibers were pulled from glass 
capillaries (World Precission Instruments) using a P-2000 laser puller (Sutter 
Instrument). The pulled fibers measured ~1-2 cm in length and were fairly flexible. Two 
fibers were glued onto a glass coverslip (~2 cm in diameter) (Fisherbrand) using the 
silicone elastomer Sylgard® (World Precission Instruments). The coverslips were placed 
on a hot plate to quickly cure the elastomer (~3-5 min). Next, the coverslips were 
mounted on plastic or glass-bottom dishes using a small amount (~1-3 µL) of Sylgard® 
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and allowed to cure overnight (Figure 3.4A). The cochlear epithelium was placed under 
the two glass capillaries to keep it in place during imaging and patch clamp recordings 
(Figure 3.4B). 
 
 
Figure 3.4. Freshly-isolated cochlear tissue held in place by glass capillaries 
A, Dish configuration used to hold the cochlear tissue in place for experiments 
performed in freshly-isolated tissue. B, Cochlear tissue placed under the glass 
capillaries imaged with a 4X objective. Four overlapping images were taken 
to cover the area shown in the picture. 
 
3.2.4 Identification of cochlear cell types  
The highly organized architecture of the cochlear epithelium allows for the 
identification of its different cell types. Here, the steps to differentiate Hensen’s from 
Claudius’ cells will be used as an example.  
i) First, the supporting cells types were identified by their location relative to the 
sensory hair cells in the x and y axes. The stereocilia bundles of the inner (IHC) and outer 
(OHC) hair cells are easily identified on the apical surface of cochlear explants (Figures 
3.5A and 3.5B) and they provide the first reference about the position of all supporting 
cells. For instance, the Hensen’s and Claudius’ cells located toward the lateral side of the 
OHC (i.e., the bottom of Figures 3.5A and 3.5C).  
ii) Because different cell types are observed at different focal planes (Figure 3.5D), at 
the beginning of every experiment a stack of bright field images spanning the entire 
thickness of the explant was obtained, with images taken every 1 µm. This image stack 
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was used as reference during the data analysis. Hensen’s cells are columnar cells 
organized in two (sometimes three) intercalated rows. The first row of Hensen’s cells is 
the closest to the OHCs and is located at a higher z plane than the second row of 
Hensen’s cells. In contrast, Claudius’ cells are short cuboidal cells arranged in a flat 
configuration (one-cell thick). 
 
 
Figure 3.5. Representative bright field images of a cochlear explant taken at 
two different focal planes  
A, Focal plane at the level of the hair cell stereocilia. One row of IHCs, three 
rows of OHCs and the cells of the Kolliker’s organ (KoC) are visible. B, 
Higher magnification of a region from A highlighting the IHC and OHC 
stereocilia bundles. C, Focal plane below the hair cell bodies, where pillar 
(PC), Deiters’ (DC), Hensen’s (HeC) and Claudius’ cells (CC) are visible. D, 
Diagram of a cross-section of the organ of Corti indicating the two focal 
planes shown in A and C. 
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iii) Lastly, the differences in cell morphology also allowed for the identification of 
boundaries between cell types. While a cross-section of a Hensen’s cell exhibits a 
hexagonal yet almost ovoidal shape, a cross-section of a Claudius’ cell looks like a 
hexagon with sides of similar length (Figure 3.5C). 
 
3.3 Immunohistochemistry 
3.3.1 PLAP immunolabeling 
Cochlear explants were fixed in a 4% paraformaldehyde (PFA) (Electron Microscopy 
Sciences) solution in 1X phosphate-buffered saline (PBS) (Gibco) for 1-4 hours. Explants 
were washed with PBS containing 0.01% Triton-X (Electron Microscopy Sciences). 
Next, the tissue was placed in a blocking solution that consisted of 10% normal goat 
serum (NGS) (Invitrogen) in wash buffer for 1h at room temperature (RT). Explants were 
incubated overnight with a mouse anti-hPLAP clone 8B6 antibody (1:100) (Sigma-
Aldrich) in blocking solution at 4°C in a humid chamber. Incubation with a goat anti-
mouse Alexa Fluor 488 secondary antibody (1:1000) in blocking solution was performed 
at room temperature for 2h. Tissue was counterstained in 300 nM 4’,6-diamidino-2-
phenylindole (DAPI) (Invitrogen) in PBS for 5 min and mounted with ProLong® Gold 
antifade medium (Invitrogen). The imaging set up used is described in section 3.3.3. 
One of the figures in Chapter 4 contains an image obtained by our collaborator K. 
Kwan (Rutger’s University) (manuscript in preparation, Vélez-Ortega, et al.). He 
followed a similar protocol of PLAP immunolabeling. The only differences were in the 
secondary antibody used (goat anti-mouse Alexa Fluor 568), staining with 500 ng/ml 
Hoechst 33235 instead of DAPI, and adding phalloidin (1:400) counterstaining as well. 
His image was obtained with an Olympus FluoView 1000 scanning confocal microscope 
equipped with at 63X PlanSApo objective (1.42 NA), at 1024x1024 resolution with a 
pixel dwell time of 2-8 µs. 
 
3.3.2 Immunolabeling of 4-HNE-modified proteins 
Tympanic bullae (from noise-exposed and control mice) were perfused with a solution 
of 4% PFA in 1X PBS and kept for 1 to 4 h at 4°C before further dissection. Perfusion 
was performed through the oval window after making a hole in the apical end of the otic 
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capsule. Tissue dissection was performed in distilled water. Samples were washed with 
PBS and permeabilized for 10 min in a 1% Triton-X solution. Tissue was blocked for 45 
min in 10% NGS in PBS and incubated with rabbit polyclonal anti-HNE (1:50) (Abcam) 
in blocking solution over night at 4°C. Incubation with the secondary mouse anti-rabbit 
Dylight 488 antibody (1:200) (Jackson Immunoresearch) was performed for 2 h at RT. 
Samples were counterstained with DAPI (600 nM) for 10 min and mounted in antifade 
medium. The anti-4-HNE antibody recognizes proteins that have been covalently 
modified by 4-HNE after oxidative stress. To test the performance of this antibody, we 
exposed cochlear explants to varying concentrations of hydrogen peroxide (H2O2) 
(Molecular Probes) over night (Figure 3.6).  
 
3.3.3 Imaging set up 
An upright Olympus BX51WI spinning disc confocal microscope was used. The 
microscope was equipped with a 100X LUMPlan FL objective (1.0 numerical aperture –
NA) (Olympus), an Olympus U-RFL-T mercury arc lamp, a nanopositioning system for 
focal plane control (Mad City Labs) and the Evolve 512 EMCCD camera (Photometrics). 
The camera was used at its full chip resolution (512x512) and digitization (16-bit). The 
filter cubes used allowed for excitation and emission bandwidths for Alexa Fluor 488, 
Dylight 488 (488/20 nm and 525/50 nm) and DAPI (350/50 and 460/50 nm) (Olympus). 
The MetaMorph for Olympus Imaging Series v.7.7 (Molecular Devices) was used for 
imaging acquisition. All imaging settings (e.g., exposure, gain, readout speed) were kept 
identical between different samples.  
 
3.4 Drug delivery 
3.4.1 Stock and working solutions of the drugs used 
ATP and several TRPA1 agonists (4-HNE, CA and AITC) were used for tissue 
stimulation during different experiments.  
4-HNE (Cayman Chemical) was purchased at a 64 mM concentration in ethanol, and 1 
µL of this solution was mixed with 320 µL of bath medium to achieve a 200 µM working 
solution. The 4-HNE stock was stored at -80°C and working solutions were made fresh 
each time. 
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Figure 3.6. Performance test of the 4-HNE antibody  
A, B, Immunolabeling with the anti- 4-HNE antibody was performed in 
cochlear explants exposed to 20 (A) or 200 µM H2O2 (B) for ~12 h. Bright 
field images (left) and maximum intensity projections of 4-HNE 
immunofluorescence (right) are shown. Notice that the levels of 4-HNE 
immunolabeling are higher in the cells exposed to the higher H2O2 
concentration. In particular, supporting cells surrounding the IHCs show the 
brightest labeling. IHC, inner hair cells; OHC, outer hair cells. 
 
CA (Sigma-Aldrich) was dissolved in 60% ethanol to make a 100 mM stock solution 
(6.3 µL of a 1.05 g/mL CA solution were mixed with 1 mL of 60% ethanol). This stock 
solution was kept at 4°C and used for up to a week. Working solutions (100 µM) were 
made by mixing 1 µL of the stock solution with 1 mL of bath medium and made fresh 
each time. 
A 95% AITC solution (Sigma-Aldrich) was dissolved in 60% ethanol to make a 200 
mM stock solution (4.9 µL of AITC with 250 µL of 60% ethanol). 1 µL of the stock 
solution was mixed with 2 mL of bath medium to achieve a working solution at 200 µM. 
AITC stock solutions were stored at -80°C. 
56 
 
ATP-Na2 (Sigma-Aldrich) was diluted in distilled water (Gibco) to a 1 mM 
concentration (stock solution) and stored at -80°C in small aliquots to avoid thawing-
freezing cycles. To achieve their final concentration (2 to 250 µM), ATP aliquots were 
diluted with bath medium immediately before use. 
 
3.4.2 Glass micro-pipettes 
Micro pipettes were pulled from glass capillaries (World Precission Instruments) using 
a P-2000 laser puller. Capillaries were made of borosilicate glass, 10 cm long, fire 
polished, contained an internal filament (to facilitate filling with liquid) and outer/inner 
diameters of 1/0.58 mm. Small diameter (~ 2-3 µm) pipettes were used during the Ca2+ 
imaging experiments while pipettes with larger diameters (~ 6-8 µm) were used during 
the patch clamping experiments. 
 
3.4.3 Puff stimulation 
Glass micro-pipettes were used to stimulate small tissue areas on the cochlear explants 
with ATP (2 to 250 µM, Sigma-Aldrich) or with the TRPA1 agonists 4-HNE (200 to 400 
µM, Cayman Chemical), CA (100 to 200 µM, Sigma-Aldrich) and AITC (100 µM, 
Sigma-Aldrich). These drugs were always dissolved in the same type of solution present 
in the bath. The pipette tips were placed ~8 to 10 µm above the tissue surface using a 
MP-285 micromanipulator (Sutter Instrument). 
A pneumatic pico-pump (World Precision Instruments) was used to apply pressure at 
the back of the pipette and, for fine pressure control, a TraceableTM manometer gauge 
(Fisher Scientific) was placed in the tubing line between the pico-pump and the pipette. 
The pico-pump was triggered by a 5 V transistor-transistor logic (TTL) signal delivered 
by a data acquisition (DAQ) board (National Instruments) controlled by the Clampex or 
Metamorph software. The delay in the puff stimulation was estimated to be ~ 40 ms 
(Figure 3.7). 
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Figure 3.7. System delay during puff stimulation 
A,B, The delay between the TTL trigger and the beginning of drug delivery 
was measured by placing a puff pipette filled with a 2 M KCl solution ~10 µm 
away from a patch clamping electrode (see section 3.7) connected to a patch 
amplifier. Changes in the standing current through the electrode were induced 
after the puff stimulation (A) and they typically started ~40 ms after the TTL 
pulse was delivered (B). 
 
The area to be stimulated was determined by the size of the pipette tip and the pressure 
applied at the back of the pipette (Figure 3.8). Typically, the pressure applied ranged 
between 2 to 4 kPa. 
 
3.5 FM1-43 labeling 
The use of the small cation dye FM1-43 to assess for the presence of functional 
TRPA1 channels in cochlear hair cells was previously reported by our laboratory [286]. 
Briefly, cochlear explants from wild type and Trpa1–/– mice were pre-treated with 10mM 
1,2-Bis[2-aminophenoxy]ethane-N,N,N′,N′-tetraacetic acid (BAPTA) (Sigma-Aldrich) in 
Ca2+-free Hank’s balanced salt solution (HBSS) (Gibco) for 10 min. Next, cochlear 
explants were incubated with 5 µM FM1-43 for 30 s in Ca2+-free HBSS and immediately 
washed with standard HBSS.  
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Figure 3.8. Puff stimulation area 
A-D, Two pipettes were filled with fluorescent dye (Fura-2) to mimic drug 
delivery. Notice how the area of puff stimulation changes between low (A) 
and high (B) puff pressures. In addition, the increase and decrease in 
fluorescence during the stimulation with low (C) and high (D) puff pressure is 
shown. Notice the time correlation between the changes in fluorescence and 
the TTL pulse (black line) in both conditions. a.u., arbitrary units. 
 
Imaging was performed within 30 min after the incubation with the FM1-43 dye, and 
it was performed in standard HBSS at RT. The same set up described in section 3.3.3 was 
used, but the microscope was equipped with a 60X LUMPlan FL N objective (1.0 NA) 
(Olympus) and with filter cubes for 488/20 nm emission and 525/50 nm excitation 
(Olympus). Imaging acquisition settings were kept identical between different samples. 
 
3.6 Ratiometric calcium imaging 
3.6.1 Loading cells with the Ca2+ indicator 
Cochlear explants were loaded with the membrane-permeable ratiometric Ca2+ 
indicator: fura-2-acetoxymethyl ester (AM) (Invitrogen). To help solubilize the dye, 50 
µg of fura-2-AM were dissolved in 10 µL of a 20% Pluronic acid solution in DMSO 
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(Invitrogen). This 5 mM stock solution of the dye was stored at < -15°C for up to a month 
and limited to 3 thawing-freezing cycles. Before each experiment, the stock solution was 
thawed in a 37°C bath (~20 min) and vigorously mixed (vortexed for ~5 min). The 
cochlear explants were incubated in L-15 medium containing 2 µL of the stock solution 
(i.e., 10 µM concentration of the fura-2 dye) for 50 min at RT. Explants were washed and 
then incubated in fresh L-15 medium for 20 min to allow the complete de-esterification 
of the dye. Imaging was performed immediately after, in L-15 medium at RT. For some 
experiments, 50 µM pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid (PPADS) was 
added to the bath solution before imaging.  
 
3.6.2 Live cell imaging  
Imaging was performed using the set up described in section 3.3.3. However, instead 
of the mercury arc lamp, the Lambda DG-4 system (Sutter Instrument) was used to 
control the fast switching between illumination at 340 and 380 nm. Therefore, because 
the Lambda DG-4 illumination path bypassed the spinning disk unit of the microscope, it 
was not possible to perform ratiometric Ca2+ imaging in a confocal mode. A filter cube in 
the microscope allowed the emission at 510/80 to be captured by the camera. Three 
different objectives were used: 40X 0.8 NA (LUMPLFLN40X/W), 60X 1.0 NA 
(LUMPLFLN60X/W) and 100X 1.0NA (LUMPLFL100XW/IR) (Olympus). In addition, 
sometimes a secondary custom-made 2X magnification lens was added in the infinity-
corrected light path of the microscope. Alternating images between the 340 (F340, Ca
2+-
bound dye) and 380 nm (F380, Ca
2+-free dye) illuminations were obtained to assess 
changes in intracellular Ca2+ levels. At the beginning of each experiment image stacks for 
the F340 and F380 illuminations were take every 1 µm and covered the entire thickness 
of the tissue. These stacks were used as references –for cell types and positions– during 
the data analysis. 
 
3.6.3 Image analysis  
Image analysis was performed using the ImageJ software [287] and the Ratio Plus 
plugin (http://rsb.info.nih.gov/ij/plugins/ratio-plus.html). Each ratio image (R) was 
obtained by dividing corresponding pixels between the F340 and F380 images (F340/F380). 
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Background subtraction for the independent signals was not performed given that the 
background light was several orders of magnitude smaller than the fura-2 signal. The 
error that this background light introduced in the ratio measurements was calculated to be 
around 0.006%. To enhance the changes in intracellular Ca2+ with time, ratio images 
were normalized to the first ratio obtained in the series (R/R0). A pixel value of 1 would 
indicate no change in intracellular Ca2+ was evident. Instead, a pixel value of 2 would 
correspond to an increase in intracellular Ca2+ but not necessarily a doubling in the 
amount of Ca2+. 
 
3.6.4 Calculating free Ca2+ concentrations from F340/F380 ratios  
Within each experiment, exposure and gain settings were kept identical for the F340 
and F380 images. However, different objectives and illumination intensities were used 
between different experiments (Table 3.1), thus a different calibration curve was 
generated for each situation. 
 
Table 3.1. Imaging conditions used during ratiometric Ca2+ imaging 
Objective 
Extra 
magnification 
F340 
intensity* 
F380 
intensity* 
R2 value of 
calibration curve 
40X 2X 
50% < 33% † 0.9979 
100% 33% 0.9981 
60X 
No 100% 33% 0.9989 
2X 100% 33% 0.9872 
100X No 50% 100% 0.9971 
* F340 and F380 intensities are controlled by changing the optical alignment of 
two galvanometers in the Lambda DG-4 illumination system. Factory preset 
values are provided to achieve 100%, 50% and 33% of the maximum output for 
each channel. 
† The alignment of the Lambda DG-4 galvanometers was modified. The F380 
intensity was lower than 33% but the exact value was not determined.  
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Briefly, a Ca2+ calibration buffer kit (Molecular Probes) containing eleven dilutions 
with free Ca2+ ranging from 0 to 39 µM was used to generate calibration curves for all 
imaging conditions used. Fura-2 pentapotasium salt (Invitrogen) was added to each 
calibration dilution at a final concentration of 10 µM. To minimize errors, a small volume 
of the fura-2 dye (6 µL) was added to a large volume of the calibration dilution (2 mL). 
Next, 300 to 500 µL of each dilution were placed on a Petri dish and F340 and F380 images 
were acquired. Special care was taken during imaging acquisition to keep the z position 
constant between samples.  
To determine the dissociation constant (Kd) of the fura-2 indicator, the 
𝐿𝑜𝑔 �[𝐶𝑎2+]𝑓𝑟𝑒𝑒� of the calibration dilutions were plotted (x axis) against  
𝐿𝑜𝑔 �
[𝑅− 𝑅𝑚𝑖𝑛][𝑅𝑚𝑎𝑥− 𝑅]  ×  𝐹380𝑚𝑎𝑥𝐹380𝑚𝑖𝑛� (y axis), where R is the F340/F380 ratio for each dilution, Rmin 
the F340/F380 ratio for the Ca2+-free dilution (0 µM), Rmax the F340/F380 ratio for the 
saturating Ca2+ dilution (39 µM), F380 max the F380 value for 0 µM Ca2+ and F380 min the 
F380 value for 39 µM Ca2+. All graphs resulted in straight lines (R2 values greater than 
0.987) (Figure 3.9 and Table 3.1) where the x intercepts corresponded to 𝐿𝑜𝑔 (𝐾𝑑). 
Lastly, free intracellular Ca2+ concentrations were estimated from experimental F340/F380 
ratios (RExp) by using the Grynkiewicz equation [288]:  
 [𝐶𝑎2+]𝑓𝑟𝑒𝑒 =  𝐾𝑑𝐸𝐺𝑇𝐴  ×  [𝑅𝐸𝑥𝑝 −  𝑅𝑚𝑖𝑛][𝑅𝑚𝑎𝑥 −  𝑅𝐸𝑥𝑝]  ×  𝐹380𝑚𝑎𝑥𝐹380𝑚𝑖𝑛  
 
3.7 Patch clamping recordings 
Glass micro-pipettes were pulled from glass capillaries using the P-1000 heating 
filament puller (Sutter Instrument). Typically, pipettes exhibiting a resistance of 5 to 12 
MΩ were used. 
In some cases, to gain access to a particular cell within the tissue, it was necessary to 
remove neighboring cells. For instance, OHCs and Deiters’ cells were removed to clear 
the access to the lateral wall of the pillar cells. The intracellular solution used in the patch 
pipettes contained (in mM): KCl (12.6), KGlu (131.4), MgCl2 (2), EGTA (0.5), K2HPO4 
(8), KH2PO4 (2), Mg2-ATP (2) and Na4-GTP (0.2). The osmolarity and pH of the 
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intracellular solution was adjusted to match that of the bath solution (typically, 310 
mmol/kg and pH 7.4). After achieving a whole-cell configuration, the cell contents were 
allowed to equilibrate with the patch pipette fluid for 5 min before any recordings were 
performed. All recordings were performed at room temperature. 
 
 
Figure 3.9. Calibration curves for the fura-2 dye  
A, B, Calibration curves from 2 (out of 5) settings are shown: 40X objective 
(with 2X extra magnification) with 50% F340 and < 33% F380 intensities (A), and 
100X objective with 50% and 100% intensities (B). Values obtained for each 
dilution were plotted (red diamonds) and data were fitted using a linear 
regression.  
 
Because all supporting cells are electro-chemically coupled (Figure 3.10), patch clamp 
recordings had to be performed in the presence of a gap junction blocker. Some of the 
blockers tested were carbenoxolone disodium salt (CBX) (Sigma-Aldrich) [289], octanol 
(Sigma-Aldrich) [290] and flufenamic acid (FFA) (Fluka, Sigma-Aldrich) [291]. These 
gap junction blockers were tested in the bath solution, the intracellular solution, or both. 
CBX (100 – 500 µM) failed to block the propagation of a fluorescent dye from the 
patched cell to its neighboring cells (indicating an incomplete block of gap junctions) 
(Figure 3.11). Octanol seemed to completely block the gap junctions at high 
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concentrations (1 mM) but impaired cell survival (data not shown), and thus limited the 
duration of the recordings. However, 100 µM FFA provided a long-lasting blockage of 
gap junctions without inducing the cell death observed with octanol. Therefore, 100 µM 
FFA was added to the bath solution (i.e. L-15 medium) for all patch clamp experiments. 
A stock solution of 100 mM FFA in DMSO was kept in small aliquots at -80°C for no 
more than 4 weeks and freezing/thawing cycles were avoided. 
 
 
Figure 3.10. Supporting cells are electrochemically coupled via gap junctions 
To test the extent of the gap junctional conductance in the cochlear 
epithelium, 265 µM fluorescein sodium salt (Sigma-Aldrich) was added to the 
intracellular solution. The results obtained when patching an inner pillar cell 
(IPC) are shown. A, B, Bright field images at the level of inner hair cell (IHC) 
stereocilia (A) and IPC feet (B) show the tissue after the removal of the 
neighboring outer hair cells and Deiter’s cells. C, The patch pipette in the bath 
solution shows the leakage of the fluorescent dye. D, During the gigaohm 
seal, no leakage of the fluorescent dye is observed. E-H, Whole-cell voltage-
clamp configuration of an IPC showing the fluorescent dye within the cell 
immediately after breaking the membrane (E) and its diffusion to neighboring 
cells 21 (F), 44 (G) and 63 min (H) later. 
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The microscope described in section 3.3.3 was used, equipped with either a 60X or 
100X objective (1.0 NA). A headstage preamplifier was mounted onto MP-285 
micromanipulators. During the experiment, the tissue was observed with a Hitachi 1/2" 
surveillance video camera. 
The MultiClamp 700B amplifier together with the pClamp 10 software (Molecular 
Devices) were used for the patch clamp recordings. The ‘membrane test’ feature in 
pClamp was used to monitor (i) pipette resistance, (ii) patch resistance (i.e. gigaohm seal 
formation) and (iii) cell parameters during the whole-cell configuration (e.g., cell 
resistance, membrane capacitance, and access resistance). These parameters were 
measured by delivering a 10 mV square pulse at 100 to 500 Hz.  
 
 
Figure 3.11. CBX fails to block the diffusion of a fluorescent dye between 
supporting cells 
A, An inner pillar cell (IPC) was patch clamped and the fluorescein dye (265 
µM) present in the intracellular solution diffused to neighboring cells even in the 
presence of 500 µM CBX in the intracellular solution. Images at two focal 
planes are shown: immediately below the inner hair cell (IHC) bundles (Left) 
and near the IHC base (Right). B, Orthogonal view from the plane indicated with 
a dashed line in A. The patch pipette on the lateral side of the IPC is visible, and 
also the propagation of the fluorescent dye to cells located on the medial side of 
the IHC. IBC, inner border cell; IPhC, inner phalangeal cell; IPC, inner pillar 
cell. 
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Preliminary experiments were performed to compare several cell parameters between 
different types of cochlear supporting cells: inner pillar (IPC), outer pillar (OPC), 
Deiters’ (DC), Hensen’s (HeC) and Claudius’ cells. After achieving a whole-cell 
configuration, current-voltage (IV) relationships were evaluated using voltage steps from 
-90 to +90 mV, with steps every 15 mV. These preliminary results indicated differences 
in membrane capacitance and resting membrane potentials between the different 
supporting cells (Figure 3.12). These results were used to decide the holding potentials 
and voltage protocols applied to each cell type. The holding potentials (in mV) were 
defined as: -40 to -50 (IPC), -20 to -30 (OPC), -10 to -20 (DC) and 0 to +10 (HeC). 
 
 
Figure 3.12. Electrophysiological characteristics of cochlear supporting cells 
A, B, Average values of membrane capacitance (A) and reversal potential (B) for 
the different types of cochlear supporting cells. The numbers of cells averaged 
are shown within parenthesis above each bar. IPC, inner pillar cells; OPC, outer 
pillar cells; D3, Deiters’ cells from the third row; HeC, Hensen’s cells; CC, 
Claudius’ cells. 
 
Current responses to the puff stimulation with 100 CA were evaluated during a step 
voltage to -90 mV. In addition, 300 ms ramps from -90 mV to +90 mV were delivered 
before, during and ~5 min after puff stimulation. Data analysis was performed using the 
Clampfit 10 software. 
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3.8 Laser uncaging 
3.8.1 Set-up configuration 
The microscope described in section 3.3.3 was equipped with a 355 nm diode pumped 
solid state laser (DPSL-355/30 system, Rapp OptoElectronic) and a 100X LUMPlan FL 
N (1.0 NA). Using a fiber optic with a diameter of 50 µm, a laser spot size of ~10 µm 
was achieved (Figure 3.13). Throughout the experiment, cell currents were measured 
using the Clampex 10 software, and alternating bright field and Ca2+ imaging were 
recorded using the Metamorph software. The Ca2+ indicator fluo-4 (Molecular Probes) 
and a filter cube for 535/45 emission and 475/40 nm excitation were used for intracellular 
Ca2+ imaging.      
 
 
Figure 3.13. Laser spot size 
A, Fluorescing grease mounted onto a glass microscope slide (Rapp 
OptoElectronic) was used to measure the size of the laser spot. B, A short 
laser pulse stimulation left a burned spot on the grease that was used to focus 
the laser, until a final ~10 µm laser spot was achieved.  
 
3.8.2  Ca2+ uncaging in pillar cells 
A photolabile Ca2+ chelator, nitrophenyl EGTA (NP-EGTA) (Molecular Probes), was 
delivered to cells via a patch pipette. The intracellular solution contained (in mM): KCl 
(12.6), KGlu (131.4), CaCl2 (0.7), NP-EGTA (1), K2HPO4 (8), KH2PO4 (2), Na4-ATP 
(2), Na4-GTP (0.2) and fluo-4 (0.05). L-15 medium supplemented with 100 M µFFA was 
used as the bath solution. Outer pillar cells were patched at their basolateral membrane 
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near their feet. Cells were held at their resting potential ~-40 mV throughout the 
experiment. In control experiments, NP-EGTA was replaced with EGTA. 
Baseline recordings were performed for 100 to 300 s before the laser stimulation, and 
continued for >500 s after that. Laser UV stimulation was performed with 15 to 25 
pulses, 1 ms each, delivered at 166 Hz. Intracellular Ca2+ and cell diameter were 
measured by monitoring fluo-4 fluorescence and bright field imaging, respectively, 
during the experiment. For details about the cell diameter measurements, see section 
3.9.3. 
 
3.9 Measurement of tissue displacements and cell contractions 
3.9.1 Imaging set-up and software 
The microscope described in section 3.3.3 was equipped with a 100X objective (1.0 
NA), a halogen bulb lamp (Olympus) and cubes for differential interference contrast 
(DIC) imaging (Olympus). Time-lapse bright field imaging was performed 
simultaneously with the ratiometric Ca2+ imaging (section 3.6) and during the laser 
uncaging experiments (section 3.8). 
 
3.9.2 Tissue displacement measurements 
TRPA1 activation caused tissue displacements evident during bright field imaging. 
These tissue movements let to changes in the pattern of light scattering. Therefore, 
images were analyzed using the ImageJ software [287]. Bright field frames that were 
taken 10 s apart were subtracted to enhance any movement in the tissue. In the subtracted 
images (32-bit), pixel values of 0 represented no movement between the two frames, 
while positive and negative values indicated the presence of tissue displacements. The 
standard deviation in the pixel values was measured within regions of interest and plotted 
against time. Due to differences in light intensity, scattering patterns and contrast 
between samples, results of different experiments were normalized and areas under the 
curve (A.U.C.) were calculated. Within each experiment, comparisons were made 
between frames taken before and after the TRPA1 agonist application.  
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3.9.3 Measuring cell diameters 
Bright field images were used to measure cell diameters using a method previously 
published for OHC electromotility quantification [292]. In summary, pixel intensity 
profiles were obtained from lines placed across the cells of interest (Figure 3.14A). These 
measurements were performed for each time frame using the MetaMorph software and its 
linescan feature (Figure 3.14B).  
 
 
Figure 3.14. Cell diameter measurements 
A, Bright field image showing the line used to measure the pixel value profile. 
B, Pixel value profiles for the line shown in A at different time points (from 
black to light grey). C, D, Cell edge movements were quantified by placing a 
horizontal line (red line) and finding the first point where each pixel profile 
was crossed. To do so, line profiles were aligned on the side to be measured 
(left edge in C and right edge in D). 
 
Cell edge movements were quantified using algorithms written in the Matlab software. 
Pixel values along each line were interpolated to increase the number of points by 50 
times. Movements at both edges of the cell were quantified after aligning the line profiles 
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on the side to be measured (Figures 3.14C and 3.14D). The first point crossing a 
horizontal line (placed by the user) was used to calculate the position of the cell edge. 
Based on the movement of each edge and the original size of the line, the changes in cell 
diameter were calculated. 
 
3.10 Auditory brainstem responses (ABR) 
3.10.1 Mouse anesthesia 
Young adult mice (3 to 4 week old) were anesthetized with intraperitoneal injections 
of 2,2,2-tribromoethanol (Avertin) (Sigma-Aldrich) at a dosage of 0.4 mg/g of body 
weight. When required, a 0.1 mg/g boost was injected. Mice were kept on a heated plate 
during the experiment. 
 
3.10.2 ABR recordings 
Subdermal needle electrodes were positioned at the base of each pinna (positive and 
negative electrodes) and on the top of the head (ground electrode). A speaker (MF-1, 
Tucker-Davis Technologies) was placed in front of the mouse, 1 inch away from the 
center of the head.  
An Auditory Workstation coupled with the BioSigRP software (Tucker-Davis 
Technologies) was used to deliver 3 ms tones of a specific frequency (8, 16, 24 and 32 
kHz) and sound pressure level decibel (SPL dB). Tones were presented at 200 Hz and 
with alternating polarity. A threshold was established to reject signals that included 
outlier signals (e.g., the QRS wave from the heart electrocardiogram). ABR signals were 
averaged 512 to 1024 times for each frequency and SPL value. A half-interval search 
algorithm was used to determine the hearing threshold value for each frequency, with a 
final ~ 3 SPL dB resolution. For conditions where no hearing threshold was detected, the 
highest SPL value evaluated was assigned (i.e. 112 SPL dB). Hearing thresholds were 
measured before and several time points after noise exposure (Figure 3.15). 
 
70 
 
 
Figure 3.15. Representative ABR traces before and after noise exposure 
A-C, Example of ABR traces from the same mouse obtained before (A), 
immediately after (B) and 2 weeks after (C) noise exposure. Notice that the 
range of SPL dB values evaluated is different for each panel. For this mouse, the 
hearing thresholds were assigned as: 30 (A), 91 (B) and 50 dB (C). 
 
For the ABR recordings, two cohorts of mice were used. The first cohort compared 
wild type and Trpa1–/– mice from the colonies that were maintained separately. In the 
second cohort, wild type and Trpa1–/– littermates were compared. Since no differences 
were observed between these two cohorts, the data were combined for plotting and 
analysis purposes. 
 
3.10.3 Noise exposure 
Anesthetized mice were exposed to a broadband noise at 100 dB for 30 min. The noise 
was delivered by a speaker placed in front of the mouse, 1 inch away from the center of 
the mouse head.  
 
3.11 Distortion product otoacoustic emissions (DPOAE) 
These experiments were performed by the technician Stephanie Edelmann, MS, under 
the supervision of A.C. Vélez-Ortega. Briefly, 3-4 week old mice were anesthetized (as 
described in section 3.10.1) and a low-noise microphone probe (ER-10B+ model, 
Etymotic Research Inc.) was placed in the mouse left ear canal. Two tones of f1 and f2 
frequencies at a ratio of 1.2 (f1/f2) were generated by electrostatic speakers and presented 
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with equal sound pressure levels (SPL). The microphone probe measured the intensity of 
the 2f1-f2 frequency in the ear canal (i.e. DPOAE) together with the noise floor level (i.e. 
intensity of the surrounding frequencies). Several stimuli frequencies (4 to 20 kHz) and 
SPL values (40 to 70 dB) were evaluated. DPOAE values were measured before noise 
exposure and at several time points of recovery. 
 
3.12 Statistical analysis 
The student’s t-test was used to compare the results from wild type and Trpa1–/– mice 
in the following experiments: (i) intracellular Ca2+ baseline levels and peak responses 
after TRPA1-agonist puff stimulation, (ii) tissue movement after TRPA1 stimulation and 
(iii) changes in intracellular Ca2+ and cell diameter after laser stimulation. Changes in 
intracellular Ca2+ levels in cells treated with FFA, were also analyzed using the student’s 
t-test. Differences in peak whole-cell current responses after TRPA1 activation between 
cells from from wild type and Trpa1–/– mice were evaluated using a t-test for samples 
with unequal variances. Two-way ANOVAs were used to compare ABR and DPOAE 
results between wild type and Trpa1–/– mice. Bonferroni corrections were performed for 
the multiple comparisons made within the ABR and DPOAE results. The GraphPad 
Prism software v.5 was used to perform the statistical analyses.  
The numbers (n) of cells, regions and/or cochlear explants included in each analysis 
are shown in the corresponding figures. Cells within a given explant were averaged and 
the statistical analyses were performed using the mean values of each explant. Error bars 
indicate the standard errors (SEM) around the mean values. Asterisks indicate statistical 
significant differences with P values < 0.05 (*), < 0.01 (**) and < 0.001 (***). 
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CHAPTER 4 
Results 
 
4.1 TRPA1 is widely expressed in the mammalian cochlea 
The presence of Trpa1 mRNA in the cochlear epithelium has been previously 
acknowledged [99, 177], however, those studies lacked the spatial resolution needed to 
clearly identify the specific cell types that express the Trpa1 gene.    
Because all commercially available antibodies against the TRPA1 protein tested so far 
exhibit various degrees of non-specific binding in cochlear explants from Trpa1–/– mice 
(personal communication from David Corey, Harvard University and Kelvin Kwan, 
Rutgers University), the presence of an active Trpa1 promoter was evaluated using an 
indirect method. In Trpa1–/– mice the human PLAP gene (i.e. the reporter gene used to 
replace the Trpa1 pore-forming region in the knockout animals [102]) is driven by the 
endogenous promoter of the Trpa1 gene. Therefore, we performed immunolabeling 
against the human PLAP protein in cochlear explants from wild type and Trpa1–/– mice.  
As expected, human PLAP expression was not detected in the cochlear epithelium 
from wild type mice (Figure 4.1A top). Instead, human PLAP was expressed throughout 
the entire cochlear epithelium from Trpa1–/– mice, including the sensory inner (IHCs) and 
outer (OHCs) hair cells and also most types of supporting cells, in particular, Kolliker’s 
organ, pillar, Hensen’s and Claudius’ cells (Figure 4.1A bottom). The staining against 
human PLAP was particularly high in the row of pillar cells. Moreover, images at a 
higher magnification confirmed the bright staining of human PLAP in the pillar cell 
region and also in the Deiters’ cells (Figure 4.1B). 
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Figure 4.1. TRPA1 is widely expressed in the cochlear epithelium. 
A, PLAP immunolabeling (red) and phalloidin counterstaining of actin 
filaments (green) in cochlear explants from wild type (top) and Trpa1–/– mice 
(bottom). Images courtesy of David Corey and Kelvin Kwan (Harvard 
University). B, PLAP immunolabeling (green) and DAPI counterstaining of a 
cochlear explant from a Trpa1–/– mouse at a higher magnification than in A. 
Left, DIC image at a focal plane by the OHC bundles shown as reference. 
Middle, PLAP and DAPI fluorescent signals at a focal plane by the OHC 
nuclei. Right, Z-axis maximum intensity projection of PLAP fluorescent 
signal within the Deiters’ cell region. 
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This approach allowed us to identify the presence of active TRPA1 promoters in most 
cell types within the cochlear epithelium; however, it did not provide information about 
whether these cells express functional TRPA1 channels or details about their subcellular 
localization. 
 
4.2 Sensory and supporting cells within the cochlear epithelium express functional 
TRPA1 channels 
To assess for the presence of functional TRPA1 channels, we evaluated the uptake of 
the small fluorescent cation FM1-43 through open TRPA1 channels after stimulation 
with the agonist cinnamaldehyde (CA) [286]. Explants were pre-treated with a BAPTA-
buffered Ca2+-free solution to disrupt the tip links within hair cell stereocilia bundles, 
thus eliminating the entry of the FM1-43 dye to IHCs and OHCs through the MET 
channels that are partially open at rest due to the tip link resting tension. A short (30 s) 
incubation with the FM1-43 dye led to small dye uptake in IHCs and all rows of OHCs in 
explants from Trpa1–/– (Figure 4.2A) and wild type mice (Figure 4.2B). This small dye 
uptake might occur via other non-selective cation channels expressed in hair cells (e.g. 
P2X and TRPV1 channels). A similar degree of dye uptake was seen in explants from 
Trpa1–/– mice when the incubation with FM1-43 was performed in the presence of 200 
µM CA (Figure 4.2C). However, in the presence of CA, the dye uptake in wild type 
explants was considerably increased in IHCs and OHCs, and it was also noticeable in 
Hensen’s cells and the Kolliker’s organ (Figure 4.2D). These results indicate the presence 
of functional TRPA1 channels in wild type IHCs, OHCs, Hensen’s and Kolliker’s organ 
cells. Interestingly, no FM1-43 uptake was observed in wild type pillar and Deiters’ cells 
in spite of the presence of PLAP labeling in these cells (Figure 4.2D). Since pillar and 
Deiter’s cells are localized mostly underneath the hair cells and have limited access to the 
apical surface of the organ of Corti, it is possible that their contact with either the FM1-
43 dye or the TRPA1 agonist was limited as well. This could explain the lack of FM1-43 
uptake in pillar and Deiters’ cells, even if they do express functional TRPA1 channels. 
Alternatively, due to the complex nature of TRPA1 activation and regulation by several 
types of agonists and second messengers (e.g., intracellular Ca2+ and downstream of 
phospholipase C –PLC– activation) (reviewed in sections 2.3 and 2.5), it is possible that 
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pillar and Deiter’s cells do express TRPA1 channels but different experimental 
conditions might be required to trigger channel gating. Similarly, most Claudius’ cells 
expressed PLAP but very few of them showed uptake of the FM1-43 dye (Figure 4.2D). 
However, as stated earlier, the lack of FM1-43 uptake does not necessarily imply that 
these cells do not express TRPA1 channels. 
 
 
Figure 4.2. IHCs, OHCs, Hensen’s and Kolliker’s organ cells express 
functional TRPA1 channels  
A-D, FM1-43 uptake (green) in cochlear explants from Trpa1–/– (A, C) and 
wild type mice (B, D) after a 30 s incubation with the FM1-43 dye alone (A, 
B) or in the presence of 200 µM the TRPA1 agonist CA (C, D). Images shown 
correspond to maximum intensity projections (z axis) from confocal stacks 
taken for each field of view. KoC, Kolliker’s organ; IHC, inner hair cell; 
OHC, outer hair cell; HeC, Hensen’s cells; CC, Claudius’ cells. 
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Even though CA-induced FM1-43 uptake does reveal the presence of functional 
TRPA1 channels, the degree of dye uptake does not necessarily correlate with the amount 
of channels expressed. Because FM1-43 is a cation, its influx through open TRPA1 
channels is greatly affected by the resting potential of a given cell. Moreover, differences 
between cells types in the kinetics of TRPA1 channel gating and inactivation can also 
influence the amount of FM1-43 uptake. For example, intracellular Ca2+ levels can 
modify the conductance of TRPA1 at the single-channel level (section 2.2.7) [175]. 
We concluded that, among the supporting cells, functional TRPA1 channels are 
present in at least the Hensen’s and Kolliker’s organ cells. 
 
4.3 TRPA1 activation evokes robust and long-lasting Ca2+ responses in Hensen’s 
cells 
Next, we used cochlear explants loaded with the ratiometric Ca2+ indicator fura-2 to 
study the responses of sensory and supporting cells to the puff application of TRPA1 
agonists. In cochlear explants from wild type mice, puff application with 200 µM 4-
hydroxy-nonenal (4-HNE) induced robust Ca2+ responses in the Hensen’s cells (Figures 
4.3A and 4.4A). Typically, we observed a ~ 40 s delay (mean = 38.1 ± 2.0 s, n = 184 
cells from 7 explants) between the start of the 4-HNE puff application and the beginning 
of the robust Ca2+ responses (Figure 4.5A). However, a small Ca2+ increase was often 
evident at earlier time points. This somewhat biphasic response would be consistent with 
the transition from low to high open probability in TRPA1 channels mediated by the 
initial increase in intracellular Ca2+ [175]. The Ca2+ responses in Hensen’s cells induced 
by 4-HNE exhibited a very slow decay as well (mean = 0.53 ± 0.05 % s-1, n = 161 cells 
from 7 explants). This led to long-lasting Ca2+ responses even after the end of the 4-HNE 
puff application (Figures 4.3A and 4.4A).  
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Figure 4.3. TRPA1 agonists induce robust and long-lasting Ca2+ responses in 
wild type Hensen’s cells 
A, B, Time-lapse ratiometric Ca2+ imaging (R = F340/F380) normalized to baseline 
(R0) of cochlear explants from wild type (top) and Trpa1–/– mice (bottom) 
stimulated by puff application of 200 µM 4-HNE (A) or 100 µM CA (B). To the 
left of each series of Ca2+ images, a bright field image is shown as reference to 
indicate the types of sensory and supporting cells within the field of view. 
Dashed lines indicate boundaries between different cell types. Arrows indicate 
the position and direction of puff application. IHC, inner hair cells; OHC, outer 
hair cells; HeC, Hensen’s cells; CC, Claudius’ cells. 
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Figure 4.4. Intracellular Ca2+ levels from Figure 4.3 without normalization to 
the baseline 
A, B, Time-lapse ratiometric Ca2+ imaging (F340/F380) of cochlear explants 
from wild type (top) and Trpa1–/– mice (bottom) stimulated by puff 
application of 200 µM 4-HNE (A) or 100 µM CA (B). To the left of each 
series of Ca2+ images, a bright field image is shown as reference to indicate 
the types of sensory and supporting cells within the field of view. Dashed 
lines indicate boundaries between different cell types. Arrows indicate the 
position and direction of puff application. IHC, inner hair cells; OHC, outer 
hair cells; HeC, Hensen’s cells; CC, Claudius’ cells. 
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Figure 4.5. TRPA1 agonists induce robust Ca2+ responses in Hensen’s cells 
from wild type but not Trpa1–/– mice 
A, C, Changes in intracellular Ca2+ levels (in nM) in Hensen’s cells from wild 
type (black) or Trpa1–/– mice (red) in response to puff application of 4-HNE 
(A) or CA (C). The traces were obtained from the same experiments shown in 
Figures 4.3 and 4.4, and the lines in the x-axis indicate the time points for each 
of the panels shown in those figures. B, D, Peak Ca2+ responses (Rmax) relative 
to baseline levels (R0) were evaluated in time windows (95 s) before 
(baseline), during and immediately after (puff) and about 5 min after 
(washout) agonist stimulation. Bars show mean ± SEM values. The number of 
cells/explants included is shown above each bar. (*) indicates a P value < 0.05 
determined by a Student’s t-test.  
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Similar robust Ca2+ responses (i.e. delayed and long-lasting) were elicited by other 
TRPA1 agonists such as CA (100 µM) (Figures 4.3B, 4.4B and 4.5C) and mustard oil 
(allyl isothiocyanate –AITC–, 100 µM) (Figure 4.6) in wild type Hensen’s cells. As 
expected, the same puff application with 4-HNE and CA failed to induce Ca2+ responses 
in cochlear explants from Trpa1–/– mice (Figures 4.3, 4.4 and 4.5).  
All three TRPA1 agonists tested also failed to induce Ca2+ responses in the supporting 
Claudius’s cells (Figures 4.3, 4.4 and 4.6). These results are consistent with the lack of 
FM1-43 uptake in Claudius’s cells after stimulation with CA (Figure 4.2). 
 
 
Figure 4.6. Mustard oil induces Ca2+ responses in Hensen’s cells with similar 
kinetics to 4-HNE and CA 
A, Time-lapse Ca2+ imaging (R/R0) of a wild type cochlear epithelium showing 
the response to 100 µM mustard oil (AITC) puff application. A bright field 
image (left) is shown as reference and the yellow arrow indicates the position 
and direction of puff application. Dashed lines indicate boundaries between 
different cell types. IHC, inner hair cells; OHC, outer hair cells; HeC, Hensen’s 
cells; CC, Claudius’ cells. B, Changes in intracellular Ca2+ (R/R0) in one of the 
Hensen’s cells shown in A. Arrows below the x-axis indicate the time points 
when the panels shown in A were taken. 
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To our surprise, puff application with either 4-HNE, CA or AITC did not induce 
prominent Ca2+ responses in the sensory IHCs and OHCs (Figures 4.3, 4.4 and 4.6). 
These results did not correlate with our findings of FM1-43 uptake in IHCs and OHCs 
after stimulation with CA (Figure 4.2). We wondered whether this discrepancy could 
arise from the different CA concentrations and delivery methods used. The FM1-43 
experiments were performed with a CA concentration (200 µM) that was double of that 
used for the Ca2+ imaging (100 µM). However, puff application with a higher 
concentration of 4-HNE (400 µM, double of what was used previously) also failed to 
induce Ca2+ responses in IHCs and OHCs (Figure 4.7).  
 
 
Figure 4.7. Sensory hair cells fail to show Ca2+ responses even after stimulation 
with a high concentration of a TRPA1 agonist  
A, B, Time-lapse Ca2+ imaging (R/R0) of cochlear epitheliums from wild type 
(A) and Trpa1–/– mice (B) showing the response to 400 µM 4-HNE puff 
application. A bright field image (left) is shown as reference and the arrows 
indicate the position and direction of the puff application. Notice that the puff 
was applied for a longer time on the Trpa1–/– explant. Dashed lines indicate 
boundaries between different cell types. OHC, outer hair cells; HeC, Hensen’s 
cells; CC, Claudius’ cells.  
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For the FM1-43 experiments, cells were stimulated by CA present in the bath solution 
while, during the Ca2+ imaging experiments, CA stimulation was performed using a puff 
pipette. CA present in the bath solution certainly stimulates a larger number of cells 
because it covers the entire tissue. However, the exposure to the CA-containing bath was 
limited to 30 s, which is a much shorter stimulation duration than the one used with the 
puff application (~ 60 s). We previously confirmed the presence of functional TRPA1 
channels in sensory IHC and OHCs, and suggested that channel expression was limited to 
the basolateral membrane in these cells [286]. Here, we believe the discrepancy between 
the FM1-43 and Ca2+ imaging experiments mainly arises from the exposure to BAPTA in 
the former. The exposure to a BAPTA-buffered Ca2+-free solution is likely to 
compromise the tight junction barrier of the reticular lamina (i.e. the barrier formed by 
the connection between all cells of the cochlear epithelium at their apical side) [293, 
294]. A compromised tight junction barrier might allow CA to activate TRPA1 channels 
in the basolateral membrane of IHCs and OHCs during the FM1-43 experiments. In 
contrast, the tight junction barrier is intact during our Ca2+ imaging experiments, thus 
limiting the access of CA to the basolateral membranes. 
Because particularly long-lasting Ca2+ responses to TRPA1 activation were observed 
in Hensen’s cells but not anywhere else within the cochlear epithelium, we believe 
Hensen’s cells could be the major sensors for oxidative damage (i.e. 4-HNE) in the 
cochlea. Therefore, we also wondered whether the absence of TRPA1 channels would 
alter the resting intracellular Ca2+ levels in Trpa1–/– Hensen’s cells. However, we found 
no differences in the baseline intracellular Ca2+ between Hensen’s cells from wild type 
and Trpa1–/– mice (Figure 4.8). 
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Figure 4.8. Hensen’s cells from wild type and TRPA1-deficient mice exhibit 
similar resting intracellular Ca2+ levels  
Intracellular Ca2+ levels (in nM) of Hensen’s cells from wild type (black) and 
Trpa1–/– mice (red) were estimated from ratiometric Ca2+ imaging with the 
fura-2 dye. Bars show mean ± SEM values. The number of cells/regions 
included in the analysis is shown for each bar. A P value > 0.86 was 
determined using a Student’s t-test. 
 
4.4 Responses to TRPA1 agonists in the Hensen’s cells are modulated by the levels 
of intracellular Ca2+ levels 
The robust long-lasting responses to TRPA1 agonists in Hensen’s cells did not lead to 
cell death. In fact, the intracellular Ca2+ levels in Hensen’s cells slowly decreased to 
baseline-like levels (Figure 4.9A). Moreover, upon subsequent stimulations with the 
same TRPA1 agonist, Hensen’s cells were able to once again exhibit similar long-lasting 
Ca2+ responses. However, the peak responses were considerably different between 
consecutive puff stimulations. We also noticed that, after TRPA1 agonist stimulation, the 
intracellular Ca2+ in the Hensen’s cells recovered to a level that was slightly higher than 
the pre-stimulation level.  
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Figure 4.9. Intracellular Ca2+ modulates responses to TRPA1 agonists 
A, Representative traces of the intracellular Ca2+ levels (R/R0) of three 
Hensen’s cells subjected to two consecutive puff stimulations with 100 µM 
CA. The breaks in the Ca2+ traces correspond to time points where imaging 
was paused to minimize cytotoxicity due to UV overexposure. B, Histogram 
showing the percentages of cells that responded to 400 M 4-HNE based on 
their intracellular Ca2+ level (in nM) at the time of puff stimulation (baseline). 
A responding cell was defined to have more than a 1.5 fold increase in 
intracellular Ca2+ after 4-HNE stimulation. Inset, Representative traces of 
changes in intracellular Ca2+ levels from some of the cells included in the 
histogram. All traces shown in the inset are from cells analyzed within the 
same field of view but over several puff applications. 
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We hypothesized that the differences in magnitude of the responses to TRPA1 agonist 
stimulation dependent on the levels of intracellular Ca2+ at the time of the puff 
application. To test this, the number of Hensen’s cells that responded to the stimulation 
with 400 µM 4-HNE was compared to their intracellular Ca2+ level at the moment of the 
puff application. To determine the ‘responding’ cells, we chose an arbitrary threshold 
level assuming that a cell was responding if we observed at least a 1.5 fold increase in 
intracellular Ca2+ upon stimulation with 4-HNE. Our results showed that the majority of 
responding cells exhibited intermediate levels of intracellular Ca2+ (~130 to 220 nM). 
However, cells with low (~100 nM) or high (> 250 nM) intracellular Ca2+ levels often 
failed to mount robust Ca2+ responses to the application of the TRPA1 agonist (Figure 
4.9B). It is noteworthy to highlight that the lack of responses in cells that had high 
intracellular Ca2+ baseline levels was not due to dye saturation (Figure 4.9B inset). These 
results further support the notion that TRPA1 channel activity is modified by intracellular 
Ca2+ [175, 194, 235]. While an increase in intracellular Ca2+ can initially potentiate the 
responses of TRPA1 to other agonists, higher Ca2+ levels seem to inactivate the channel. 
 
4.5 Cells of the Kolliker’s organ exhibit oscillating Ca2+ responses after TRPA1 
agonist stimulation 
In contrast to the delayed and long-lasting responses to TRPA1 agonists exhibited by 
Hensen’s cells, 4-HNE puff stimulation led to fast and short-lived Ca2+ waves in the 
Kolliker’s organ (Figure 4.10). These differences in the kinetics of TRPA1-induced Ca2+ 
responses might arise from the differences in Ca2+ handling properties between cell types.  
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Figure 4.10. 4-HNE induces fast and short-lived Ca2+ responses in the cells of 
the Kolliker’s organ  
A, Time-lapse Ca2+ imaging (R/R0) of the Kolliker’s organ from a wild type 
mouse during puff stimulation with 200 µM 4-HNE. A bright field image (left) 
is shown as reference and the yellow arrow indicates the position and direction 
of puff application. Dashed lines indicate boundaries between different cell 
types. KoC, Kolliker’s organ cells; IHC, inner hair cells. B, Traces showing 
the changes in intracellular Ca2+ in response to 4-HNE in 15 Kolliker’s organ 
cells from the region shown in A. 
 
We also observed striking differences between the Ca2+ responses in supporting cells 
evoked by activation of TRPA1 channels and ATP receptors. In contrast to TRPA1 
channels, puff application of low doses of ATP (e.g. 2 µM) induced oscillating and 
relatively short-lived Ca2+ responses in Kolliker’s organ, Hensen’s and Claudius’ cells 
(Figure 4.11A). The oscillating nature of these Ca2+ waves is presumed to involve the (i) 
activation/inactivation cycles of the G protein-coupled P2Y receptors, (ii) IP3-induced 
release of Ca2+ from intracellular stores and (iii) feedback inhibition of Ca2+ on IP3 
receptors (Figure 4.11C) [295].  
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Figure 4.11. Oscillating and sustained Ca2+ responses in cochlear supporting 
cells might reflect different Ca2+ handling properties 
A, Representative Ca2+ traces showing the changes in intracellular Ca2+ (R/R0) 
in Kolliker’s organ (left), Hensen’s (middle) and Claudius’ cells (right) after 
stimulation with increasing concentrations of ATP (2, 20 and 250 µM). B, 
Intracellular Ca2+ traces (R/R0) of Hensen’s cells after stimulation with 
increasing concentrations of 4-HNE (200 and 400 µM). C, Diagrams showing 
the signaling pathways involved after activation of TRPA1, P2Y or P2X 
receptors/channels.  
 
On the other hand, stimulation with high doses of ATP (e.g. 250 µM) activates P2X 
ionotropic channels as well (Figure 4.11C). The large influx of Ca2+ through P2X 
channels might overwhelm Ca2+ buffers in the cell and lead to a sustained increase in 
intracellular Ca2+ instead of the oscillating behavior. While puff stimulation with 250 µM 
ATP led to sustained Ca2+ responses in Kolliker’s organ and Hensen’s cells, Claudius’ 
cells continued to exhibit oscillating Ca2+ responses  (Figure 4.11A). Because all of these 
cochlear supporting cells seem to express functional P2X channels (reviewed in [62]), the 
different Ca2+ responses to the same concentration of ATP are likely to arise from unique 
Ca2+ handling properties within each cell type. However, we cannot rule out the 
88 
 
possibility that differences in the expression levels and subunits of P2X and P2Y 
receptors underlie these results.   
Interestingly, puff stimulation with a high concentration of ATP did not lead to long-
lasting Ca2+ responses in the Hensen’s cells like the ones observed after stimulation with 
TRPA1 agonists (compare the middle panel in Figure 4.11A with 4.11B). This result 
indicates that Hensen’s cells are able to clear a large increase in intracellular Ca2+ 
quickly. Therefore, the long-lasting Ca2+ responses elicited by the TRPA1 agonists might 
indicate that the channel itself gets temporarily locked into an open configuration (Figure 
4.11C). In fact, the three TRPA1 agonists tested (4-HNE, CA and AITC) are reactive 
agonists that can covalently bind to TRPA1 subunits to trigger channel gating [201, 202, 
210]. Differences in the redox state between Hensen’s and Kolliker’s organ cells (e.g., 
expression and availability of antioxidants) could also explain the different Ca2+ 
responses observed upon stimulation with TRPA1 agonists. 
 
4.6 TRPA1-dependent Ca2+ responses in the Hensen’s cell can propagate to the 
Kolliker’s organ 
When applying multiple puff stimulations with TRPA1 agonists within a specific 
Hensen’s cell region, we often observed the development of Ca2+ waves in the cells of the 
Kolliker’s organ (Figure 4.12A). The Kolliker’s organ can spontaneously trigger Ca2+ 
waves during the early postnatal development (section 1.7.1), however, the Ca2+ waves 
that we noticed in the Kolliker’s organ seemed to coincide with the time of puff 
application in the Hensen’s cell region (Figure 4.12B).  
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Figure 4.12. Puff stimulation with TRPA1 agonists at the Hensen’s cell region 
also triggers Ca2+ waves in the Kolliker’s organ 
A, Time lapse ratiometric Ca2+ imaging (R/R0) of a cochlear epithelium after 
puff stimulation with 400 µM at the Hensen’s cell region. A bright field image 
(top) is shown as reference and the yellow arrow indicates the position and 
direction of puff application. Dashed lines indicate boundaries between different 
cell types. KoC, Kolliker’s organ cells; IHC, inner hair cells; OHC, outer hair 
cells; HeC, Hensen’s cells. B, Representative Ca2+ traces from two Hensen’s 
(shades of green) and Kolliker’s organ cells (shades of red) from the experiment 
shown in A. Breaks in the traces represent time point where imaging was paused 
to minimize cytotoxicity due to UV overexposure. The numbers in the x axis 
indicate the time points where the frames in panel A where taken. 
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To test whether these ‘secondary’ Ca2+ waves were the result of TRPA1 agonist 
diffusion, we performed a similar experiment in cochlear explants dissected on very early 
postnatal days (P1-P2). At this developmental age, the cells of the Kolliker’s organ did 
not respond to direct puff stimulation with TRPA1 agonists (Figure 4.13A bottom and 
data not shown). However, puff stimulation with 4-HNE at the Hensen’s cell region of 
the same explant (and field of view) was indeed able to trigger Ca2+ waves in the 
Kolliker’s organ (Figure 4.13A top). 
  
 
Figure 4.13. TRPA1-dependent activation of Hensen’s cells propagates to the 
Kolliker’s organ and triggers Ca2+ waves that require extracellular ATP 
A, B, Time-lapse ratiometric Ca2+ imaging of cochlear explants dissected on 
postnatal days 1 or 2. The imaging was performed in the absence (A) or presence 
(B) of the P2X and P2Y antagonist PPADS (50 µM). Stimulation with 400 µM 
4-HNE was delivered via puff pipettes (yellow arrows) at the Hensen’s cell 
region (A top and B) or at the Kolliker’s organ (A bottom). Dashed lines indicate 
boundaries between different cell types. KoC, Kolliker’s organ cells; IHC, inner 
hair cells; OHC, outer hair cells; HeC, Hensen’s cells. 
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The Ca2+ responses that propagated to the Kolliker’s organ –after puff stimulation 
with TRPA1 agonists at the Hensen’s cell region– were able to travel from cell to cell at a 
much faster speed (e.g., 0.3 µm/s in the Hensen’s cells vs. 8 µm/s in the Kolliker’s 
organ). In addition, the Ca2+ waves in the Kolliker’s organ exhibited rising speeds and 
clearance rates that were higher than for the Ca2+ responses in the Hensen’s cells (as an 
example, compare the traces in Figure 4.12B). The kinetics of the ‘secondary’ Ca2+ 
waves observed in the Kolliker’s organ resembled those of the spontaneous Ca2+ waves 
that these cells exhibit during early postnatal days (section 1.7.1). The mechanism of 
propagation of the spontaneous Ca2+ waves has been previously elucidated and, among 
other signaling molecules, it involves the release of ATP to the extracellular space and 
the activation of P2Y receptors on neighboring cells (Figure 1.10) [34, 70]. Therefore, we 
wondered whether extracellular ATP was also involved in these ‘secondary’ Ca2+ waves. 
In the presence of 50 µM PPADS –a P2X and P2Y antagonist– the puff stimulation with 
4-HNE in the Hensen’s cell region generated Ca2+ responses that were still able to 
propagate toward the medial cochlear side. However, in the presence of the purinergic 
receptor blocker, the Ca2+ waves were limited to the rows of supporting cells immediately 
adjacent to the IHCs, presumably the inner border cells (Figure 4.13B). These results 
suggest that activation of TRPA1 channels in the Hensen’s cells is able to trigger the 
already known ATP-dependent and self-propagating Ca2+ waves.  
Interestingly, the TRPA1-induced Ca2+ responses in the Hensen’s cells never 
propagated toward the lateral side of the cochlea (i.e., toward the Claudius’ cells and the 
spiral prominence). Moreover, the propagation of these Ca2+ responses toward the medial 
side of the cochlea did not involve the sensory hair cells given that we never observed 
changes in the intracellular Ca2+ of IHCs or OHCs. As previously described [65], we did 
observe that, after these ATP-dependent Ca2+ waves were generated in the Kolliker’s 
organ, some of them were able to induce an increase in intracellular Ca2+ in the IHCs 
(e.g., compare panels 5 and 6 in Figure 4.12A). Because all supporting cells are 
electrochemically coupled via gap junctions, it is possible that the TRPA1-induced Ca2+ 
responses in the Hensen’s cells propagate to the Kolliker’s organ via Deiters’ and pillar 
cells. Sadly, we were not able to test this hypothesis using Ca2+ imaging because the fura-
2 dye failed to load such cells (Figure 4.14).  
92 
 
 
Figure 4.14. The ratiometric fura-2 Ca2+ indicator fails to load pillar and 
Deiters’ cells  
A, Representative images of the fura-2 fluoresce with 340 (F340) and 380 nm 
(F380) illuminations showing one row of IHCs, three rows of OHCs and one row 
of Hensen’s cells. The corresponding bright field image at the same focal plane 
is shown as reference (left). Dashed lines indicate the boundaries between cell 
types. B, Orthogonal view of the same tissue shown in A from stacks of images 
taken every 1 µm. Notice that the fluorescent images were not taken in a 
confocal mode and, therefore, there is plenty of out-of-focus light above and 
below the hair cells. IHC, inner hair cells; PC, pillar cells; OHC, outer hair cells; 
HeC, Hensen’s cells. 
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4.7 In the presence of a gap junction blocker Claudius’ cells exhibit TRPA1-
mediated Ca2+ responses  
Because TRPA1-dependent Ca2+ responses in the Hensen’s cells might be able to 
propagate across the cochlear epithelium via the gap juntional conductance between 
supporting cells, we decided to evaluate the responses to TRPA1 agonists in the presence 
of a known gap junction blocker, FFA. 
FFA behaves as an agonist of rat and human TRPA1 (see section 2.3.6) but it is 
unknown whether it can activate mouse TRPA1 channels as well. First, we tested 
whether the presence of FFA in the bath solution could alter the levels of intracellular 
Ca2+ in the Hensen’s cells, but found no differences between FFA-treated and control 
cells (Figure 4.15). 
 
 
Figure 4.15. Presence of FFA in the bath solution does not change the resting 
Ca2+ level in Hensen’s cells 
Resting intracellular Ca2+ levels (in nM) of Hensen’s in the presence (grey) or 
absence (black) of the gap junction blocker FFA (100 µM) in the bath 
solution. Intracellular Ca2+ levels were determined from ratiometric Ca2+ 
images of cells loaded with the fura-2 dye. Ca2+ levels from cells that were 
monitored for up to 50 min after adding FFA are included in the graph. Mean 
± SEM values are shown. The number of cells/regions included in the analysis 
is shown for each bar. A P value > 0.4 was determined using a Student’s t-
test. 
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Next, we evaluated the Ca2+ responses to the application of 200 µM 4-HNE before and 
after the addition of the gap junction blocker FFA to the bath solution. As shown 
previously, in the absence of FFA the stimulation with 4-HNE led to delayed, robust and 
long-lasting Ca2+ responses in the Hensen’s cells but no responses were observed in the 
Claudius’ cells (Figures 4.16A and 4.16B). To our surprise, in the presence of FFA 
Claudius’ cells were now able to respond to the puff stimulation with the TRPA1 agonist 
(Figures 4.16C to 4.16F). The 4-HNE-induced Ca2+ responses in Claudius’ cells were 
more robust after a 30 min exposure to FFA than they were after only 10 min with the 
blocker (compare Figures 4.16C and 4.16E). Moreover, in the presence of FFA, the delay 
in the Ca2+ responses –relative to the beginning of the puff application– decreased with 
time for both Hensen’s and Claudius’ cells (Figures 4.16B, 4.16D and 4.16F).  
Two alternative scenarios could explain the TRPA1-mediated responses in Claudius’ 
cells that are only seen after the incubation with FFA. First, FFA might be acting as an 
agonist for mouse TRPA1. In this case, a concentration of 100 µM FFA may have been 
too low to elicit changes in intracellular Ca2+ (Figure 4.15) but, FFA together with 200 
µM 4-HNE could have exerted a synergistic effect on the TRPA1 channels present in 
Claudius’s cells. FFA and 4-HNE activate TRPA1 channels through different 
mechanisms. While 4-HNE is a reactive agonist that binds intracellular cysteine residues 
in TRPA1, FFA is a non-reactive agonist that might activate TRPA1 after interacting 
with, perhaps, a pocket-like domain. Interestingly, FFA is known to have a synergistic 
action when applied together with CA –another reactive agonist that activates TRPA1 in 
a manner similar to 4-HNE [201]. Of note, high concentrations (400 µM) of 4-HNE alone 
failed to induce Ca2+ responses in Claudius’ cells (Figure 4.13 and data not shown). 
Therefore, a synergistic effect between FFA and 4-HNE seems a more likely explanation 
than a simple additive effect of both agonists. 
If FFA does not behave as an agonist for mouse TRPA1, an alternative explanation 
would involve FFA-induced changes in the intracellular environment that could favor 
TRPA1 gating. It is plausible that blocking the electrochemical connection between 
different types of supporting cells might lead to changes in resting potentials and/or 
intracellular redox states which can potentiallyalter TRPA1 channel activation kinetics.  
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Because the presence of the gap junction blocker changed the responses of the cells to 
TRPA1 activation, we were not able to test whether the gap junctional conductance is 
require for the propagation of TRPA1-induced Ca2+ waves from the Hensen’s cells to the 
Kolliker’s organ. 
 
 
Figure 4.16. In the presence of FFA, 4-HNE induces Ca2+ responses in 
Claudius’ cells 
A, C, E, Time-lapse ratiometric Ca2+ imaging (R/R0) showing the responses to 
4-HNE (200 µM) in cochlear explants before (A) and 10 min (B) and 30 min 
(C) after adding the gap junction blocker FFA (100 µM) to the bath solution. 
A bright field image (left) is shown as reference and the yellow arrow 
indicates the position and direction of puff application. Dashed lines indicate 
boundaries between different cell types. IHC, inner hair cells; OHC, outer hair 
cells; HeC, Hensen’s cells; CC, Claudius’ cells. B, D, E, Traces indicating the 
changes in intracellular Ca2+(R/R0) in two Hensen’s cells (shades of green) 
and two Claudius’ cells (shades of purple) from the data shown in panels A, C 
and E.  
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4.8 Deiters’ cells express functional TRPA1 channels 
Given that the membrane-permeable fura-2 dye failed to load pillar and Deiter’s cells 
(Figure 4.14), we decided to perform patch clamp recordings to test whether these cells 
express functional TRPA1 channels or not. Changes in whole-cell currents after the puff 
application of 100 µM CA were monitored. However, in order to measure the currents in 
individual cells, the gap junction blocker FFA was added to the bath solution. As shown 
previously, the presence of FFA did not seem to change resting intracellular Ca2+ levels 
or inhibit the responses to TRPA1 agonists in Hensen’s cells (Figures 4.15 and 4.16). 
Therefore we were confident that, even if FFA behaves as an agonist for mouse TRPA1 
channels, we should still be able to see TRPA1 currents after the stimulation with CA. In 
fact, FFA and CA have a synergistic effect in rat TRPA1 channels [208]. 
As expected, puff stimulation with CA induced large inward currents in Hensen’s cells 
from wild type but not from Trpa1–/– mice (Figures 4.17A and 4.17D). The current-
voltage (I-V) relationship of the CA-induced responses in Hensen’s cells exhibited 
prominent rectification at negative potentials and, presumably, channel inactivation at 
positive potentials. This I-V relationship differs from the typical behavior of TRPA1 
channels in heterologous expression systems (see Appendix D for a typical I-V 
relationship obtained in HEK-293 cells transfected with a mouse TRPA1 construct). 
Although the behavior of TRPA1 can differ between transfected and native channels 
[245, 267, 268, 296], we wondered whether FFA could be modifying the I-V relationship 
of TRPA1 currents in Hensen’s cells. To test this, we evaluated the CA-mediated currents 
in the presence of a different gap junction blocker. We performed whole-cell patch clamp 
recordings of Hensen’s cells in the presence of 1 mM octanol in the bath solution. 
Octanol was chosen because this gap junction blocker does not seem to be an agonist for 
mouse TRPA1 channels [205]. However, the I-V relationships obtained in the presence of 
octanol were indistinguishable from the ones obtained in the presence of FFA (compare 
Figures 4.17A and 4.18). 
 
97 
 
 
Figure 4.17. TRPA1-mediated inward currents in Hensen’s and Deiters’s cells 
A-C, Representative current-voltage (I-V) relationships for CA-induced currents 
(IPuff – IBaseline) in Hensen’s (A), Deiters’ (B) and pillar cells (C) from wild type 
(black) and Trpa1–/– mice (red). Insets, Representative inward currents elicited 
by the puff application of 100 µM CA. D, Average peak inward currents 
triggered by the puff application of CA and measured at a holding potential of -
86 mV. Bars show mean ± SEM values. The number of cell included in the 
analysis is shown for each bar. (*) indicates a P value < 0.05 determined by a t-
test for samples with unequal variance. 
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Figure 4.18. Current-voltage relationship of TRPA1 activation in the presence 
of a different gap junction blocker 
Current-voltage relationship of a wild type Hensen’s cell during the puff 
stimulation with CA (IPuff – IBaseline) (green) and 5 min after washout (IWashout – 
IBaseline) (black). Recordings were performed in the presence of 1 mM octanol. 
 
We also observed CA-mediated current responses in wild type Deiters’ cells and they 
had I-V relationships similar to the ones seen in Hensen’s cells (Figure 4.17B). These 
results indicate that Deiter’s cells express functional TRPA1 channels as well. However, 
the magnitude of the TRPA1 responses (i.e. peak currents) appeared to be smaller in 
Deiters’ than in Hensen’s cells (Figure 4.17D).  
When similar recordings were performed in pillar cells, we were not able to observe 
changes in whole-cell currents elicited by the puff application of CA (Figures 4.17C and 
4.17D). These results were unexpected given the bright PLAP staining exhibited by pillar 
cells (Figure 4.1). However, as it was the case for Claudius’ cells, it is possible that the 
experimental conditions used here (e.g., Ca2+ levels in the intracellular solution, type and 
concentration of the agonist used, whole-cell instead of perforated patch) were not ideal 
to allow TRPA1 channel gating. 
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4.9 TRPA1 stimulation induces tissue movement that seems to originate at pillar 
and Deiter’s cells 
Bright field imaging performed during puff stimulation with 200 µM 4-HNE indicated 
the presence of slow, yet prominent, tissue movements within the cochlear epithelium 
(Figure 4.19A). These 4-HNE-induced tissue displacements were often delayed relative 
to the beginning of the puff stimulation (Figure 4.19B), a feature similar to the delay in 
the TRPA1-induced Ca2+ responses seen in Hensen’s cells. Interestingly, puff stimulation 
with 4-HNE induced prominent tissue movement in cochlear explants from wild type but 
not from Trpa1–/– mice (Figures 4.19C and 4.19D).  
The TRPA1-induced tissue displacements were large and caused changes in the field 
of view and/or focal plane during imaging. However, when bright field imaging was 
performed near the pillar cell feet, prominent cell contractions were observed specifically 
in outer pillar cells (Figure 4.20B) and, sometimes, in Deiters’ cells as well (Figure 
4.20C). 
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Figure 4.19. TRPA1 activation induces prominent tissue movement 
A, Changes in time-lapse bright field (top) and Ca2+ imaging (R/R0) (bottom) of 
a wild type cochlear explant during puff stimulation with 200 µM 4-HNE. The 
top panel shows subtracted frames from images taken 10 s apart to enhance the 
areas were tissue movement was observed. A non-subtracted bright field image 
(left) is shown as reference. The yellow arrow indicates the position and 
direction of puff application. Dashed lines indicate the boundaries between 
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different cell types. OHC, outer hair cells; HeC, Hensen’s cells; CC, Claudius’ 
cells. B, top, Trace showing the changes in the standard deviation (SD) of pixel 
values from the subtracted bright field (BF) images shown in A. B, bottom, 
Trace showing the intracellular Ca2+ levels (R/R0) of one of the Hensen’s cells 
from panel A. Arrows indicate the time points where the panels in A were taken. 
C, SD changes in subtracted BF images from wild type (top) and Trpa1–/– 
explants (bottom) stimulated with 200 µM 4-HNE. Individual traces (grey) were 
normalized to the same height. For drawing purposes, the average traces for 
explants from wild type (black) and Trpa1–/– mice (red) were normalized to 
comparable baseline levels (i.e. the region of each trace before the puff 
application). D, Bar graph showing the fold changes in area-under-the-curve 
(AUC) values obtained from the traces shown in C and comparing time points 
before and during/after the puff stimulation with 4-HNE (AUCPuff/AUCBaseline). 
A value of 1 (dashed line) indicates that the TRPA1 stimulation did not induce 
tissue movement. Bars show mean ± SEM values. The number of 
regions/explants included in the analysis is shown for each bar. (*) indicates a P 
value < 0.05 determined by a Student’s t-test. 
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Figure 4.20. Tissue displacements seem to originate by the contractions of 
pillar and Deiters’ cells 
A, Bright field image showing the axis (yellow double-headed arrows) used to 
measure cell diameter changes in OHCs and OPCs. Hensen’s cells were 
removed so the puff application could reach areas underneath the tight 
junction barrier. Dashed lines show the boundaries between cell types. The 
yellow single-headed arrow indicates the position and direction of puff 
application. B, Changes in cell diameter after puff stimulation with 200 µM 4-
HNE in an OPC (black) and an OHC (grey) from the wild type explant shown 
in A. For comparison, the diameter measurements of an OPC from a Trpa1–/– 
explant (red) are shown as well. C, Changes in cell diameter after puff 
stimulation with 200 µM 4-HNE in OPCs (black and red) and DCs (grey and 
pink) from wild type (black and grey) and Trpa1–/– (red and pink) mice. Cell 
diameters were measured using the same axis shown in A. KoC, Kolliker’s 
organ cells; IPC, inner pillar cells; OPC, outer pillar cells; OHC, outer hair 
cells. 
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In section 4.6, we showed that TRPA1 activation in Hensen’s cells is able to trigger 
Ca2+ waves that depend on the release of ATP to the extracellular space. Since ATP itself 
can lead to changes in the shape of the Kolliker’s organ cells [65, 66], we wondered 
whether ATP could trigger shape changes in pillar cells as well. In fact, puff stimulation 
with 2 µM ATP induced changes in the cell diameter of pillar cells that were similar to 
the ones observed after TRPA1 stimulation (Figure 4.21). Interestingly, ATP puff 
stimulation was sometimes able to induce changes in the shape of OHCs (Figure 4.21). 
These ATP-induced changes in OHCs were observed in cochlear explants at about 
postnatal day 6, a developmental age when the functional expression of prestin –the OHC 
motor– could be starting. Therefore, we believe that ATP stimulation is depolarizing 
OHCs via the activation of P2X channels and triggering prestin-indued cell shape 
changes. Therefore, the tissue movements observed after ATP puff stimulation were far 
more complex that the TRPA1-induced tissue displacements. 
 
 
Figure 4.21. ATP puff stimulation induces pillar cell contraction 
A, Bright field image showing the OHC and PC (yellow arrows) used to 
measure cell diameter changes. Hensen’s cells were removed so the puff 
application could reach areas underneath the tight junction barrier. Dashed 
lines show the boundaries between cell types. The puff pipette was located at 
the edge of the field of view as indicated by the black arrow. PC, pillar cell; 
OHC, outer hair cell. B, Changes in cell diameter after puff stimulation with 2 
µM ATP in an outer PC (black) and OHC (grey) from the wild type explant 
shown in A. KoC, Kolliker’s organ cells; PC, pillar cells; OHC, outer hair 
cells. 
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4.10 Cochlear pillar cells posses Ca2+-dependent contractile machinery 
The phalangeal processes of Deiter’s cells are known to exhibit mechanical responses 
after the stimulation with ATP or after Ca2+ uncaging [56, 57]. However, it is unknown 
whether pillar cells can exhibit similar Ca2+-dependent active mechanical responses. 
Activation of ATP receptors or TRPA1 channels can both lead to an increase in 
intracellular Ca2+. Therefore, we decided to test whether an increase of the cytosolic Ca2+ 
concentration was sufficient to trigger changes in the shape of pillar cells. We used the 
photo-labile Ca2+ chelator o-nitrophenyl ethylene glycol tetraacetic acid (NP-EGTA) to 
deliver ‘caged Ca2+’ to outer pillar cells using a whole-cell patch clamp configuration 
(Figure 4.22A). Stimulation with a UV laser produced an immediate increase of 
intracellular Ca2+ (Figure 4.22B) that was followed by a slow cell contraction (Figure 
4.22C). These changes in intracellular Ca2+ and cell diameter were not observed in 
control outer pillar cells were the photo-labile Ca2+ chelator had been replaced with 
regular EGTA (Figures 4.22D and 4.22E).  
Cell currents were also monitored during the experiment and only cells that did not 
exhibit changes in the holding current were considered for the quantification of cell 
diameters. Changes in the holding currents after the UV stimulation were similar (P > 
0.56) between cells containing caged Ca2+ (ΔIm = -4.29 ± 2.8 pA) and control cells (ΔIm 
= -3.23 ± 0.9 pA). Therefore, the Ca2+-induced shape changes in pillar cells are unlikely 
to be driven by the potential osmotic responses associated with Ca2+-dependent ion 
conductances. 
In addition to the mechanical responses driven by Deiters’ cells, here we show that 
active changes in the shape of pillar cells could also underlie the tissue movements 
observed in the cochlear epithelium after TRPA1 stimulation. We believe this is the first 
report showing that cochlear pillar cells possess Ca2+-dependent contractile machinery. 
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Figure 4.22. Outer pillar cells exhibit cell contractions after an increase in 
intracellular Ca2+ 
A, Bright field image illustrating the experimental approach used to deliver the 
caged Ca2+ to individual outer pillar cells via whole-cell patch clamping. The 
caged compound (1 mM, NP-EGTA) was present in the intracellular solution 
(which contained 0.7 mM CaCl2). PC, pillar cells; OHC, outer hair cells. B, 
Representative change in intracellular Ca2+ evaluated through the fluorescent 
dye fluo-4 present in the intracellular solution (50 µM). Images were obtained 
before (1) and after (2) stimulation with the UV laser. a.u., arbitrary units. C, 
Representative traces showing the changes in intracellular Ca2+ (top), whole-
cell currents (middle) and cell diameter (bottom) of a cell loaded with the caged 
compound (black) or with regular EGTA (grey). The dashed line represents the 
time where UV stimulation occurred. D, E, Average peak increase in 
intracellular Ca2+ (Fmax/F0) (D) and decrease in cell diameter (E) of cells loaded 
with caged Ca2+ (filled bars) or control EGTA (open bars). Bars show mean ± 
SEM values. The number of cells included for both analyses are shown in panel 
E. (*) indicates a P value < 0.05 determined by a Student’s t-test. 
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4.11 TRPA1 contributes to a long-lasting inhibition of cochlear amplification after 
noise exposure 
We hypothesized that the activation of cochlear TRPA1 channels in vivo may occur 
after the oxidative damage following acoustic trauma. This activation would induce 
changes in the pillar cell shape and modify the geometry of the cochlear epithelium and 
alter hearing sensitivity. Therefore, we decided to test hearing thresholds and cochlear 
amplification after exposing young adult (3-4 weeks old) wild type and Trpa1–/– mice to 
noise. 
First, we confirmed that, in agreement with published literature [101, 102], Trpa1–/– 
mice and their wild type littermates exhibit identical hearing thresholds before noise 
exposure (Figure 4.23).  
 
 
Figure 4.23. Trpa1–/– mice exhibit normal hearing thresholds 
Hearing thresholds were determined in wild type (black) and Trpa1–/– mice (red) 
by evaluating the auditory brainstem responses (ABR) to tone stimulations at 8, 
16, 24 and 32 kHz. Mean ± SEM values are plotted. A P value > 0.6 was 
determined using a two-way ANOVA. 
 
Next, we exposed the mice to a broadband noise at 100 dB for 30 min. Immediately 
after the noise exposure, hearing thresholds were significantly higher in Trpa1–/– mice 
(Figure 4.24A). However, five days after the noise exposure, wild type mice were the 
ones exhibiting significantly higher hearing thresholds (Figure 4.24A).  
 
107 
 
 
Figure 4.24. TRPA1 channels mediate a long-lasting inhibition of hearing 
thresholds after noise exposure 
A, Hearing threshold shifts (i.e. relative to thresholds before noise exposure) 
measured via auditory brainstem responses (ABR). B, OHC function 
essesntial for cochlear amplification was measured with distortion product 
otoacoustic emissions (DPOAE) at 16 kHz. Wild type (black) and Trpa1–/– 
mice (red) were evaluated immediately after (dash-dot lines) and/or 5 days 
after (dashed lines) noise exposure. Mean ± SEM values are plotted. (**) 
indicates a P value < 0.01 determined using a two-way ANOVA, and (*) P < 
0.05 determined after Bonferroni corrections. 
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The changes in the hearing thresholds after noise exposure indicated that, in spite of 
initially exhibiting a greater hearing loss, Trpa1–/– mice are able to recover hearing 
thresholds a faster rate than wild type mice (Figure 4.25). The hearing thresholds in 
mammals crucially depend on the cochlear amplification provided by the OHC 
electromotility. Thus, we wondered whether the differences in the recovery of hearing 
thresholds between wild type and Trpa1–/– mice resulted from the modulation of the 
electromechanical feedback of OHCs that can be assessed by measuring distortion 
product otoacoustic emissions (DPOAE). We found that 5 days after noise exposure the 
DPOAE was significantly lower in wild type mice (Figure 4.24B). These results suggest 
that, after noise exposure, TRPA1 channels maintain hearing thresholds elevated by 
delaying the recovery of the cochlear amplifier. 
 
 
Figure 4.25 Faster recovery of ABR hearing thresholds in Trpa1–/– mice 
Degree of recovery of auditory brainstem responses (ABR) in 5 days for wild 
type (black) and Trpa1–/– mice (red). Data were calculated as the difference 
between hearing thresholds immediately after noise exposure minus the 
hearing thresholds 5 days later. The same data shown in Figure 4.24A were 
used for this analysis. Bars show mean ± SEM values. (*) indicates a P value 
< 0.05 determined by Student’s t-tests.  
 
Because the delayed recovery of hearing thresholds in wild type mice might represent 
the effect of a TRPA1-mediated ‘protective’ mechanism, we exposed mice to a second 
round of noise on day 5 of recovery. Two weeks after the second noise exposure, the 
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hearing thresholds at 8 and 16 kHz had recovered to normal levels but were still elevated 
for 24 and 32 kHz (Figure 4.26). Therefore, this protocol of noise exposure led to a 
mixture of temporary (TTS) and permanent (PTS) threshold shifts in both wild type and 
Trpa1–/– mice. We did not observe significant differences between the hearing thresholds 
of wild type and Trpa1–/– mice after the two weeks of recovery (P > 0.6). Because we 
observed PTS even in wild type animals, it is very plausible that the noise protocol used 
was too damaging to reveal the potential protective effect of TRPA1 activation.  
 
 
Figure 4.26. The noise exposure used leads to permanent threshold shifts in the 
high frequency range 
Hearing thresholds were determined in wild type (black) and Trpa1–/– mice (red) 
before (Baseline, solid lines) and 2 weeks after a second noise exposure (dotted 
lines) by evaluating the auditory brainstem responses (ABR) to tone stimulations 
at 8, 16, 24 and 32 kHz. Mean ± SEM values are plotted. (***) indicates a P 
value < 0.001 (after Bonferroni corrections) between hearing thresholds at 
baseline and after 2 weeks of recovery for each mouse group. 
 
Noise exposure leads to the generation of reactive oxygen and nitrogen species in the 
cochlea. Moreover, these reactive species continue to be generated for days after the 
initial acoustic trauma [285]. Therefore, we wondered whether our protocol of noise 
exposure was able to lead to an increase in oxidative damage that could last for at least 5 
days. We performed immunolabeling of 4-HNE-modified proteins in cochleae from wild 
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type mice. In agreement with our hypothesis, we found increased amounts of 4-HNE-
modified proteins 5 days after noise exposure (Figure 4.27). These results indicate that, 
even 5 days after the noise exposure, TRPA1 channels could get activated due to 
prominent presence of oxidative tissue damage. Moreover, the TRPA1-mediated changes 
of the shape of pillar cells could maintain the geometry of the cochlear epithelium in a 
modified shape that decreases the cochlear amplification. 
 
 
Figure 4.27. 4-HNE-modified proteins are increased in the cochlear epithelium 
5 days after noise exposure 
A-C, Immunolabeling against 4-HNE-modified proteins in cochleae from wild 
type mice not exposed to noise (A) or at 5 days (B) or 2 weeks (C) after noise 
exposure. ISC, inner sulcus cells; IHC, inner hair cells; OHC, outer hair cells; 
HeC, Hensen’s cells. 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © A. Catalina Vélez-Ortega 2014  
111 
 
 
 
 
 
 
 
 
CHAPTER 5 
Discussion of results, study limitations and future directions 
 
TRPA1 channels have gained the reputation of broad damage sensors in numerous 
tissues and pathological conditions. They are highly expressed in a subset of nociceptive 
neurons where they are involved in the detection of ‘harmful’ stimuli and the modulation 
of mechanical –and perhaps thermal– hyperalgesia. TRPA1 channels are also expressed 
in non-neuronal tissues where they might alter inflammatory and immune responses, 
through poorly understood mechanisms. TRPA1 mRNA expression has also been 
reported in the mammalian inner ear [177]. However, Trpa1–/– mice have normal hearing 
and balance (i.e. cochlear and vestibular functions, respectively), as well as normal 
mechano-electrical transduction in the inner ear sensory cells (hair cells) [101, 102]. We 
hypothesized that, similar to its function in other tissues, TRPA1 channels in the inner ear 
act as tissue damage sensors; for instance, during the oxidative damage induced by 
acoustic trauma. 
Our results show that, indeed, TRPA1 channels in the cochlear epithelium can be 
activated by byproducts of oxidative tissue damage. However, in the inner ear, TRPA1 
channels seem to be doing more than merely “sensing” the damage. Our results 
uncovered a novel TRPA1-initated pathway of communication between different types of 
non-sensory (supporting) cochlear cells. The Hensen’s cells seem to act as major 
‘sensors’ for tissue damage, while other supporting cells (i.e. pillar and Deiters’ cells) 
types are the main ‘effectors’ by changing the geometry of the organ of Corti thus 
altering hearing sensitivity. This pathway represents a hitherto unknown mechanism of 
cochlear regulation.  
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5.1 Propagation of TRPA1-mediated signals across the cochlear epithelium 
Our results indicate the presence of an active TRPA1 promoter throughout the entire 
cochlear epithelium. We also demonstrated TRPA1 channel activity in most supporting 
cell types either with FM1-43 uptake, Ca2+ imaging or whole-cell patch clamp 
recordings. In some supporting cells, these different techniques produced different 
results. We did find that the kinetics of the responses to TRPA1 activation were 
somewhat unique for each type of supporting cell. For instance, Hensen’s cells exhibited 
robust and long-lasting Ca2+ responses to all TRPA1 agonists tested, while Claudius’ 
cells only responded to TRPA1 agonists when the gap junction blocker FFA was present 
in the bath solution. 
The particularly long-lasting behavior of the TRPA1-mediated responses in Hensen’s 
cells seems to indicate that in these cells the channel is locked in an open configuration. 
This might arise from (i) the reactive nature of the TRPA1 agonists tested and/or (ii) a 
positive feedback provided by the intracellular Ca2+ levels. To test whether the long-
lasting responses to TRPA1 stimulation are the result of long-lasting covalent 
modifications in its intracellular N-terminus, additional experiments should be performed 
using non-reactive agonists, such as icilin, since they seem to activate TRPA1 via a 
‘classical’ lock-and-key mechanism.   
Interestingly, the TRPA1-mediated Ca2+ responses in Hensen’s cells never propagated 
to their immediate neighbors, the Claudius’ cells. Instead, TRPA1-mediated Ca2+ 
responses in the Hensen’s cells always propagated toward the medial side of the cochlea, 
and elicited Ca2+ waves in the Kolliker’s organ. These ‘secondary’ Ca2+ waves in the 
Kolliker’s organ required the release of ATP to the extracellular space for their cell-to-
cell propagation. Therefore, we believe the Ca2+ responses that we observed in the 
Kolliker’s organ are secondary to the activation of TRPA1 channels in Hensen’s cells and 
correspond to the Ca2+ waves that have been previously described by others (Figure 1.10) 
[37, 70]. 
Extracellular ATP is thought to be an important signaling molecule during tissue 
damage in the cochlea. Damage of a single sensory hair cell is able to trigger robust ATP-
dependent self-propagating Ca2+ waves in the cochlear epithelium; mice lacking P2X2 
receptors are more susceptible to noise-induced permanent hearing loss [81]; and low 
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levels of ATP have been detected in the cochlear fluids after acoustic overstimulation 
[68]. It has been demonstrated that ATP-initiated Ca2+ waves in the cochlear epithelium 
are sustained by and critically depend on the Ca2+-evoked release of ATP into the 
extracellular fluid [295]. However, the exact mechanism initiating the very first release of 
ATP into cochlear fluids remains unknown. Our results revealed a previously unknown 
and never considered mechanism: the activation of TRPA1 channels in the Hensen’s cells 
might initiate Ca2+ waves that trigger the release of ATP to the extracellular space. Once 
the ATP is released outside the cell, it can maintain secondary Ca2+ waves through 
previously described mechanisms (Figure 1.10) [37, 70] and/or activate TRPA1 channels 
in other supporting cells downstream of metabotropic P2Y receptors (manuscript in 
preparation, Vélez-Ortega AC, et al., see Appendix D for details). Therefore, the 
activation of TRPA1 channels may represent a long-sought event that initiates protective 
ATP signaling in the cochlea during noise exposure. Obviously, our results do not refute 
other potential mechanisms of ATP release, such as the one hypothesized for cells within 
the stria vascularis [68, 297]. However, ATP release associated with Ca2+ waves 
propagating after TRPA1 activation in Hensen’s cells would result in the most effective 
local rise of extracellular ATP right in the organ of Corti region. 
The activation of TRPA1 channels downstream of P2Y receptors has been studied in 
transfected HEK-293 cells but not in cochlear supporting cells (manuscript in 
preparation, Vélez-Ortega AC, et al., see Appendix D for details). Therefore, patch clamp 
recordings could be performed in cochlear supporting cells from wild type and Trpa1–/– 
mice to evaluate for the presence of TRPA1-induced inward currents after puff 
stimulation with a very low concentration of ATP –that may activate P2Y but not P2X 
receptors–. 
TRPA1 activation in the Hensen’s cells is unlikely to stimulate direct ATP release 
from these cells to the extracellular fluid; otherwise, the Claudius’ cells –which express 
P2Y receptors– would have exhibited Ca2+ responses secondary to the TRPA1 
stimulation of Hensen’s cells. If Hensen’s cells do release ATP to the extracellular space 
after TRPA1 activation, one plausible explanation for the absence of responses in the 
Claudius’ cells would require the (i) release of ATP through the basolateral membrane of 
Hensen’s cells and (ii) the expression of P2Y receptors in the apical surface of Claudius’ 
114 
 
cells. However, the exact subcellular localization of P2Y receptors in Claudius’ cells is 
unknown. 
The exact mechanism of propagation of TRPA1-dependent Ca2+ responses from the 
Hensen’s cells toward the Kolliker’s organ has not been completely resolved. We did not 
observe the involvement of inner (IHC) and outer (OHC) hair cells in this propagation 
but, because the ratiometric Ca2+ dye used failed to load pillar and Deiters’ cells, we were 
unable to see whether the Ca2+ responses propagated through these two types of 
supporting cells. Several unsuccessful attempts to load pillar and Deiters’ cells with the 
Ca2+ dye were performed as follows: 
i) Nearby supporting and/or hair cells were removed to disrupt the tight junctional 
barrier at the reticular lamina of the cochlear epithelium and thus allow uptake of the 
Ca2+ dye through the basolateral membranes. Unfortunately, supporting cells can quickly 
re-seal the reticular lamina. Therefore, we had to remove a substantial number of cells to 
guarantee that the reticular lamina would not be resealed during the incubation with the 
Ca2+ dye. This caused extensive damage to the tissue and considerable alterations of its 
geometry and cell shapes. 
ii) The approach described above resulted in the uptake of the Ca2+ dye only by pillar 
and Deiters’ cells that were in close proximity to the site of tissue damage. Therefore, to 
increase the amount of Ca2+ dye present underneath the reticular lamina, puff pipettes 
were used to establish a perfusion system between the rows of pillar cells (i.e. the space 
that constitutes the tunnel of Corti in the adult cochlea). This perfusion strategy often led 
to pressure build up underneath the tissue when the “exit” pathway was resealed (i.e. 
secondary area where cells had been removed to allow for the perfusion to occur). This 
increase in fluid pressure underneath the reticular lamina disrupted connections between 
the basolateral membranes of supporting cells, as evidenced during bright field imaging.  
iii) To minimize the excretion of the intracellular Ca2+ dye, we also loaded the 
cochlear explants in the presence of 250 µM of the organic anion-transport inhibitor 
sulfinpyrazone (Invitrogen) [298, 299]. This strategy slightly improved the loading of 
other cell types, but not of pillar and Deiters’ cells. 
iv) Normally, the cochlear explants were incubated in the presence of the Ca2+ dye for 
50 min at room temperature. In order to decrease incubation times in some of the 
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approaches described above, the dye concentration was increased and/or the incubation 
was performed at 37°C. Once again, this approach failed to improve the loading of pillar 
and Deiters’ cells with the Ca2+ dye. 
v) The loading of the ratiometric Ca2+ dye was also evaluated in rat cochlear explants 
because they have slightly larger cells and, therefore, a greater surface area of pillar and 
Deiters’ cells that would be exposed to the Ca2+ dye. However, rat pillar and Deiters’ 
cells also failed to uptake the Ca2+ dye.  
vi) The goal of the five strategies described above was to improve the loading of pillar 
and Deiters’ cells in freshly-dissected cochlear explants. The loading with the Ca2+ dye 
greatly improved in Deiters’ cells from explants that had been cultured for 2-3 days. 
However, after this time in culture, the Deiters’ cells were no longer located underneath 
the OHCs; instead, the OHCs had slid between the rows of Deiters’ cells. In addition to 
the alterations in tissue organization after 2-3 days in culture, the OHCs were more 
susceptible to undergo apoptosis after the stimulation with the TRPA1 agonists. 
Therefore, we were not able to use cultured cochlear explants to evaluate the propagation 
of TRPA1-induced Ca2+ waves from the Hensen’s cells toward the Kolliker’s organ. 
To overcome the difficulties in loading pillar and Deiters’ cells with the membrane-
permeable ratiometric Ca2+ dye (fura-2, AM), other types of Ca2+ indicators could be 
employed such as the genetically encoded G-CaMP3 [300] or D3cpv [301] Ca2+ 
reporters. Vectors encoding these Ca2+ indicators are commercially available (Addgene 
plasmids #22692 and #36323, respectively) and could be used to transfect cells from 
cochlear explants via electroporation [302, 303] or gene gun [304]. Alternatively, 
transgenic mice with conditional expression of G-CaMP3 limited to cells expressing the 
Cre recombinase are also commercially available (Jackson laboratories, stock number 
014538). They could be bred with mice that express Cre under a ubiquitous promoter or 
under promoters specific for cochlear supporting cells (e.g., Cre expression under the 
Prox1 promoter would be limited to outer pillar and Deiters’ cells [305]). 
It is possible that TRPA1-initiated Ca2+ responses at the Hensen’s cells propagate 
through the gap junctional conductance to the Kolliker’s organ via Deiters’ and pillar 
cells. Interestingly, the permeability of gap junctions connecting Hensen’s to pillar cells 
is very different from the permeability between Hensen’s and Claudius’ cells [33, 34].  
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Our whole-cell recordings showed that Deiters’ cells express functional TRPA1 
channels too but we were unable to detect TRPA1-mediated currents in pillar cells. 
However, if pillar cells do express TRPA1 channels, it is possible that they were simply 
not gated due to the conditions of our experimental approach. In fact, Claudius’ cells 
failed to exhibit TRPA1-mediated Ca2+ responses during our initial experimental 
conditions, but we eventually revealed the presence of functional TRPA1 channels in 
these cells as well. 
Regardless of the exact mechanism of cell-to-cell propagation, the TRPA1-induced 
Ca2+ responses in the Hensen’s cells consistently traveled in a unidirectional way. This 
behavior differed from other types of Ca2+ waves elicited after hair cell damage. ATP-
dependent self-propagating Ca2+ waves triggered after the death of a single hair cell can 
propagate in all directions around the damaged site, even to Claudius’ cells [37, 38]. 
TRPA1-initiated Ca2+ responses in Hensen’s cells are likely to require the propagation of 
a second messenger that may be specific for some unique gap junctions between these 
cell types [33, 34], which would account for the inability of the signal to propagate 
toward the Claudius’ cells. The physiological significance of this special mechanism of 
propagation of TRPA1-initiated Ca2+ responses from the Hensen’s cells toward the 
Kolliker’s organ may be to simply ensure the activation of supporting cells that have poor 
access to the apical surface of the cochlear epithelium (e.g. pillar and Deiters’ cells). This 
could be the case when, for instance, byproducts of oxidative stress are mainly present in 
the endolymph.  
Altogether, our results indicate that (i) Hensen’s cells mount robust Ca2+ responses in 
the presence of oxidative damage via the activation of TRPA1 channels; and (ii) this 
responses are able to propagate to the Kolliker’s organ and trigger Ca2+ waves that 
release ATP to the extracellular space (Figure 5.1). 
The ATP-induced Ca2+ waves after hair cell death are known to activate intracellular 
signaling cascades that may promote cell survival [37, 69]. Because TRPA1 activation 
can trigger ATP-dependent Ca2+ waves, it is possible that similar –if not the same– 
signaling pathways are activated. Of note, Hensen’s cells might exert anti-inflammatory 
actions by releasing into the extracellular space the contents of their lipid droplets, which 
are rich in the anti-inflammatory protein annexin A1 [61]. Perhaps, the long-lasting 
117 
 
increase in intracellular Ca2+ induced after TRPA1 activation of Hensen’s cells can 
activate the signaling pathways involved in the release of the lipid contents.  
 
 
Figure 5.1. Diagram of Ca2+ responses and their propagation after TRPA1 
stimulation in the cochlear epithelium 
Hensen’s cells seem to be the major sensors of oxidative damage in the 
cochlea. The TRPA1-mediated Ca2+ responses in Hensen’s cells can 
propagate toward the Kolliker’s organ (presumably involving the gap 
junctional conductance through Deiters’ and pillar cells) but do not 
propagate toward the Claudius’s cells. After making their way to the 
Kolliker’s organ, ATP-dependent self-propagating Ca2+ responses are 
elicited. Because extracellular ATP can activate TRPA1 channels 
downstream of P2Y receptor signaling, the release of ATP in the Kolliker’s 
organ could initiate secondary activation of TRPA1 channels. Deiters’ cells 
express TRPA1 channels and can respond to direct agonist stimulation. 
Pillar cells may also express TRPA1 channels despite our inability to evoke 
TRPA1 responses in these cells during whole-cell patch clamp experiments.  
 
The activation of TRPA1 channels in the cochlear epithelium after the stimulation 
with 4-HNE, a byproduct of oxidative tissue damage, indicates that TRPA1 channels 
behave as tissue damage sensors in the cochlea, similarly to their role in nociceptive 
neurons. TRPA1 channel activation in nociceptive neurons leads to membrane 
depolarization and triggers action potentials that result in the sensation of pain. ‘Ear pain’ 
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is generated by the activation of nociceptive neurons innervating the outer and middle ear 
since the inner ear is not considered to have nociceptive innervation. Cochlear supporting 
cells do not trigger action potentials; instead, TRPA1 activation leads to an increase in 
cytosolic Ca2+ that might activate several signaling cascades. The signaling cascades 
activated after TRPA1 gating in cochlear supporting cells might be similar to those 
observed in TRPA1-expressing non-neuronal cells (e.g., epithelial and smooth muscle 
cells in the lung). In particular, the A549 cell line derived from human lung epithelial 
cells shows a robust increase in the phosphorylation of ERK1/2 and Akt2 after TRPA1 
stimulation with mustard oil [306]. Similar, results were obtained in HEK-293 cells 
transfected with human or mouse TRPA1 [306]. Therefore, activation of TRPA1 
channels in the inner ear might trigger pro cell-survival signaling cascades similar to 
those activated by extracellular ATP (i.e. involving ERK1/2 phosphorylation). 
In this study, however, we did not pursue the changes in cell signaling cascades after 
TRPA1 activation. Instead, we decided to study the effect of TRPA1 activation in the 
mechanical properties of the cochlear epithelium. This approach was considered after 
noticing that TRPA1 activation induced prominent tissue displacements observed during 
bright field imaging. 
 
5.2 TRPA1 activation induces changes in the geometry of the cochlear epithelium 
The TRPA1-mediated Ca2+ responses described above led to a slow but prominent 
movement within the cochlear epithelium. Because the tissue displacements involved 
changes in a three-dimensional (3D) fashion, they were hard to study through imaging 
obtained from a 2D plane. Luckily, when the direction of the tissue movement was 
aligned with the focal plane that was being imaged, we noticed prominent cell 
contractions in the pillar cells and Deiters’ cells.  
Flash photolysis of caged Ca2+ led to long-lasting contractions in outer pillar cells, 
indicating that these cells possess Ca2+-dependent contractile machinery. The phalangeal 
processes of Deiters’ cells have been reported to exhibit mechanical responses after an 
increase in intracellular Ca2+ [56, 57]. Therefore, outer pillar cells together with Deiters’ 
cells might contribute to the TRPA1-dependent tissue movements observed. However, 
we believe we are the first to show that pillar cells in the organ of Corti possess Ca2+-
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dependent contractile machinery. Notably the phalangeal processes of Deiter’s cells and 
the stalks of pillar cells possess a cytoskeleton rich in microtubules and actin filaments 
(reviewed in [32]). To understand the machinery driving the Ca2+-dependent changes in 
cell shape, future studies could evaluate TRPA1-dependent tissue displacements in the 
presence of pharmacological treatments that modify the cytoskeleton dynamics. In 
particular, several drugs that enhance or inhibit the polymerization of actin filaments o 
microtubules have been shown to modify the stiffness of cochlear pillar cells [307]. 
Moreover, an inhibitor of myosin II was able to both increase and decrease –depending 
on the developmental age– the stiffness of pillar cells [307]. 
In an attempt to ‘quantify’ the magnitude of the TRPA1-induced tissue displacements, 
we tried to perform an optical flow analysis of the bright field time-lapse image 
sequences. This type of analysis measures the relative motion of specific pixels within a 
sequence of images, and it is often used to track the movement of edges and objects. The 
analysis was performed with the collaboration of Dr. Brandon K. Fornwalt and Dr. 
Jonathan Suever from the Department of Physiology at the University of Kentucky. 
Unfortunately, we were unable to track the changes in cell shape with this technique. The 
major problem arises from the assumption that the pixels to be tracked will not exhibit 
significant changes in grayscale values over time. However, changes in the shape of cells 
alter the light scattering pattern in the image, which results in prominent changes in pixel 
value intensity (Figure 5.2). To overcome the problem of pixel value changes for optical 
flow analysis, we would need to perform significant modifications to existing algorithms.  
120 
 
 
Figure 5.2. Tissue movement during bright field imaging leads to changes in 
pixel intensity values 
A, Bright field image showing an example of a region within the cochlear 
epithelium where tissue displacements were evaluated after puff stimulation 
with TRPA1 agonists. The white arrow indicates the position and direction 
of puff application. B-C, Sub-region from the image in A (indicated by the 
dashed window) is shown at a higher magnification and from three different 
time points (B-C) during the time lapse imaging. Yellow arrows indicate 
areas where cell contractions led to changes in pixel intensity values 
between frames (compare arrows in panel C, with the corresponding pair in 
either B or D).  
 
A simpler approach we used to detect the presence of tissue movements by subtracting 
frames taken 10 s apart. This analysis is sensitive to both pixel movement as well as 
changes in pixel value. It revealed two distinct peaks in the average trace for 4-HNE-
induced movement from the wild type explants (Figure 4.19C, top). Due to the type of 
analysis used, a second peak could simply represent the time point when the tissue is 
recovering toward its original shape. However, the study of the individual bright field 
recordings showed that, in some explants, the 4-HNE-induced movements occurred 
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several minutes after the puff stimulation (i.e. near the end of the recording) (data not 
shown). Therefore, the second peak observed in Figure 4.19C (top) indicates the average 
time point where the movement occurred in the explants that exhibited a delay.  
To fully understand which cell types are involved and what type of changes (e.g., 
elongation vs. contraction) orchestrate the tissue displacements triggered after TRPA1 
stimulation, we believe that the imaging technique used needs to provide information in 
4D (x, y, z and time). Using a cell-membrane dye (CellMaskTM, Molecular Probes) we 
successfully labeled the plasma membrane of hair cells and supporting cells within the 
cochlear epithelium (Figure 5.3).  
 
 
Figure 5.3. Labeling of cell membranes in the cochlear epithelium for 3D 
imaging reconstruction 
A, Representative 3D view of a cochlear explant labeled with the plasma 
membrane dye CellMaskTM. B, An orthogonal view from the tissue shown in A. 
C, Diagram illustrating the cell types observed in the image from B.  
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Using a spinning disc confocal microscope (section 3.3.3) for the time-lapse imaging, 
we were able to obtain 3D stacks every ~ 3-5 s. The stacks consisted of 5 to 10 confocal 
images acquired every 3 µm. Because the TRPA1-induced tissue displacements are slow, 
we believe this imaging speed is sufficient for the study of this type of movements. 
However, this type of labeling seemed to compromise the integrity of the plasma 
membrane and caused cell death in some sensory and supporting cells during the puff 
application of 4-HNE. As an alternative, 4D imaging could be performed using tissue 
from the mT/mG mouse, a reporter mouse that exhibits ubiquitous expression of a 
membrane-targeted fluorescent marker. In fact, this mouse was recently used to study the 
architecture of live cochlear epithelium via 3D image stacks [308]. In a future study, we 
consider collaborating with Dr. Anthony Ricci (Stanford School of Medicine) to cross the 
mT/mG transgenic mice with our TRPA1-deficient mice, in order to study the TRPA1-
mediated shape changes in the organ of Corti of older mice. 
In the adult cochlear epithelium, the heads of inner and outer pillar cells are in close 
contact while their feet are separated at the basilar membrane. This ‘triangular’ 
orientation of the pillar cells forms the tunnel of Corti, a fluid-filled space between the 
rows of inner and outer hair cells. Regardless of the type of movement induced by 
TRPA1 stimulation, it is clear that any changes in the shape of pillar cells can potentially 
modify the entire geometry of the organ of Corti (Figure 5.4).  
As a consequence, the resting angle between the OHC stereocilia and the tectorial 
membrane (Figure 1.4) might change, and this would have an impact on hearing 
sensitivity.  
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Figure 5.4. Changes in pillar cell shape can alter the geometry of the organ of 
Corti 
Diagram illustrating how the changes in the shape of pillar cells can alter the 
angle between the reticular lamina and the tectorial membrane. This change in 
the tissue geometry would modify the angles between the OHC stereocilia and 
the tectorial membrane during sound stimulation. Consequently, changes in 
pillar cell shape would alter the hearing sensitivity. 
 
5.3 TRPA1-mediated inhibition of cochlear amplification 
After acoustic trauma, ATP is released into the cochlear fluids [68] and reactive 
oxygen and nitrogen species are generated in the cochlear epithelium [284, 285]. 
Therefore, noise exposure could lead to the activation of cochlear TRPA1 channels either 
through endogenous agonists or downstream of P2Y receptor activation (manuscript in 
preparation, Vélez-Ortega AC, et al., see Appendix D for details). 
We showed the contraction of pillar cells in response to puff application of TRPA1 
agonists or ATP. The release of ATP into cochlear fluids may mediate changes in pillar  
and Deiters’ cell shape during and immediately after the noise exposure. In contrast, the 
byproducts of oxidative stress could continue to activate TRPA1 channels and lead to the 
changes in pillar cell shape for several days after the acoustic trauma. 
As reviewed in section 1.9, noise exposure is known to cause changes in the 
architecture of the organ of Corti. However, whether these changes were simply the result 
of mechanical damage or were driven by active changes in the shape of some cells was 
unknown. Here we propose that acoustic overstimulation leads to TRPA1-mediated Ca2+-
dependent changes in the shape of pillar and Deiters’ cells that can potentially alter the 
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entire geometry of the cochlear epithelium. Interestingly, a reduction in cochlear 
microphonics (i.e. an alternative method to test the cochlear sensitivity) has been shown 
to correlate with changes in the shape of cochlear supporting cells after acoustic 
overstimulation [85]. We found that wild type mice have a delayed recovery of hearing 
sensitivity after noise exposure when compared to Trpa1–/– mice. And we believe this 
reduction in hearing sensitivity results from the TRPA1-initiated changes in the geometry 
of the organ of Corti. Therefore, TRPA1 activation in cochlear supporting cells could be 
one of the mechanisms driving the development of TTS via the changes in the geometry 
of the organ of Corti. 
We propose a model where noise exposure leads to the activation of the cochlear 
TRPA1 channels through two different pathways (Figure 5.5). During noise exposure, the 
ATP that is acutely released into the cochlear fluids could activate TRPA1 channels 
downstream of the P2Y receptors. TRPA1 activation may result in changes in the 
geometry of the organ of Corti that would decrease hearing sensitivity and provide some 
degree of protection to the cochlear sensory epithelium. For instance, a reduction in 
glutamatergic excitotoxicity would result in a lesser degree of postsynaptic afferent 
terminal retraction from the IHC. The loss of this TRPA1-mediated protection could 
explain why immediately after noise exposure Trpa1–/– mice exhibited higher hearing 
thresholds than wild type mice.  
OHC electromotility via the piezoelectric behavior of prestin in the plasma membrane 
constitutes the cochlear amplifier. Given that TRPA1 channels are expressed in OHC 
[286], TRPA1 activation during noise exposure could also modulate hearing sensitivity 
by exerting a direct effect on prestin function. However, we did not observe Ca2+ 
responses in OHCs after puff application with any of the TRPA1 agonists tested. 
Nevertheless, it is necessary to study the impact of TRPA1 activation on OHC 
electromotility to fully understand its contribution in the differences that we observed 
between wild type and Trpa1–/– mice during and immediately after noise exposure. 
While the release of ATP into cochlear fluids might be an acute phenomenon after 
noise exposure, the generation of reactive oxygen species after acoustic overstimulation 
can last for several days or weeks [285]. During this period of time, TRPA1 channels 
would continue to be activated, for example, by lipid peroxidation byproducts like 4-
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HNE. This long-lasting activation of TRPA1 channels might maintain a modified 
geometry of the organ of Corti and explain the longer-lasting TTS that we observed in 
wild type mice.  
 
 
Figure 5.5. TRPA1 activation after ATP release or 4-HNE production in the 
cochlea modulates hearing thresholds 
Diagram illustrating representative changes in hearing thresholds for wild type 
(black) and Trpa1–/– mice, and the two pathways that could activate TRPA1 
channels after noise exposure. The acute release of ATP into the cochlear 
fluids could initiate the changes in tissue geometry during the noise exposure 
and limit the damage-induced increase in hearing threshold. Later, the chronic 
exposure to byproducts of oxidative tissue damage, like 4-HNE, might 
maintain the tissue with the modified geometry for days after the acoustic 
trauma. This long-lasting inhibition of cochlear amplification might protect 
from damaging loud sounds while the organ of Corti structures are repaired. 
 
Further studies could be designed, using multiple noise exposure protocols, to test 
whether TRPA1-mediated changes in hearing sensitivity in fact protect against noise-
induced hearing loss. We tried a couple of protocols with noise exposure at 2 or 3 
different time points. However, 2 weeks after the last episode of noise exposure, all mice 
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exhibited high levels of PTS across most frequencies tested. We believe that, for multiple 
noise exposures, it will be necessary to decrease the magnitude of the noise used. 
Moreover, we evaluated hearing thresholds 2 weeks after the noise exposure to assess for 
the development of permanent threshold shifts (PTS) after noise exposure. We now 
believe that it would appropriate to continue measuring the recovery of hearing 
thresholds for longer time points (e.g., 4 to 6 weeks after noise exposure) to better 
estimate the development of PTS. Additionally, it would be interesting to test whether 
exposure to low noise makes Trpa1–/– mice more susceptible to develop age-related 
hearing loss. Similarly, it has not been reported whether patients suffering from the 
familial episodic pain syndrome due to a gain-of-function mutation in TRPA1 channels 
exhibit elevated hearing thresholds or perhaps age-related hearing loss [103]. To this 
date, there is only one human pedigree reported to carry mutations in the TRPA1 gene. 
Interestingly, these individuals are from a small region near my hometown in Colombia 
and I am quite familiar with one of the groups involved in the original report of the 
mutation: the Molecular Genetics group from the University of Antioquia (Colombia) led 
by Dr. Grabiel Bedoya. I performed the research for my Master’s degree in the same 
institution –and the exact same building– where this group is located which might 
facilitate future collaborations. Initially we could perform hearing tests in all members of 
this pedigree and establish whether carriers of the mutation exhibit higher hearing 
thresholds than age-matched non-carriers within the same family. 
 
5.4 Closing remarks 
In summary, in this study I have demonstrated that: 
i) TRPA1 agonists, including the endogenous byproducts of oxidative stress, evoke 
robust and long-lasting Ca2+ responses in Hensens’ cells; 
ii) these responses are able to propagate to the Kolliker’s organ and trigger Ca2+ waves 
that release ATP to the extracellular space; 
iii) the propagation of Ca2+ waves is accompanied by prominent tissue displacements 
originated at pillar and perhaps Deiters’ cells; 
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iv) pillar cells possess active Ca2+-dependent contractile machinery that could change 
the geometry of the organ of Corti and regulate hearing sensitivity during and long after 
noise exposure; and 
v) the hearing thresholds of TRPA1-deficient mice are indeed more susceptible to 
acoustic trauma during noise exposure and show a decrease in the long-lasting temporal 
shift of hearing thresholds due to, we believe, the loss of the protective component in this 
threshold shift. 
To the best of our knowledge, all of these results are novel and represent a hitherto 
unknown mechanism of cochlear regulation after noise exposure. 
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APPENDIX A 
 
 
List of syndromes associated to mutations in human TRP genes with their respective 
entry numbers in the Online Mendelian Inheritance in Man (OMIM) catalog (i.e. MIM 
numbers). The OMIM catalog can be accessed at http://www.omim.org. 
 
AD  Autosomal dominant 
AR  Autosomal recesive 
Ref.  References 
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TRP 
gene 
Syndrome Inheritance 
MIM 
number 
Ref. 
TRPA1 Familial episodic pain syndrome AD 615040 [103] 
TRPC6 
Focal segmental glomerulosclerosis 
2 
AD 603965 [112, 113] 
TRPM1 
Congenital stationary night 
blindness type 1C 
AR 613216 [118-121] 
TRPM2 
Coding SNP associated with 
bipolar disorder  
 609633 [123] 
TRPM4 
Progressive familial heart block 
type 1B 
AD 604559 [128-130] 
TRPM6 
Hypomagnesemia with secondary 
hypocalcemia 
AR 602014 [135, 136] 
TRPM7 
Susceptibility to amyotrophic 
lateral sclerosis- Parkinsonism/ 
dementia complex  
 105500 [138] 
TRPML1 Mucolipidosis IV  AR 252650 [143, 144] 
TRPP1 
Polycystic 
kidney disease  
AD 613095 
Reviewed 
in [146] 
TRPV3 Olmsted syndrome  AD 614594 [152] 
TRPV4 
Brachyolmia type 3 AD 113500 [159] 
Digital arthropathy-brachydactyly  AD 606835 [162, 163] 
Metatropic dysplasia  AD 156530 
[161, 309, 
310] 
Charcot-Marie-Tooth neurophathy 
type 2C 
AD 606071 [164-167] 
Congenital nonprogressive distal 
spinal muscular atrophy 
AD 600175 [164] 
Scapuloperoneal spinal muscular 
atrophy 
AD 181405 [164, 165] 
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Parastremmatic dwarfism  AD 168400 [160] 
TRPV4  
Maroteaux spondyloepiphyseal 
dysplasia 
AD 184095 [160] 
Kozlowski spondylometaphyseal 
dysplasia 
AD 184252 [161] 
Coding SNP associated with 
hyponatremia 
 613508 [168] 
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APPENDIX B 
 
 
Protein BLAST: Sequence alignment between the human (top, UCSC ID: uc003xza.3) 
mouse (bottom, UCSC ID: uc007ajc.1) and rat (UCSC ID: RGD_1303284) TRPA1 
proteins. There percentage of identity between ortholog pairs and the percentage of 
coverage for each alignment are shown below: 
 
% identity (including gaps)  % coverage (of both) 
 Human Mouse Rat   Human Mouse Rat 
Human --- 80.2 80.1  Human --- 99.5 99.5 
Mouse  --- 96.7  Mouse  --- 99.9 
Rat   ---  Rat   --- 
 
| Identical amino acid residues 
+ Similarly charged amino acid residues 
– Gap inserted in the amino acid sequence 
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APPENDIX C 
 
 
Prediction of transmembrane domains in human (UCSC ID: uc003xza.3), mouse 
(UCSC ID: uc007ajc.1), and rat (UCSC ID: RGD_1303284) TRAP1 protens using the 
TMpred software (http://www.ch.embnet.org/software/TMPRED_form.html) [311] 
release 25 (which is based on the SwissProt database release 25). Windows of 14 to 33 
amino acid residues were used for the predictions. TMpred scores higher than 500 are 
considered significant (red dashed lines). 
TMpred compares an amino-acid sequence of interest to a database of naturally 
occurring transmembrane proteins. Sequence, hydrophobicity score, flanking regions, 
domain orientation, among others, are used for the comparisons and score calculations. 
Notice that, in addition to the six channel forming transmembrane segments (S1 to 
S6), a highly hydrophobic domain was predicted in the N-terminal region of human, 
mouse and rat TRPA1 proteins (roughly from amino acid residues 350 to 360). In 
addition, a hydrophobic domain was predicted in the C-terminal region of the human 
TRPA1 protein (around the amino acid residue 1020). These intracellular hydrophobic 
regions might constitute domains that closely interact with the plasma membrane. 
 
i-o  Inside (cytoplasmic) to outside (luminal) orientation 
o-i  Outside to inside orientation 
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APPENDIX D 
 
 
TRPA1 channels are activated downstream of ATP metabotropic P2Y receptors. 
These set of experiments were performed by Ruben Stepanyan, PhD, during his 
postdoctoral training in the Frolenkov laboratory.  
 
Current-voltage responses to 20 μM AITC (A) and 10 μM ATP (B) puff stimulation of 
HEK-293 cells transfected with a Trpa1-IRES-GFP construct (blue squares), a GFP-only 
construct (“mock”, black circles) or not transfected (black triangles). Insets show 
representative current traces to the puff stimulation with AITC or ATP. 
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2010-Present The Association for Research in Otolaryngology (ARO) 
 
2011-2014 American Association for the Advancement of Science (AAAS) 
 
2012-Present Biophysical Society 
 
2013-2014 Kentucky Physiological Society (KY-PHYS), American Physiological 
Society (APS) chapter 
 
 
Invited Seminars 
 
Nov/4/2007 “CD19 deficiency in humans: A Model for the Characterization of BCR-
mediated Signal Transduction in Human B cells”. Research Seminar. 6th Summer School 
in Primary Immunodeficiency Diseases. Miami, FL. 
 
Dec/14/2007 “X-linked susceptibility to mycobacteria is caused by mutations in the 
NEMO impairing CD40-dependent IL-12 production”. Short Research Seminar. 1st 
Update in Primary Immunodeficiencies, Minisymposium. Group of Primary 
Immunodeficiencies, University of Antioquia. Medellín, Colombia. 
 
May/8/2008 “About biomedical engineers and research”. Invited speaker, Ignacio 
Escobar Mejía Symposium. Biomedical Engineering Program, Antioquia School of 
Engineering (EIA), Colombia. 
 
Dec/12/2008 “Novel mutations in a Japanese patient with CD19 deficiency”. Short 
Research Seminar. 2nd Update in Primary Immunodeficiencies, Minisymposium. Group 
of Primary Immunodeficiencies, University of Antioquia. Medellín, Colombia. 
 
Dec/14/2011 “Do TRPA1-mediated responses in supporting cells protect the cochlea 
from noise damage?” Research Seminar. Physiology Department Seminar Series, 
University of Kentucky, Lexington, KY. 
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Oct/4/2012 “Studying the cellular and molecular mechanisms of hearing”. Research 
Seminar. Invited speaker, Biomedical Engineering Program, Antioquia School of 
Engineering (EIA), Colombia. 
 
Feb/25/2014 “TRPA1 channels regulate cochlear amplification”. Podium Presentation. 
ARO 37th Midwinter Meeting, San Diego, CA. 
 
Jul/12/2014 “TRPA1 channels in supporting cells regulate cochlear amplification”. 
Podium Presentation. Gordon Research Seminar, Bates College, Lewiston, ME. 
 
 
Published Abstracts (Poster Presentations) 
 
1. Moncada MA, Vélez-Ortega AC, Hershfield M, Orrego JC, Candotti F, Olivares M, 
Coll Y, Patiño PJ, Franco JL. Preferential expansion of T cells in a patient with severe 
combined immunodeficiency (SCID) due to adenosine deaminase (ADA). 2007. XII 
Latin American Group for Primary Immunodeficiencies (LAGID) Meeting. Sao Paulo, 
Brazil. Clinics, 62, Suppl: 2, S48.  
 
2. Vélez-Ortega AC, Rios NA, Patiño PJ, Orrego JC, Franco JL. Common variable 
immunodeficiecy (CVID): An update from the group of primary immunodeficiencies in 
Colombia. 2007. XII Latin American Group for Primary Immunodeficiencies (LAGID) 
Meeting. Sao Paulo, Brazil. Clinics, 62, Suppl: 2, S48. 
 
3. Vélez-Ortega AC, Moncada MA, Muñoz S, Patiño PJ and Franco JL. Differences in 
T-cell dependent B cell stimulation in common variable immunodeficiency (CVID) 
patients and healthy controls after allogenic stimulation. 2007. XII Latin American Group 
for Primary Immunodeficiencies (LAGID) Meeting. Sao Paulo, Brazil. Clinics, 62, 
Suppl: 2, S48. 
 
4. Vélez-Ortega AC, Moncada MA, Patiño PJ, Franco JL. Coestimulación T-
dependiente en la diferenciación del linfocito B en inmunodeficiencia común variable 
(IDCV). 2007. VI Congreso de Alergia, Asma e Inmunología. Medellín, Colombia. 
Revista de Inmunoalergia, May 2007, 100. 
 
5. Vélez-Ortega A, Cardona L, Moncada M, Franco J. Differences after heterologous 
T-cell dependent costimulation in B cells from common variable immunodeficiency 
(CVID) patients and healthy controls. 2008. Federation of Clinical Immunology Societies 
(FOCIS) Meeting. Boston, MA. Abst. #F.85. Clinical Immunology, 127 (S1), S71. 
 
6. Franco J, Moncada M, Vélez-Ortega A, Orrego J. Abnormalities in peripheral blood 
B cells in patients with hyperimmunoglobulinemia E syndrome (HIES). 2008. Federation 
of Clinical Immunology Societies (FOCIS) Meeting. Boston, MA. Abst. #F.86. Clinical 
Immunology, 127 (S1), S71. 
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7. Vélez-Ortega AC, Moncada MA, Cardona LF, Muñoz S, Franco JL. Defective T-
dependent costimulation of B cells in common variable immunodeficiency. 2008. XIIIth 
European Society for Immunodeficiencies (ESID) Meeting. 's-Hertogenbosch, The 
Netherlands. Clinical and Experimental Immunology, 154 (S1), 214. 
 
8. Franco JL, Moncada MA, Vélez-Ortega AC, Gómez-Rodriguez J, Dutra AC, Muñoz 
S, Orrego JC, Montoya J.  CD4 deficiency in a child with a congenital syndrome and 
recurrent infections. 2008. XIIIth European Society for Immunodeficiencies (ESID) 
Meeting. 's-Hertogenbosch, The Netherlands. Clinical and Experimental Immunology, 
154 (S1), 216. 
 
9. Ellis GI, Reneer MC, Vélez-Ortega AC, Norris A, Martí F. Control of human 
induced regulatory T cell differentiation by peroxisome proliferator activated receptor-γ 
through the endogenous synthesis of retinoic acid. 2010. 18th United European 
Gastroenterology Week (UEGW). Barcelona, Spain. Gut, 59, Suppl: III, A23. 
 
10. Vélez-Ortega AC, Indzhykulian AA, Sinha GP, Frolenkov GI. Imaging stereocilia 
links in live auditory hair cells. 2012. 56th Annual Meeting of the Biophysical Society. 
San Diego, CA. Abst. #3326-Pos. Biophysical Journal, 102 (3), Suppl:1, 655a. 
 
11. Vélez-Ortega AC, Belov O, Novak P, Rawashdeh SA, Sinha GP, Korchev YE, 
Frolenkov GI. High-Speed Hopping Probe Scanning Ion Conductance Microscopy. 58th 
Annual Meeting of the Biophysical Society. Abst. #4024-Pos. Biophysical Journal, 106 
(2), Suppl:1, 797a-8a. 
 
 
Other Abstracts (Poster Presentations) 
 
1. Kermicle MC, Vélez-Ortega AC, Martí F. Molecular mechanisms of pheripheral 
Treg development. 2008. 37th Autumn Immunology Conference (AIC). Chicago, IL. 
 
2. Vélez-Ortega AC, Kermicle MC, Daniel J. Estes, Michael Mayer, Martí F. 
Characterization of early TCR-signaling events in induced regulatory T cells. 2008. 37th 
Autumn Immunology Conference (AIC). Chicago, IL. 
 
3. Kermicle MC, Vélez-Ortega AC, Temprano J, Martí F. Role of PPARγ in the 
generation of peripherally-induced human suppressor T cells. 2009. Center for Clinical 
and Translational Science (CCTS) Spring Conference. Lexington, KY. 
 
 
4. Vélez-Ortega AC, Kermicle MC, Norris A, Kiefer A, Estes DJ, Mayer M, Martí F. 
Rewiring the cell signaling network: A molecular strategy to control the functional 
plasticity of T cells. 2009. Center for Clinical and Translational Science (CCTS) Spring 
Conference. Lexington, KY. 
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5. Kermicle MC, Vélez-Ortega AC, Norris A, Gardner T, Temprano J, Martí F. Effects 
of hormonal intake on regulatory T cell development. 2009. 38th Autumn Immunology 
Conference (AIC), Chicago, IL. 
 
6. Vélez-Ortega AC, Stepanyan R, Indzhykulian A, Frolenkov GI. TRPA1-mediated 
damage sensing in the inner ear. 2011. Association for Research in Otolaryngology 
(ARO) 34th Midwinter Meeting. Baltimore, MD. Abst. #943. 
 
7. Sinha G, Vélez-Ortega AC, Frolenkov G. Scanning ion conductance imaging of 
highly convoluted nanoscale structures at the surface of living cells: adaptive approach 
curve analysis. 2011. 55th Annual Meeting of Biophysical Society. Baltimore, MD. Abst. 
#4416. 
 
8. Moncada-Vélez M, Vélez AC, Rojas J, Prando C, Marín N, Montoya JH, Gómez-
Rodríguez J, Dutra A, Orrego JC, García LF, Boisson-Dupuis S, Casanova JL, Franco JL. 
Immunodeficiency associated to a germline mutation in the human CD4 gene. 2011. 2nd 
The Latin American Society for Immunodeficiencies (LASID) Meeting. Mexico City, 
Mexico.  
 
9. Vélez-Ortega AC, Stepanyan R, Sinha GP, Frolenkov GI. Does oxidative stress 
generate distinct types of calcium waves in the supporting cells of the organ of Corti? 
2012. Association for Research in Otolaryngology (ARO) 35th Midwinter Meeting. San 
Diego, CA. Abst. #141. 
 
10. Vélez-Ortega AC, Indzhykulian AA, Sinha GP, Frolenkov GI. Time-lapse nanoscale 
imaging of stereocilia in live auditory hair cells using hopping probe scanning ion 
conductance microscopy. 2012. Biophysical Society Kentucky Regional Networking 
Meeting, Bluegrass Molecular Biophysics Networking Symposium. Lexington, KY. 
 
11. Vélez-Ortega AC, Indzhykulian A, Frolenkov GI. Stereocilia tenting is present in 
live hair cells and involves remodeling of the actin core. 2013. Association for Research 
in Otolaryngology (ARO) 36th Midwinter Meeting. Baltimore, MD. Abst. #466.  
 
12. Vélez-Ortega AC, Maimaiti S, Stepanyan R, Frolenkov GI. TRPA1-mediated 
damage sensing by the cochlear supporting cells. 2013. Kentucky Physiological Society 
(KY-PHYS) Inaugural Meeting, a Chapter of the American Physiological Society (APS). 
Lexington, KY. Abst. #30. 
 
13. Syam D, Alexander AJ, Velez-Ortega C, Sinha GP, Frolenkov GI. Does Myosin-
XVa deficiency result in constitutively open mechanotransduction channels? 2013. 
Kentucky Physiological Society (KY-PHYS) Inaugural Meeting, a Chapter of the 
American Physiological Society (APS). Lexington, KY. Abst. #37. 
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14. Syam D, Alexander AJ, Velez-Ortega C, Sinha GP, Frolenkov GI. Degeneration of 
cochlear outer hair cells in the mouse model of non-syndromic deafness DFNB3. 2013. 
8th Annual Center for Clinical and Translational Science (CCTS) Spring Conference. 
Lexington, KY. 
 
15. Syam D, Alexander AJ, Velez-Ortega C, Sinha GP, Frolenkov GI. Does sustained 
activation of mechanotransduction channels result in stereocilia degeneration in the 
mouse model of non-syndromic deafness, DFNB3? 2013. Kentucky EPSCoR Annual 
Conference. Louisville, KY. 
 
16. Vélez-Ortega AC, Edelmann SE, Park C, Stepanyan R, Kwan KY, Sinha GP, Corey 
DP, Frolenkov GI. TRPA1 channels regulate cochlear amplification. Gordon Research 
Conference in Auditory System. 2014 in Bates College, Lewiston, ME.  
 
 
Podium Presentations 
 
1. Vélez-Ortega AC, Edelmann SE, Park C, Stepanyan R, Kwan KY, Sinha GP, Corey 
DP, Frolenkov GI. Supporting cells sense noise-induced damage via TRPA1 channels 
and protect the cochlea by actively changing the geometry of the organ of Corti. ARO 
37th Midwinter Meeting. 2014 in San Diego, CA. 
 
2. Vélez-Ortega AC, Edelmann SE, Park C, Stepanyan R, Kwan KY, Sinha GP, Corey 
DP, Frolenkov GI. TRPA1 channels regulate cochlear amplification. Gordon Research 
Seminar in Auditory System. 2014 in Bates College, Lewiston, ME.  
 
 
Published Manuscripts  
 
1. Mocada-Vélez M, Vélez-Ortega A, Orrego J, Santisteban I, Jagadeesh J, Olivares M, 
Olaya N, Hershfield M, Candotti F, Franco J. Somatic mosaicism due to monoallelic 
reversion of a homozygous mutation in T cells of a patient with Severe Combined 
Immunodeficiency due to Adenosine Deaminase Deficiency. Scand J Immunol. 2011; 74 
(5): 471-81. 
 
2. Reener MC, Estes DJ, Vélez-Ortega AC, Norris A, Mayer M, Marti F. Peripherally 
induced human regulatory T cells uncouple Kv1.3 activation from TCR-associated 
signaling. Eur J Immunol. 2011; 41 (11): 3170-5.  
 
3. Stepanyan R, Indzhykulian AA, Vélez-Ortega AC, Boger ET, Steyger PS, Friedman 
TB, Frolenkov GI. TRPA1-mediated accumulation of aminoglycosides in mouse cochlear 
outer hair cells. J Assoc Res Otolaryngol. 2011; 12 (60): 729-40. 
 
4. Ellis GI, Reneer MC, Vélez-Ortega AC, Norris A, Martí F. Generation of induced 
regulatory T cells from primary human naïve and memory T cells. J Vis Exp. 2012; (62): 
e3738.  
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5. Vélez-Ortega AC*, Temprano J*, Reener MC, Norris A, Marti F. Enhanced capacity 
to generate suppressor T cells associated with improved asthma symptoms in patients 
taking oral contraceptive treatment. J Asthma. 2013; 50(3): 223-30. 
 
6. Vélez AC*, Castaño DM*, Patiño PJ, Gómez RD, Orrego JC, Moncada MA, Cardona 
LF, Franco JL. Common variable immunodeficiency: clinical and immunological 
characterization of patients and homogeneous subgroup definition by means of B 
lymphocyte subpopulation typing [Article in Spanish]. Biomédica. 2015; 35(1): (in 
press). 
 
 
Pending Manuscripts 
 
1. Vélez-Ortega AC, Stepanyan R, Edelmann SE, Park C, Kwan KY, Sinha GP, Corey 
DP, Frolenkov GI. TRPA1 channels in supporting cells of the inner ear regulate cochlear 
amplification. (To be submitted) 
 
2. Vélez-Ortega AC, Indzhykulian AA, Frolenkov GI. Stereocilia tip remodeling in 
mammalian auditory hair cells. (In preparation) 
 
3. Vélez-Ortega AC, Moncada-Vélez MA, Cardona LF, Muñoz S, Orrego JC, Franco 
JL. Evaluation of the T-dependent costimulation in B cells from patients with common 
variable immunodeficiency. (In preparation) 
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